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Abstract 
Intestinal cancer is a leading cause of death, and epidemiological studies associate high intakes 
of fruits and vegetables to reduced risk of the disease.  
This study investigated the effects of carrot consumption on intestinal tumourigenesis in the 
Apcmin/+mouse model, homologous to the human Familial Adenomatous Polyposis mutation. 
Mice were fed either standard RM3 mouse feed (control) or diets enriched with 20% freeze-
dried carrot powder prepared from blanched carrots. In Experiment 1, both diets were fed as 
pellets, manufactured by SDS Diets by mixing, extruding and drying at 90-120oC for 20-30 
minutes, while in experiment 2; both diets were fed to the mice as unprocessed powder. Dams 
were fed either carrot enriched or control diets from two weeks prior to mating with Apcmin/+ 
sires and throughout pregnancy and lactation. At weaning, all offspring were randomised to 
either carrot enriched diet or control diets. At 15 weeks post-natal, intestinal tumour number, 
size and location were recorded alongside body and organ weights. Using tissue from tumours 
and normal intestinal segments from min and wild-type mice in experiment 2, Total RNA was 
isolated, reverse transcribed and Real-time PCR performed, to assess expression of 6 potentially 
cancer related genes: Retinoid X receptor beta, (RXRb); Retinoid acid receptor alpha, (RARα); 
Cyclin D; ββ-Carotene 15,15-monooxygenese-1, (BCMO1); Cyclooxygenase-2, (COX-2); and 
Metrilysin-7, (MMP7). 
In experiment 1, consumption of carrot pellets post weaning increased total gut tumour number 
by 42% (P = 0.038) whereas in experiment 2, carrot powder feeding post weaning reduced the 
total gut tumour number by 21% (P = 0.037). The control diet tumour numbers did not differ 
between experiments and maternal/pre weaning diets did not affect tumour numbers in 
offspring significantly. Powdered diets did not affect expression of the measured genes. 
So while powdered carrot as expected reduced cancer severity, pellets had the opposite effect. 
According to Duan and Barringer, (2012) paper, using high temperature for drying of carrot 
causes formation of the volatile carcinogen furan, providing a possible explanation for this 
difference. 
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1 Chapter 1 Introduction 
1.1 Carrots 
Carrots (Daucas carota var. satirus) form a group of vegetables that have been widely studied 
because of their bioactive compound content. They belong to the Apiaceae family and are 
widely distributed in temperate regions (Zidorn et al., 2005). They are known to contain a 
number of bioactive compounds such as polyphenols, carotenoids and falcarinol-type 
polyacetylenes with many functional characteristics (antifungal, antiallergenic, cytotoxic,  anti-
platelet aggregation and anti-inflammatory) that suggest cancer preventive effects (Brandt et al., 
2004). These plant metabolites, modulate gene expression, epigenetic regulation, cell signaling, 
inflammation, antioxidant function, detoxification and immune function (Andarwulan et al., 
2012).  
 
1.1.1 Bioactive Compounds 
Fruits and vegetables constitute the fundamental source of micronutrients, fibre, carotenoids 
and phytochemicals (Bernart et al., 1996; de Andrade Júnior and Andrade, 2014) which 
traditionally are of no nutritional significance but exert a biological effect. The characteristics 
of these compounds suggest health promoting effects thus making them the subject of 
epidemiological, clinical and experimental investigations. Many of such studies have examined 
the protective effects of fruits and vegetables in cardiovascular diseases (CVDs) and cancers 
(Kris-Etherton et al., 2002). A number of epidemiological studies consistently associated high 
intake of fruits and vegetables with reduced incidence of chronic diseases including cancer 
(Cook et al., 2013; Singh, 2013).   
These bioactive compounds show wide variations both in structure and function and are 
grouped as phenolic compounds , carotenoids and polyacetylenes (Kris-Etherton et al., 2002).  
 
1.1.2 Carotenoids  
1.1.3 Beta- carotene 
Beta-carotene, the most nutritionally active carotenoid constitutes about 15 – 30 % of the total 
serum carotenoids many of which are said to promote immune response, inhibition of 
mutagenesis, reduce induced nuclear damage and also provide protection against neoplastic 
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events in cells, tissues and whole animals. β-carotene prevents nuclear damage and has a 
chemo-preventive or chemo-protective function against cancer, especially skin cancer (Bendich 
and Olson, 1989; Krinsky, 1989). Prospective and retrospective epidemiological studies 
indicate an inverse relationship between serum β-carotene, associated with intake of fruits and 
vegetables high in carotenoids, and the risk of cancer development (Bendich and Olson, 1989).  
In spite of the evidence of anti-carcinogenic properties of β-carotene and other carotenoids, 
inconsistencies exist within the literature. Results of meta-analysis of data from alpha-
tocopherol, beta-carotene lung cancer prevention study (ATBC) by Albanes at al., (1996) 
suggest increased incidence of lung cancer with β-carotene (20mg) supplementation especially 
among heavy cigarette smokers and alcoholics whereas data from base line dietary and serum 
β-carotene concentration suggested protective effect. Furthermore, investigations into β-
carotene and Vitamin A supplementation by Omenn et al. (1996) in Beta-Carotene and Retinol 
Efficacy Trial (CARET) also suggested that β-carotene and vitamin A enhanced the incidence 
of lung cancer. In the CARET study individuals received β-carotene and Vitamin A 
supplements together thus there was distinction between the individual effects of β-carotene 
and vitamin A. Beta-carotene was also reported to accelerate the development of 7,12-
dimethyelbenz[a]anthracene (DMBA) 12-0-tetradecanoylphorbol-13-acetate (TPA) induced 
papillomas tumours in mice in a dose-dependent manner (Chen et al., 1993).  
The increased incidence of lung cancer associated with β-carotene supplementation was 
attributed to high blood β-carotene concentrations which was 17 fold higher than observed with 
dietary intake of β-carotene (Albanes et al., 1996). On the other hand the inverse association 
between dietary intake of β-carotene and lung cancer was probably not due solely to β-carotene 
considering the many different compounds present in plant diet, but possibly other compounds, 
acting as individuals or synergistically.(Bendich and Olson, 1989) . A Chinese intervention 
study of more than 29,500 adults between the ages of 40 and 69 years suggested that β-carotene 
supplementation in combination with vitamin E and selenium showed significant reduction in 
mortality as a result of reduced rates of stomach cancer (Blot et al., 1993).  This study like the 
previous ones could not associate the observed risk reduction wholly to beta-carotene.  
Anticancer activities of beta-carotene is effected through retinoic acid which inhibits tumour 
cell invasion and metastasis in a process mediated by retinoid X receptor and retinoic acid 
receptor (Dillard and Lane, 2007b; Pham et al., 2013). A study involving the examination of 
colonic biopsy specimens taken from patients with adenoma polyps before and after β-carotene 
supplementation showed that β-carotene inhibits colonic crypt cell proliferation.(Cahill et al., 
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1993). Animal model studies also suggest protective effects of β-carotene against colon cancer 
(Temple and Basu, 1987; Alabaster et al., 1995). Alabaster et al. (1995), fed rats high fat diets 
containing either high or low fibre and varying amounts of beta-carotene supplements and 
reported that beta-carotene significantly reduced aberrant crypt foci and tumour development.  
Temple and Basu (1987), tested the effect of beta-carotene enriched diet on 1, 2-
dimethylhydrazine induced intestinal tumourigenesis by varying amounts of beta-carotene in 
laboratory chow fed to female Swiss Webster mice. Feeding mice β-carotene significantly 
reduced adenomas and more significantly adenocarcinoma, suggesting that beta-carotene is 
most effective at preventing progression from adenoma to carcinoma. Though no clear  
mechanism of action was defined in these studies for β-carotene, it was believed that beta-
carotene acted either by preventing oxidative damage of cell membrane, DNA and other cell 
constituents or by enforcing ‘ immune response system in the colonic tissues (Temple and Basu, 
1987; Alabaster et al., 1995). Bendich and Olson (1989), also proposed that the protective 
mechanism of β-carotene could be by preventing free radicals from lipid peroxidation reactions 
therefore inhibiting damage of membranes, enzymes and nucleic acids. Other carotenoids that 
have been implicated in cancer risk reduction include lutein, lycopene and β-cryptoxanthin. 
 
1.1.4 Phenolic Compounds 
Polyphenols form an important health enhancing functional group of plant metabolites. They  
are found in many different plant species and vary widely in structure from C6 ring structure to 
highly polymerized forms such as tannins (Kris-Etherton et al., 2002). The high structural 
diversification coupled with variation in quantity makes accurate determination of dietary 
intake difficult. Their concentrations in foods are affected by a number of factors such as plant 
species, variety, light, the degree of ripeness, processing and storage (Duthie et al., 2000). 
Phenolic acid, flavonoids, stilbenes and lignans are the most commonly occurring polyphenols 
in plants. Flavonoids are the most abundant, forming 60 % of the highest occurring polyphenols 
with phenolic acids forming 30 % of dietary polyphenols. The most common phenolic acids in 
plants are derived from hydroxybenzoic acid (gallic acid, vanillic acid, procatechnic acid and 
syringic acid) and from hydroxy cinnamic acid (p-coumaric acid, caffeic acid and ferulic acid) 
(Nichenametla et al., 2006). They are associated with some plant properties such as colouring 
of the leaves and fruits to either attract or repel insects and also protect the plant against 
herbivores. They occur largely in fruits, vegetables, leaves, nuts, seeds, flowers and barks of 
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plants and are essential to the plant’s physiology in diverse functions such as structure, 
pigmentation, pollination, pathogen and predator resistance and growth and development 
(Dewick, 2011). Besides their physiological functions in plants, polyphenols produce beneficial 
health effects such as modulating gene expression, epigenetic regulation, cell signaling, 
inflammation, antioxidant function, detoxification and immune function in human (Andarwulan 
et al., 2012). It is believed that the disease prevention properties of fruits and vegetables are 
probably due to their polyphenol content and are associated with their antiviral, 
immunomodulatory, antibacterial, cytotoxic and antiproliferative properties (Rapta et al., 1995; 
Rice-Evans et al., 1996; Agullo et al., 1997). Acting as antioxidants, phenolic compounds 
prevent oxidative mechanisms that may lead to degenerative illness by reducing or donating 
hydrogen to compounds scavenging free radicals and quenching singlet oxygen (Çalişkan and 
Aytekin Polat, 2011). 
 One of the most studied polyphenol groups, flavonoids, are hypothesized to be responsible for 
the  protection against diseases such as cancer and cardiovascular diseases associated with fruits 
and vegetables (Prior and Cao, 2000). Several studies associate flavonoid consumption with 
reduced risk of certain types of cancer (Kris-Etherton et. al., 2002). Although some reports 
suggest in vitro mutagenicity of flavonoids, in vivo and other in vitro studies support their 
anticarcinogenic properties (Harborne, 1993).  
A Finish study of 9,959 subjects, suggest dietary intake of flavonoids significantly reduced the 
risk of lung cancer (Knekt et al., 1997). The study also observed a reduction in colorectal cancer 
risk though this was not significant.  The effect of flavonoid intake was attributed to quercetin 
which formed about 95 % of the flavonoids intake in the Finnish population (Knekt et al., 1997). 
Later, in vitro studies reported the induction of apoptosis in gastric cancer cells (BGC-823) 
(Wang et al. (2011) and in human breast cancer cells (MDA-MB-2) (Chien et al., 2009) treated 
with  quercetin. 
The health promoting properties of flavonoids is linked to their antioxidant activities which 
may be exhibited in many different ways: either by breaking the oxidation chain, recycling 
antioxidants (e.g. tocopherol), and preventing lipid peroxidation or by donating a hydrogen 
atom to the tocopherol molecule. They may also chelate pro-oxidant metal ions (iron, copper) 
preventing them from forming free-radicals while maintaining their own free-radical 
scavenging abilities (Kris-Etherton et. al., 2002).  
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Other phenolic compounds suggested to reduce cancer risk include curcumin (Kubota et al., 
2012) catechin (Epigallocatechin 3-Gallate) (Ju et al. (2005)) and isothiocyanate (sulforaphane) 
(Hu et al., 2006). 
Several in vitro investigations have investigated the antitumour characteristics of phenolic acids. 
Caffeic acid phenethyl ester (CAPE) was shown to significantly inhibit the invasion and 
metastasis of human fibrosarcoma cells (HT1080) by down regulating the expression of matrix 
metalloproteinase-2 (MMP-2) and -9 (MMP-9) (Hwang et al., 2006). Matrix metalloproteinases 
(MMPs) are zinc-dependent proteolytic endoenzymes that degrade extracellular matrix and 
facilitate tumour cell evasion and migration (Ellerbroek and Stack, 1999; Kleiner and Stetler-
Stevenson, 1999).  
By its cytotoxic effect, CAPE inhibited both in vitro and in vivo growth of tumour cells, 
angiogenesis, NF-kB 1 and 2 activity, induced apoptosis and caused cell cycle arrest at the S-
phase in MDA-231 and MCF-7 human breast cell (Wu et al., 2011). Deactivation of NF-kB 
resulted in increased apoptosis (Beg and Baltimore, 1996). 
In addition to the supporting evidence from in vitro studies, some in vivo evidence supports the 
anti-carcinogenic activities of phenolic acids. In rat model studies by Tanaka et al. (1993),  
chlorogenic and ferulic acids reduced preneoplastic tongue lesions. Caffeic acid was also shown 
to prevent the development of tongue neoplasms(Tanaka et al., 1993). CAPE, exhibiting its 
anti-proliferation properties reduced the development of azoxymethane induced aberrant crypts 
in rat colon (Borrelli et al., 2002). CAPE and curcumin reduced intestinal tumour formation by 
63 % in the Apcmin/+ mouse model, whereas CAPE reduced tumour formation at a dietary 
concentration  of 0.15 %, curcumin was effective at 0.1 % (Mahmoud et al., 2000). 
Nagaoka et al. (2003), tested the effect of CAPE on lung cancer metastasis in female Balb/C 
mice. CAPE was orally administered to the mice before and after intravenous inoculation with 
cultured colon 26-L5 carcinoma cells. Results showed inhibition of metastasis by a reduction 
in lung tumour weight and number of nodules by 50 %, suggesting chemotherapeutic properties 
of CAPE. The observed effect was probably due to cytotoxicity, growth inhibition or inhibition 
of cancer cell invasion. 
Whilst many studies suggest phenolic acids are anticarcinogenic, one reported carcinogenic 
properties. Lee et al. (2000b), observed that caffeic acid enhanced the development of stomach 
papillomas when fed to F344 rats over a two-year period in a multi-initiation model. 
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1.1.5 Polyacetylenes 
Polyacetylenes are chemically reactive compounds that are widely distributed in many plant 
families including Apiaceae (carrot/celery/parsley) and Araliaceae (aralia) (Hansen and Boll, 
1986; Christensen, 1992).   
Carrots are exclusively the main source of polyacetylenes in human diet (Kobæk-Larsen et al., 
2005) and  include, falcarinol, falcarindiol, falcarindiol-3 acetate, of which the most abundant 
and most biologically active is falcarinol (Hansen et al., 2003)  
Falcarinol type polyacetylenes (falcarinol, falcarindiol, falcarindiol-3 acetate) have been 
reported to have anti-inflammatory characteristics (Resch et al., 2001). These characteristics 
enable them to modify prostaglandin metabolism by inhibition of 15-hydroxyprostaglandin 
dehydrogenase (prostaglandin catabolising enzyme) and also to prevent the action of 
lipoxygenases (Christensen and Brandt, 2006). They are also known to inhibit diacylglycerol 
acyltransferase, nitric oxide synthase, cholesteryl ester transfer protein and microsomal and 
mitochondrial enzymes (Zidan et al., 2005). The activities of this enzyme are very significant 
in the growth and development of colorectal cancer. Increased expression of 15-
hydroxyprostaglandin dehydrogenase  reduces the level of prostaglandin E2 and the number of 
intestinal polyps in Apcmin+ mice (Backlund et al., 2005) Lipoxygenase like COX-2 is involved 
in the metabolism of polysaturated fatty acid, arachidonic and linoleic acid, the products of 
which are closely linked with carcinogenesis. Whilst the metabolic products of 5-, 8- and 12-
lipoxygenase  are thought to be procarcinogenic those of 15-lipoxygenase-1 and -2 are said to 
be anticarcinogenic (Shureiqi and Lippman, 2001). Induced nitric oxide synthase is involved in 
the production of nitric oxide which is genotoxic, causing DNA deamination and single strand 
breaks in the DNA (Felley-Bosco, 1998). The concentration of nitric oxide synthase correlates 
positively with tumour angiogenesis (Cianchi et al., 2003). According toAhn and Ohshima 
(2001), inhibition of nitric oxide synthase in Apcmin/+ mice significantly reduced the 
development of intestinal polyps. 
Falcarinol-type polyacetylenes, exemplified by falcarinol, have biphasic properties promoting 
cell proliferation in vitro when applied within a low concentration range of 0.01 to 0.05 µgml-
1 falcarinol, while inhibiting cell growth beyond 1 µgml-1 falcarinol with maximum inhibition 
of over  90 % at 10µgml-1 falcarinol (Hansen et al., 2003). In separate experiments, Young et 
al., (2007) and Purup et al., (2009) supported earlier findings that C17 aliphatic polyacetylenes 
have a hormesis effect when tested in cultures of human intestinal epithelial (FHs 74 Int) and 
cancer cells (CaCO-2). The ability of falcarindiol to inhibit intestinal cell proliferation was 
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significantly enhanced when applied at low concentration in combination with falcarinol 
suggesting  synergistic inhibitory effect (Purup et al., 2009) .  
In vivo studies involving falcarinol-type polyacetylenes confirm that falcarinol and some other 
plant metabolites hold the potential for the prevention and/or treatment of cancer in humans 
particularly colorectal cancer (Ju et al., 2005; Kobæk-Larsen et al., 2005; Purup et al., 2009). 
Kobaek-Larsen et al., (2005) investigated the effects of supplementing standard rat feed with 
purified falcarinol and freeze-dried carrot containing the equivalent falcarinol quantity on the 
development of azoxymethane (AOM) induced colon cancer in male BDIX rats. After 20 weeks 
of feeding, compared to mice fed a control diet those fed diets supplemented with both purified 
falcarinol and freeze-dried carrot had less (pre)-cancerous lesions.  Mice have the ability to 
detect and reject nutritionally inadequate diet and select for diets that support normal growth 
especially those with the complements of indispensable amino acids (IAAs) (Gietzen et al., 
2007). Freeze dried carrot supplementation provided dietary concentration of 35 µgfalcarinol/g 
which was considered as physiologically relevant as that was the amount of freeze-dried carrot 
(10 %) chosen by the rats when given free access to both freeze dried carrot and laboratory 
chow. This translates into 370 g cooked carrot in human diet which is just below the 
recommended minimum daily intake of 400 g suggested to reduce the risk of cancer (World 
Health Organisation, 2004). According to Gundgaard et al. (2003), daily vegetable intake of 
400 – 600 g  reduce cancer incidence by 19 and 32 %. 
 
1.2 Colorectal Cancer 
1.2.1 Epidemiology of Colorectal Cancer 
Colorectal cancer (CRC) is the third most common cancer in the world after lung and breast 
cancer. CRC accounts for 9.7 % of the global 14.1 million new cases of all cancers and is the 
third leading cause of cancer related death comprising 8.5% of 8.2 million deaths worldwide 
attributed to cancer in 2012.  Colorectal cancer accounted for approximately 10 % and 9.2 % 
of e new cancer cases in men and women respectively in 2012, making it the third most 
diagnosed cancer in men and the second in women (Ferlay et al., 2015).  
There is global disparity in the incidence and mortality rates of the disease.  Of the 1,233,700 
new cases reported in 2008, the highest diagnosis of 29.4 % and 14.4 % occurred in Eastern 
Asia and North America respectively. The incidence in Western Europe was 11.2 % whilst it 
was 10.5 % in Central and Eastern Europe.  Africa accounted for 2.8 % of the world total with 
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the highest and lowest diagnosis of 0.8 % and 0.2 % occurring in North and Middle Africa 
respectively. Except in South Africa and West Africa where estimated new cases decreased by 
3 and 4 % respectively, there was a general increase in diagnosis from 2008 to 2012. Also apart 
from North America where estimated new cases decreased by 5.6 % and South Eastern Asia 
where diagnosis appeared stable there was general increased in estimated diagnosis in the 
Americas and Asia. Increases in new cases over Europe was generally low compared to other 
regions of the world with rates ranging between - 0.5 % for Western Europe to 3.7 % for Central 
and Eastern Europe (Ferlay et al., 2010; Ferlay et al., 2015).  However, incidence rates are still 
high in the Czech Republic and Slovakia in Eastern Europe and Kuwait and Israel in Western 
Asia, areas hitherto considered as low risk areas. For example, males in the Czech Republic 
rank fourth in the world for CRC incidence with mortality to incident ratio of 0. 5. (Dusek et. 
al., 2015). These high rates have been attributed to the prevalence of risk factors such as 
physical inactivity, obesity, excessive alcohol intake and consumption of diets low in fruits and 
vegetables (Center et al., 2009; Dusek et. al., 2015). 
 In spite of the estimated new cases and deaths, incidence and mortality rates have been on the 
decline in the developed countries over the past two decades (American Cancer, 2015). 
Whereas about 55 to 60 % of estimated CRC new cases were reported in developed countries, 
most of estimated mortality occurred in less developed countries. These declining trends in 
developed countries could be accounted for by decrease in the prevalence of risk factors coupled 
with increased screening tests (colonoscopy and sigmoidoscopy) and removal of precancerous 
adenoma (Center et al., 2009; Edwards et al., 2010). 
Diagnosis of CRC cancer in individuals increases with age. More than 90 % of new cases were 
reported in people who are 50 years and above (American Cancer, 2015) with diagnosis over 
40-fold in people aged  60 and 79 years and above compared to those under 45 years (Society, 
2013). 
Also affecting the incidence rate of colorectal cancer is hereditary and medical history of 
individuals. Persons with chronic inflammatory bowel disease (ulcerative colitis and Crohn 
disease) are at a higher risk of developing the disease (Janout and Kollárová, 2001). In addition 
people whose close relations had CRC are more likely to develop the disease especially, if these 
relatives were diagnosed of the disease below 60 years of age (Boardman et al., 2007). 
Incidence and mortality rates worldwide were lower in women than in males, a phenomenon 
attributed to menopausal hormone therapy involving the use of oestrogen and progestin 
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especially in the developed world (Johnson et al., 2009). For instance in Europe 47 and 46 % 
of estimated new cases for 2008 and 2012 respectively were in women whilst in Asia the rate 
was 44.3 and 42.8 %. Of the estimated deaths in Europe for the same period 48 and 47.3 % 
occurred in women whilst 45.7 and 44.2 % respectively were in women (Ferlay et al., 2010; 
Ferlay et al., 2015).  
Migration is another contributing factor. Migrants from countries with low-incidence rates to 
industrialised high incidence rate countries show higher incidence of the disease compared to 
their relations in their home countries as a result of adaptation to westernised life styles of the 
host nations to underscore the importance of environmental influence in colorectal cancer risk 
(Curado et al., 2007). CRC incidence rate was also known to vary between ethnic groups within 
a population. For instance in Singapore, Chinese and Malay migrants showed different 
incidence rates (Lim et al., 2003) and in Israel, the Jews differ in incidence rates from the non-
Jew Arabs (Center et al., 2009). 
 
1.2.2 Aetiology of Colorectal Cancer 
The development of CRC is a multistep process which is developed over decades through an 
accumulation of genetic alterations in tumour suppressor genes, oncogenes and mismatch repair 
genes in individuals (Fearon and Vogelstein, 1990; Kinzler and Vogelstein, 1996b; Xu et al., 
2012). It is suggested that mutation in APC,  tumour suppressor gene and the loss of normal 
function is the initiating process of neoplastic transformation of normal epithelia cells to 
carcinoma(Kinzler and Vogelstein, 1996b). This dysregulates cell proliferation, and the 
progress of cellular transformation is enhanced by mutations of oncogenes (Fearon and 
Vogelstein, 1990) (Fig. 1.1) 
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Figure 1. 1 A model of genetic alterations from adenoma to carcinoma in Colorectal cancer 
development  (Smith et al., 2002). 
 
Whereas K-RAS is activated by allelic mutation, DCC and P53 are activated after mutation of 
the allelic pair (Fearon and Vogelstein, 1990). Other genes believed to be involved in the 
process are mismatch repair genes (hMSH2, hMLH1, hPMS1, hPMS1 or hPMS2) (Gryfe et al., 
1997). These genes enhance the rate of tumourigenesis in hereditary non-polyposis colorectal 
cancer patients whilst in familial adenomatous polyposis patients, tumour initiation is enhanced 
by mutation in APC gene (Lynch et al., 1996).  Although the genetic alterations of 
tumourigenesis occur in a  preferred order, the biological characteristics of the tumour is 
determined by the accumulated alterations and not order of mutational events (Fearon and 
Vogelstein, 1990). 
 Colorectal cancer may be classified into stages according to the severity of the disease thus 
making the stage of diagnosis critical for the survival of the patient. For example, five year 
survival for Duke’s stage A (Table 1.1) is over 90 % but it is 5 % for Duke’s stage D (Albert 
de la Chappelle, 2004). 
Other systems of tumour classification include Astler-Coller’s (Table 1.2) modification of 
Duke’s classification and the Tumour, Node and Metastasis (TNM) (Table 1.3).   
 
 
 
 
11 
 
Table 1. 1 Duke’s Stages of Colorectal Cancer 
Stage                                              Definition 
A Carcinoma limited to walls of rectum 
B Carcinoma spreads to extra rectal tissue but no nodal involvement 
C Lymph nodes involved 
D Distant metastasis 
    Source:  (Zinkin, 1983) 
 
Table 1. 2 Astler-Coller 
Stage        Definition 
A Tumours invade through the muscularis mucosa into the submucosa  
B1 Tumours invade into the muscularis propria 
B2 Tumours completely penetrate the smooth muscle layer into the serosa 
C Tumours encompass any degree of invasion but are defined by regional lymph 
node involvement 
C1 Tumours invade the muscularis propria with fewer than four positive nodes 
C2 Tumours completely penetrate the smooth muscle layer into the serosa with 
four or more involved nodes 
D Lesions with distant metastases  
     John Hopkins Colon cancer Centre 
 
 
 
 
 
 
 
 
 
 
12 
 
Table 1. 3: Tumour, Node, Metastasis (TNM) Staging System for Colorectal cancer 
T1 Tumour invades submucosa 
T2  Tumour invades muscularis propria 
T3 Tumour spreads through the muscularis into subserosa or in to 
the pericolic ornperirectal tissue 
T4 Tumour invades other organs or structures, and/or perforates 
Nodes 
N0 No regional lymph node metastasis 
N1 Metastasis in 1 to 3 
N2 Metastasis on 4 or more regional lymph nodes 
M0 No distance metastasis 
M1 Distance metastasis present 
Stage Groupings 
Stage T1 N0 M0: T2 N0 M0 
Cancer spread but still in 
inner lining 
Stage II T3 N0 M0: T4 N0 M0 
Cancer spreads to organs near 
colon or rectum but not in 
lymph nodes 
Stage III Any T, N1-2, M0 Cancer spread to lymph nodes 
only 
Stage IV T, Any N, M1 
Cancer spread through lymph 
to body, liver and lung 
(metastasis) 
Source:  http://www.healthcommunities.com/colon-cancer/staging.shtml#TNM (02/07/2015) 
 
1.2.3 Hereditary colorectal cancer  
Colorectal can be categorised as sporadic or familial. Familial CRC is reported to be responsible 
for between 15-30 % (De la Chapelle, 2004; Rustgi, 2007). 
Hereditary nonpolyposis colorectal cancer (HNPCC) forms about 3 – 4 % of familial CRC, 
while about 1 % of CRC cases are associated with familial adenomatous polyposis (FAP) and 
less than 1 % are associated with a number of conditions such as  hamartomatous polyposis 
syndrome, MYH-associated polyposis (MAP) and hyperplastic polyposis (Rustgi, 2007; Shen 
et al., 2007). 
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1.2.4 Hereditary Non-polyposis Colorectal Cancer (HNPCC)  
Hereditary non-polyposis colorectal cancer (HNPCC) – Lynch Syndrome, is an autosomal 
dominant disease defined by the development  of colorectal cancer at an early age and is 
associated with extra colonic tumours (endometrium, ovaries, stomach, small bowel, 
hepatobiliary epithelium, ureopithelia epithelium and brain tumours) and microsatellite 
instability (Umar et al., 2004; de la Chapelle, 2004). It is usually right sided and largely 
proximal colorectal cancer (Lynch and de la Chapelle, 2003). It is the most common hereditary 
disorder and has an early onset of about 45 years (Lynch and Lynch, 2000). The disease is 
caused by mutations in DNA mismatch repair (MMR) genes [(MutL homologue 1 (MLH1), 
MutS homologue (MSH2 MSH3, MSH6) ), (Prokaryotic  MutL gene homologue (PMS1 and 
PMS2), ),] and carriers of germline mutations in these genes have 80 % , 60% and 20 % life 
time risk of developing colorectal, endometrial and other forms of cancer respectively (De la 
Chapelle, 2004; Rustgi, 2007). Even though individuals may carry germline mutations in the 
mismatch repair genes, loss of heterozygosity is necessary for the development of  the disease 
and occurs by  somatic mutation either by MLH1, CpG island methylation or by deletion 
(Hemminki et al., 1994; Liu et al., 1995; Rustgi, 2007). In HNPCC mutations in MSHS6 have 
lower penetrance (proportion of individuals carrying a mutation and show phenotypic features 
associated with the mutation) relative to mutations in MLH1, MSH2 (Miyaki et al., 1997). 
MSH2 mutations are associated with higher-penetrance predisposition to extra colonic cancer. 
About 60 – 80% of germline mutations characterizing HNPCC could be associated with MLH1, 
MSH2 and MSH6 genes (Rustgi, 2007). Microsatellite instability involving MLH1 methylation 
alone accounts for nearly 15% of all colorectal (Umar et al., 2004).  
 
1.2.5 Familial Adenomatous Polyposis (FAP) 
FAP is an autosomal dominant disease characterized by the development of thousands of 
adenomatous polyps in the large intestine during the second and third decades of life of affected 
individuals. The disease is linked to germline mutations on chromosome 5q21 in the APC gene 
(Galiatsatos and Foulkes, 2006).  According to Knudson’s ‘two hit’ hypothesis, an inherited 
germline mutation of one allele is not enough to cause the disease suggesting that a second ‘hit’ 
somatic mutation of the wild-type is the rate-limiting step to FAP (Green et al., 1998). 
FAP accounts for about 1 % of the total colorectal cancer burden, affects 1 in 10,000 individuals 
and has close to 100 % penetrance (Lal and Gallinger, 2000). Individuals affected by FAP are 
14 
 
characterized with loss of heterozygosity (LOH) and development of  large number of 
colorectal adenomas at an average age of forty years (Nugent et al., 1994; Segditsas and 
Tomlinson, 2006). The disease is also associated by extra colonic manifestations, including 
upper gastrointestinal tract polyps, retinal lesions (congenital hypertrophy of retinal pigment 
epithelium – CHRPE), desmoids tumours, and brain osteoma. These extra colonic phenotypic 
features distinguish FAP patients based on the region of mutation in the APC gene (Kinzler and 
Vogelstein, 1996).  Individuals carrying mutations between codons 169–1,600 are generally 
associated with the development of develop 1000s or more adenomas. Whilst retinal lesions 
(CHRPE) are features associated with mutations between codon 463 – 1387 mutations between 
codons 1,403 and 1,578 referred to as Gardner’s syndrome lead to osteomas, skin fribromas 
and epidermoid cysts (Olschwang et al., 1993; Kinzler and Vogelstein, 1996b; De la Chapelle, 
2004). Mutations occurring before codon 157 are associated with the development of relatively 
fewer adenomas at a later age, an attenuated form of FAP (AFAP) (de la Chapelle (1999), 
Kinzler and Vogelstein (1996).  
 
1.2.6 Genomic Instability 
Genomic instability is fundamental to carcinogenesis and promotes accelerated genetic 
alteration for tumour formation (Matsubara, 2012). It is caused by a) mutation and/or altered 
methylation of regulatory genes (name genes) in the DNA repair system.  Genomic instability 
may be divided into 2 groups, each with a distinct developmental pathway, chromosomal 
instability (CIN) and microsatellite instability (MSI).  
 
1.2.7 Microsatellite Instability and Colorectal Cancer 
Microsatellites are repeats of simple DNA base pairs that occur abundantly and randomly 
throughout the human genome. It may consist of approximately 10 – 50 repeats of 1 – 6 bps 
that are normally relatively stable (Weber, 1990; Wheeler et al., 2000). These repeat sequences 
are usually transmitted without any alterations through the process of mitosis and meiosis 
(Thibodeau et al., 1993). Cytosine and adenine dinucleotide repeats are the most abundant 
microsatellite and are widely distributed in the human genome (Thibodeau et al., 1993). 
Microsatellite instability (MSI) thus refers to the situation where the base pair repeat sequence 
(microsatellite) undergoes  frequent change in length due to either deletion or insertion of 
repeated units (Wheeler et al., 2000; Söreide et al., 2006). In colorectal cancer MSI is 
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characterized by accumulation of germline mutations and hypermethylation in DNA mismatch 
repair (MMR) genes (MLH1, MSH2, MSH6, PMS1 and PMS2) and transforming growth factor 
β-type II receptor and BAX? (Lynch and de la Chapelle, 1999; Matsubara, 2012) These 
mutations and hypermethylation  result in the loss of DNA mismatch repair function (Sinicrope 
and Sargent, 2012) The errors most often encountered in microsatellite instability are base 
mismatches and insertion/deletions in DNA coding regions. This results in frameshift mutations 
and subsequent protein truncations and loss of MMR function (Sinicope and Sargent, 2012). 
Tumours in this pathway have diploid DNA and occur most in the right colon.  About 15 % and 
90 % of  sporadic colorectal cancer and HNPCC colorectal cancer respectively are caused by 
MSI (Umar et al., 2004; Söreide et al., 2006). 
In HNPCC, MSI is caused by germline mutations in one of three MMR genes (MLH1, MSH2, 
and MSH6) (Grady, 2004; Soreide et al., 2006). These germline predisposing mutations 
associated with MLH1 and MSH2 are either by missense, deletions or insertion. One wild-type 
allele is enough to maintain MMR activity. HNPCC kindreds exhibit loss of heterozygosity at 
the gene loci either due to germline mutation or somatic mutation of the remaining wild-type 
allele (Hemminki et al., 1994). This makes the lifetime risk of developing colorectal cancer in 
children of  HNPCC parents more than 80 % while the risk is about 6 % in general population 
(Schoen, 2002; Replication, 2003).  
In sporadic colorectal cancers, MSI is due to somatic inactivation of MMR genes, 
predominantly MLH1 (suggesting that MLH1 is more susceptible to somatic alterations). This 
is achieved by hypermethylation (epigenetic silencing) of CpG islands of the promoter region 
of MLH1 (Kane et al., 1997; Thibodeau et al., 1998).  
 
1.2.8 Chromosomal Instability (CIN) 
The second pathway, chromosomal instability (aneuploidy) (CIN), describes the frequent 
changes in the number and structure of the chromosome of cancer cells over time (Negrini et 
al., 2010a) and is characterized by systematic mutations or deletions of K-RAS, APC, P53 and 
DCC. CIN is the most common genomic instability (Negrini et al., 2010b) and occurs in about 
85 % colon tumours (Grady, 2004). 
Tumours associated with CIN possess aneuploid DNA, are left sided and invasive (De la 
Chapelle and Lynch, 1999 and Matsubara, 2012). CIN is linked to inactivation of regulatory 
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genes such as TP53, ataxia telangiectasia mutated (ATM) and ATM-related genes, and human 
homologue of budding uninhibited benzimidazole (BUB) at the mitotic-spindle check points 
during DNA replication. The protein products of these genes are known to be involved in sister-
chromatid separation at mitosis and induce cycle arrest at metaphase-anaphase when activated. 
The loss of normal function of these genes affects effective regulation of DNA replications 
which is necessary for maintenance of structural consistency) (Cahill et al., 1998; Grady, 2004; 
Negrini et al., 2010a).  
 
1.2.9 Epigenetics and Colorectal Cancer 
 Epigenetics refers to heritable chemical modifications of cytosine bases and histone proteins 
of the genome that do not affect the basic DNA sequence. These modifications are covalent 
methylation of cytosine and occurs predominantly in the CpG (cytosine , phosphoguanine ) 
dinucleotides of the DNA and post-translational modifications of histone such as acetylation, 
methylation, phosphorylation and ubiquitination (Bernstein et al., 2007). CpG Island is a short 
segment of DNA with a high concentration of cytosine-phosphoguanine nucleotides and is 
usually located in the promoter region (region of first exon) of the gene where DNA 
transcription is initiated. The cytosine bases in this region are often methylated, blocking 
transcription and therefore determine the expression/silencing of a gene. The addition of methyl 
group to cytosine is mediated by the enzyme, DNA-methyltransferase (DNMT) to form 5-
methylcytosine. Half of mammalian genes have CpG islands located in the promoter region and 
about 70 % of these CpG islands are unmethylated in normal cells. Methylation is  important 
in fundamental biological processes  such as imprinting, cell differentiation and silencing of the 
X chromosome throughout the lifecycle of a female mammal (Feinberg and Tycko, 2004; Jones 
and Baylin, 2007). According  to Knudson’s model, epigenetics provides an alternative pathway 
of inactivation of tumour-suppressor genes in carcinogenesis (Kondo and Issa, 2004). Aberrant 
DNA methylation patterns exhibited by cancer cells are usually global hypomethylation and 
concurrent hypermethylation of gene-specific promoter regions (Kanai and Hirohashi, 2007; 
Matsubara, 2012).  
 Gene inactivation/silencing mediated by CpG methylation may be explained by two 
mechanisms: 
1. Transcription repression is by methyl-CpG binding protein (MeCP-1) which limits access of 
transcription factors to promoter sites. Inactivation is due to exclusion of transcription factors 
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by MeCP-1 which are attached to the promoters in methylated-CpG Island (Boyes and Bird, 
1992b). Gene silencing is affected by the density of methylation. In high density methylation a 
stable interaction with the MeCP-1 is formed (Boyes and Bird, 1992a) leading to permanent 
silencing as in the X chromosome of the female mammal(Goel and Boland, 2012). 
2. The inhibition of the ability of transcription factors to bind to the methylated promoter sites 
for transcriptional activation (Kando and Issa, 2004).Methyl groups are covalently attached to 
the promoter sites of the CpG islands in a reaction catalysed by DNA-methyltransferase to 
prevent any interaction between the transcription factors and their DNA binding sites (Goel and 
Boland, 2012). 
Hypermethylation of CpG islands is associated with the transcriptional silencing of tumour 
suppressor genes (Jones and Takai, 2001) and is related to the microsatellite instability (MSI) 
pathway (mutated pathway) in colorectal carcinogenesis (Curtin et al., 2011; Matsubara, 2012). 
Tumours with widespread CpG island methylation constitute a subset of colorectal cancers 
referred to as CpG island methylator phenotype (CIMP)   and are distinguished by promoter 
CpG island methylation of MLH1. Other genes affected in CIMP include CDKN2A (p16), 
BRAF, KRAS, MINT (methylated in tumours) (Hughes et al., 2012; Matsubara, 2012). It was 
suggested that CIMP + occur most in the elderly, women, right colon and in the proximal colon 
position (Toyota et al., 2000; Hawkins et al., 2002). CIMP has further been classified as positive 
(CIMP+) or negative (CIMP-) depending on panel of markers adopted for their classification. 
These panels vary among authors leading to the classification of 24 % to 51 % of colorectal 
cancers as CIMP+. The most used markers however, include HLM1, p16, MINT1, MINT2 and 
MINT 31(Toyota et. al., 1999). Weisenberger et al. (2006), addressed the inadequacy associated 
with the earlier panel of markers by proposing CACNAIG, IGF2, NEUROGI, RUNX3, SOCSI 
as alternative markers. With these panels all CRC with BRAF mutation are defined as CIMP+.  
 
1.3 Tumour Suppressor Genes 
 
1.3.1 Adenomatous polyposis coli (APC) 
The APC gene encodes a multifunctional protein, 312 kDa in size with several proteins binding 
sites which enables it to regulate many processes including intercellular adhesion, and Wnt-
signaling pathway (Leslie et al., 2002; Aoki and Taketo, 2007). APC consists of 15 exons and 
is located on chromosome 5q21-q22. Most of the coding sequence occur in exon 15 and is often 
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the target of mutations (Béroud and Soussi, 1996; Brenner and Duggan, 2004). This is mutation 
cluster region (MCR) and contains over 90 % of mutations found in sporadic and familial 
cancers (Kinzler and Vogelstein, 1996a). Adenomatous polyposis coli (APC) gene functions as 
the “gate keeper” to colon tumorigenesis and its inactivation is considered the initiation of CRC 
(Smith et al., 1993; Swamy et al., 2006). Most of the tumours in colorectal cancer (FAP, 
HNPCC) carry mutations in APC gene, a negative regulator of the Wnt/β-catenin pathway (Liu 
et al., 1996) The majority of these mutations (insertions and deletions) affect the C-terminal of 
the protein leading to stabilization of β-catenin and its accumulation in the nucleus where it 
binds to transcription factor T-cell factor/lymphocyte and subsequently activate transcription 
of c-MYC, Cyclin D1, MMP7 and other Wnt target oncogenes (Sierra et al., 2006).   
The functional APC gene antagonizes the Wnt/β-catenin pathway (Giles et al., 2003) through 
the formation of a ‘destruction complex’ with, axin, glycogen synthase kinase 3 (GSK3) and 
casein kinase 1 (CK1) in the absence of Wnt/β-catenin signaling (Munemitsu et al., (1995). 
This ‘destructive complex’ targets β-catenin for proteasome degradation by phosphorylating its 
N-terminal.  
This regulatory role is realised by three different mechanisms:  
1. APC protein at the nuclear level binds to β-catenin (i.e. nuclear β-catenin) and prevents its 
interaction with transcription factor T-cell factor/ lymphocyte enhancer factor (TCF/LEF)to 
reduce the expression of β-catenin dependent genes Neufeld et al. (2000) and Hood and Silver 
(1999),  
2. The nuclear APC protein-β-catenin complex formed is exported into the cytoplasm where 
the β-catenin is degraded (Henderson, 2000; Neufeld et al., 2000; Rosin-Arbesfeld et al., 2000).  
The involvement of wild type APC in regulation of cell proliferation further suggests its role as 
a tumour suppressor gene. APC protein restricts cell cycle progression from G1 to S phase by 
interacting with CDK proteins. This restriction is however blocked or downregulated by over 
expression of CDK2 alongside cyclin E depending on the levels of their expression. In cells 
overexpressing APC protein, the activity of CDK2 is down regulated (Baeg et al., 1995). The 
pathway of this restriction was different from that of p53 and retinoblastoma protein. 
APC protein possess active β-catenin binding site which enables it to bind to and export β-
catenin from the nucleus to the cytoplasm for destruction or attached to E-cadherin and to 
adherens junctions where it functions in cell adhesion. This reduces free β-catenin in the nucleus 
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and limits its transcriptional activation of the nuclear target genes (Bienz, 2002; Rosin‐
Arbesfeld et al., 2003). 
 
1.3.2 Kirsten Ras (K-ras)  
An important oncogene in colorectal cancer tumorigenesis is the Kirsten Ras (K-ras). K-ras is 
activated by allelic mutation at codon 12 or 13 and explains the 90% K–ras mutations observed 
in colorectal cancer (Gryfe et al., 1997). Ras proteins belong to the guanosine triphosphatases 
family of proteins that regulate a number of signalling pathways including cell proliferation, 
differentiation, angiogenesis and apoptosis (Boguski and McCormick, 1993). Mutated K–ras 
genes have been identified in about 13 – 58 % of aberrant crypt foci presumed as precursors of 
colorectal cancer (Pretlow et al., 1993; Smith et al., 1994; Yamashita et al., 1995). Thus a 
mutation of the Kras proto-oncogene is considered an early event in adenoma development 
(Kinzler and Vogelstein, 1996; Gryfe et al., 1997). It is suggested that mutations in K-ras gene 
is necessary for transformation of adenomatous polyps formed in second and third decades in 
FAP patients to adenocarcinomas in later life.  
K-ras mutations are usually in the gene structure and results in alterations of particular amino 
acids which affects the regulation of the protein. There is therefore continuous signaling for cell 
growth through activated signal transduction pathway and individuals are exposed to high risks 
of specific cancers when these mutations are carried in the heterozygote state (Levine et al., 
1994). 
 
1.3.3 Deleted In Colorectal Cancer  
Deleted in colorectal cancer (DCC) is a large gene situated on chromosome 18q21. It belongs 
to a family of dependence receptors and functions as a tumour suppressor gene by enhancing 
apoptosis in the absence of its ligand netrin-1.((Mehlen et al., 1998; Krimpenfort et al., 2012) 
It is deleted in about 70 % colorectal cancers (Mehlen and Guenebeaud (2010). Lost or reduced 
expression of the gene is associated with most  advanced CRCs (Mehlen and Fearon, 2004; 
Krimpenfort et al., 2012). It is a late cancer gatekeeper gene and its deletion is not necessary 
for primary tumour development. In normal function DCC protein undergoes caspase cleavage 
at the intracellular domain to induce apoptosis. In the presence of netrin-1, DCC enhances cell 
differentiation and migration whiles its apoptotic properties are inhibited. In normal intestinal 
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epithelium at the base of the crypt where netrin-1 is high in concentration there is rapid cell 
proliferation but at the apex there is programmed cell death where DCC is high. The loss of 
DCC products promotes aggression and metastases of p53 deficient cells thus favouring the 
survival of cells. The DCC as a tumour suppressor gene provides a safe guard mechanism by 
enhancing apoptosis in the absence of its ligand (netrin 1) (Castets et al., 2011; Krimpenfort et 
al., 2012). 
 
1.3.4 P53  
This is a tumour suppressor gene was located on chromosome 17p and is associated with a 
number of sporadic and inherited forms of human cancer (Levine et al., 1991). In normal 
function, the P53 protein is involved in spindle checkpoint control, identifying DNA damage, 
causes cell cycle arrest for DNA repair processes, induction of apoptosis and  elimination of 
cells with genetic abnormalities (Kastan et al., 1991; Kuerbitz et al., 1992; Lowe et al., 1993; 
Cross et al., 1995). In response to DNA damage P53 protein induces the transcription of p21, 
Cdk inhibitor which inhibits cell cycle progression by binding to PCNA (proliferating cell 
nuclear antigen) and also by inhibiting Cdk-cyclin complexes. The P53 protein is activated by 
a number of stimuli such as DNA damage, heat shock, metabolic changes, hypoxia and 
cytokines (Steele et al., 1998). The tumour suppression role of P53 is evidenced by the fact that 
about 60% of human cancers and 75 – 80% of colon carcinomas carry mutations in the P53 
gene through missense (point mutation) and deletion leading to complete loss of wild-type 
alleles (Levine et al., 1991; Levine et al., 1994). Most of the mutations occur between codons 
120 and 290 (DNA-binding domain) resulting in the loss of transcription factor functionality of 
the of the P53 protein.(Levine et al., 1994; Steele et al., 1998). In mice, a complete loss of wild-
type P53 alleles leads to the development of cancers within 9 months of birth. (Donehower et 
al. (1992) and Levine et al., (1994)), Many mutant P53 alleles behave in a dominant manner, 
promoting growth and transformation of cells carrying wild-type P53 alleles. Wild-type P53 
protein has a short life-span not exceeding 30 mins while the mutant form are more stable and 
accumulate to reach concentration far above the level seen of wild-type proteins (Weinberg, 
1991). Cells with mutant P53 genes are resistant to apoptosis when exposed to DNA damaging 
stimuli such as chemotherapeutic drugs used in cancer treatment, oxygen and growth factor 
deficiencies (Lodish et al., 2000) 
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It was suggested that mutations in P53 are relatively late events in colorectal tumourigenesis 
and coincide with the transition from adenomas to invasive carcinomas (Xu et al., 2012). Thus 
even though P53 is involved in colorectal cancer unlike APC it does not initiate the process 
(Kinzler and Vogelstein, 1996).  
 
1.3.5 Cyclin D1 
Cyclin D1 is one of the prominent regulators of cell proliferation that characterises cancer 
development and it is encoded by CCND1 gene, whose expression is modified in cancer cells 
either by chromosome translocation or gene amplification (Balcerczak et al., 2005).  Cyclin D1 
affects cell proliferation at G1 to S phase of the cell cycle by modulating the activities of 
retinoblastoma protein (pRb) (Fu et al., 2004; Hulit et al., 2004). Retinoblastoma protein 
restricts cell cycle progression when it binds to transcription factor, EF2 and prevents 
transcription of genes whose transcription products are required for progression (Sherr, 2000). 
Cyclin D1 is activated through phosphorylation by CDK4 and CDK6 and the complex formed 
phosphorylates pRb causing it to release EF2 to initiate DNA replication(Donnellan and Chetty, 
1998).  Besides colorectal cancer, the expression of cyclin D1 is dyregulated in most human 
cancers including breast, bladder, oesophageal, and endometrial and it is an early event in 
carcinogenesis (Zhang et al., 1997; Donnellan and Chetty, 1998). Amplification of cyclin D1 
is induced in different cells by different growth factors such as epithelial growth factor and 
IGF-1 and IGF 11, amino acids, retinoic acids and peroxisome proliferator-activated receptor 
gamma (PPAR)γ ligand and gastrointestinal hormones (Fu et al., 2004). It is suggested that 
cyclin D1 enhances cell proliferation as oncogene with its normal protein and does not undergo 
any mutational transformation (Rosenberg et al., 1993). The high level of cyclin D1 observed 
in cancer is due in part to amplification and largely to post-translational dysregulation (Alao, 
2007). Cyclin D1 is a downstream target for β-catenin in the Wnt signalling or β-catenin/LEF 
(lymphoid enhancing factor)/T-cell factor pathway and the transcriptional activation by β-
catenin could be a contributor to the high concentration (Shtutman et al., 1999). It was 
suggested that very high levels of cyclin D1 inhibit DNA replication by binding to PCNA and 
cdk2 and its degradation is therefore necessary for DNA synthesis (Fukami-Kobayashi and 
Mitsui, 1999). 
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Cyclin D1 is degraded through phosphorylation by glycogen synthase kinase-3β (GSK-3β). 
GSK-3β phosphorylates cyclin D1 and causes its translocation to the cytoplasm and subsequent 
destruction in ubiquitin-proteasome system (Shtutman et al., 1999; Alao, 2007)  
Hulit et al., (2004), investigated the involvement of cyclin D1 on colonic epithelial cell 
differentiation and tumour number in ApcMin mice by mating ApcMin mice with cyclin D1-/- 
mice. The results of this study suggest decreased cell proliferation and increased differentiation 
accompanied by reduced tumour number in ApcMin mice heterozygous or nullizygous for cyclin 
D1, an indication that downregulating cyclin D1 expression offer protection against CRC. 
Silibinin, a nontoxic chempopreventive agent was shown to decrease size and number of 
intestinal polyp in ApcMin/+ mice alongside reduction in the expression of cyclin D1, c-Myc and 
beta-catenin in the polyps (Rajamanickam et al., 2009). The results showed a positive 
correlation between expression of cyclin D1 in intestinal polyps and polyp size and number. 
Thus suggesting increased expression of cyclin D1 is associated with polyp proliferation. 
Studies have also shown that Cyclin D1 deficient mice are resistant to development of 
mammary carcinoma induced by neu and ras oncogene, an indication of  the critical 
involvement of cyclin D1 in cancer (Sutherland and Musgrove, 2004).  
  
1.3.6  Cyclooxygenase-2 (COX-2) 
Prostaglandin G/H synthases (COX-1 and COX-2) are the main enzymes that catalyse the 
synthesis of prostaglandins from arachidonic acid. Whereas cyclooxygenase-1 (COX-1) is 
constitutively expressed, cyclooxygenase-2 (COX-2) is induced by growth factors including 
epidermal growth factor and tumour growth factor α(TGF-α)  and inflammatory cytokines  such 
as interleukin-1 (IL-1), and interferon gamma (INF-γ) at the sites of inflammation (Brown and 
DuBois, 2005; Palozza et al., 2005).  The level of COX-1 remained unchanged in intestinal 
tumour cells and is involved in the synthesis of prostacyclin (cytoprotective prostaglandin) and 
PGE2, associated with the protection of gastric mucosa (Williams et al., 1999).  About 85 % 
human colorectal adenocarcinomas show high level expression of both the protein and mRNA 
of COX-2 but are undetected in normal intestinal tissue (Tsujii et al., 1997). It was also shown 
to be highly expressed in  azoxymethane induced polyps in the colon of rodents (DuBois et al., 
1996), in human colon tumours (Eberhart et al., 1994; Soslow et al., 2000) and in colon cancer 
cells (HCA-7)  treated with  tumour growth factor-α and also in rat intestinal epithelial cells 
(Palozza et al., 2005).  It was suggested, expression of COX-2 enhances tumourigenesis by 
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inhibition of apoptosis, promoting angiogenesis  and tumour invasiveness (Richter et al., 2001; 
Sinicrope and Gill, 2004),  enhanced expression of anti-apoptotic protein (Bcl-2) and decreased 
levels of pro-apoptotic Bax and Bcl-x) (Liu et al., 2001).  
A number of colorectal cancer chemopreventive studies have shown that inhibiting COX-2 with 
non-steroidal antinflammatory drugs (NSAID) reduced colorectal cancer related death by 40-
50 %. In vitro application and dietary administration of celecoxib (selective Cyclooxygenase-2 
inhibitor, a nonsteroidal anti-inflammatory drug (NSAID)) and atorvastatin (hydrxy-3-
methyglutaryl CoA reductase, (HMGR)) inhibitor in combination to colon cancer cells (HT-
29) (Malisetty et al., 2002) and Apcmin/+ mice (Swamy et al., 2006) respectively, showed 
induction of apoptosis and suppression of tumourigenesis. Rajamanickam et al. (2009), treated 
ApcMin/+ mice with silibinin and showed reduced (P <0.001) expression of COX-2 in the 
intestinal polyps alongside a reduction (P< 0.001) in polyp number and size.  Also a decreased 
expression of COX-2 and PGE-2 were observed by Rajamanickam et al. (2010) and is 
accompanied by reduced cell proliferation and inhibition of angiogenesis, two important 
processes of carcinogenesis. Oshima et al. (1996), showed that intestinal polyps number and 
size in Apc∆716 could be by significantly enhanced by increasing the expression of COX-2. 
COX-2 production may involve different mechanisms along different pathways such 
hypoxia/NF-kB vascular endothelial system or APC/Wnt pathway (Brown and DuBois, 2005) 
and the fact that it occurs in almost all cancers make it important biomarker in cancer 
chemopreventive investigation.  
 
1.3.7 RXRalpha and RARbeta     
These are members of steroid/thyroid hormone superfamily of nuclear receptor known to 
mediate the anti-tumour activities of carotenoids (Allenby et al., 1993; Lee et al., 2000a; Pham 
et al., 2013). They modulate many biological processes (may function) as heterodimer or may 
exert their regulatory effects as separate entities along different pathways. Different isoforms 
(α, β, γ) of these receptors exist and affect a wide variety of genes (Allenby et al., 1993). 
Retinoid, its natural and synthetic derivatives are associated with the modulation of a cell 
proliferation and differentiation, two critical processes in tumourigenesis (Dillard and Lane, 
2007b; Pham et al., 2013). These regulatory functions are mediated by RXR and RAR. These 
receptors have N-terminal that contains ligand-independent activation function-1(AF-1) and C-
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terminal with ligand-dependent activation-function-2 (AF-2) and are known to inhibit or 
promote DNA transcription in the absence or presence of their respectively ligands (Xiao et al., 
2003). The transcription repression is achieved by retinoid receptors acting as transcription 
factors through recruitments of histone deacetylases which prevent opening of chromatins for 
attachment of transcription factors (Freemantle et al., 2003). The concentrations of retinoid 
receptor proteins are modulated by degradation upon binding to their respective ligand and 
effecting transcription (Osburn et al., 2001). RXR is known to provide a third alternative 
pathway (retinoid-X-receptor (RXR) dependent degradation) by which the concentration of 
beta-catenin in the cytoplasm is regulated.  Dysregulation in beta-catenin degradation pathways 
is common and underlie the development of many cancers (Dillard and Lane, 2007b). In vitro 
study by Dillard and Lane (2007b), showed that retinol induced β-catenin protein destruction 
in the cytoplasm of three human colon cancer cells  (HCT-116, WiDr, SW620) by proteasomal 
degradation mediated by RXR. Retinol enhanced the expression of RXR and induced 
dimerization between RXR and beta-catenin in the nucleus (Lu et al., 2005). The dimer then 
translocates into the cytoplasm where the beta-catenin is destroyed. This reduced the expression 
of mRNAs of β-catenin/TCF/LEF target genes (c-Myc, Cyclin D1) that are associated with cell 
proliferation. 
Of the RAR isoforms,  RARb is considered the most important because of its role in the 
maintenance of epithelial homeostasis and its reduced or loss of expression  is found in many 
human tumours (Gebert et al., 1991; Tanaka et al., 2012). It was suggested RARb induces 
sensitivity to retinol in retinoic acid resistant colon cancer cells and promotes apoptosis in 
malignant cells (Lee et al., 2000a). Also a significant clinical response of premalignant oral 
lesions to retinol was observed in patients with increased expression RARb (Lotan et al., 1995). 
The expression of RARb is affected by the tissue concentration of vitamin A. In Vitamin A 
deficient rat models, RARb was lowly expressed in many organ but these was reversed with 
increased retinoic acid (Verma et al., 1992). This relates positively to the suggestion by de The 
et al. (1990) that retinoic acid modulates the transcription of its own receptor. Studies have 
shown that RARβ inhibits epidermal growth factor receptor (EGFR), activator protein-1 (AP-
1), reduces COX-2 activity and prevents phosphorylation of ERK1/2 in cancers (Song et. al., 
2009; Sun et al., 2012). It was suggested that RAR inhibit cancer promoting activities of beta-
catenin at the transcription level by binding to LEF/TCF transcription factors to prevent 
transcription of beta-catenin target genes (Cyclin D1, C-Myc etc) and subsequently decrease 
cell proliferation (Easwaran et al., 1999). 
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These observations suggest nuclear retinoic receptors could serve as intermediate biomarker in 
molecular studies involving diet plant.  
 
1.3.8 Matrix metalloproteinase (MMP7) and β, β 15,15-monooxygenase (BCMO1)  
β,β-carotene 15,15’-monooxygenase (BCMO1,also known as BCDO1) is an enzyme involved 
in the central cleavage pathway of β-carotene  and other pro vitamin A carotenoids metabolism 
and converts β-carotene to retinaldehyde which may be converted to retinol or retinoic acid 
(Olson and Hayaishi, 1965). However, the activity of  BCMO1 is influenced by quantity and 
quality of protein eaten (Lietz et al., 2010).  Mice fed protein deficient diet showed reduced 
BCMO1 enzyme activity in the intestine than those fed protein rich diet. Also vitamin A 
deficient rats showed increased BCMO1 activity when fed diet containing higher amount of 
protein compared to those fed diet with reduced protein content (Parvin and Sivakumar, 2000; 
Hosotani and Kitagawa, 2005). The intestine is the main site for the conversion β-carotene to 
retinaldehyde though it is also produced in the liver, kidney and testis (Takitani et al., 2011). 
Retinaldehyde, a product of BCMO1 activity prevents tumour cell invasion and metastasis by 
inhibiting the formation of RXR/PPARα which modulates fatty acid oxidation and creation of 
oxidative stress leading DNA damage (Pyper et al., 2010; Leclerc et al., 2013). Cells treated 
with β-carotene showed increased activity BCMO1 and increased concentration of retinoic acid 
alongside a reduction in expression of MMP7 in an in vitro study to suggest that the anti-tumour 
property of β-carotene was mediated by BCMO1 and retinoic acid (Leclerc et al., 2013). 
MMPs are zinc-dependent proteolytic endoenzymes that degrade extracellular matrix and 
facilitate tumour cell evasion and migration (Ellerbroek and Stack, 1999; Kleiner and Stetler-
Stevenson, 1999). The high incidence of these enzymes in cells is linked to disease stage 
(Zucker and Vacirca, 2004). Of all MMPs associated with invasion and progression of tumours, 
MMP-7 is considered the most important because of its small size and unique structure(Gaire 
et al., 1994). It is reportedly involved in the invasion and metastasis in gastrointestinal cancer 
and overexpressed in many primary tumours and in 80% colorectal cancers (Zeng et al., 2002; 
Pham et al., 2013) suggesting, its expression is an early event in tumourigenesis (Wilson et al., 
1997; Zucker and Vacirca, 2004). In a study involving MMP-7 deficient Min/+ mice Wilson et 
al. (1997) showed that MMP-7 is necessary not only for tumour multiplicity but also for tumour 
growth. MMP-7 is a downstream target of β-catenin (Brabletz et al., 1999) and it is 
overexpressed by the tumour cells in CRC (Zucker and Vacirca, 2004) 
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1.4 Fruits and Vegetables and Health 
Fruits and vegetables form very important component of a healthy human’s diet and are known 
rich sources of nutritive factors many of which are vital for normal metabolic functions of the 
body. According to World Health Organization (2005), less than 400g daily intake of fruits and 
vegetable constitute one of the top 10 risk factors of global death and was estimated to have 
caused 1.7 million deaths globally, 14 % of which was attributed to gastrointestinal cancer, 11 % 
to ischaemic heart diseases and 9 % to stroke.  
A critical review of relationships between fruits and vegetable intake and the risk of chronic 
diseases supports World Health Organization (2005) held health position on increased intake 
of fruits and vegetables to reducing CVD, diabetes, stroke, and cancer among others (Hung et 
al., 2004; Boeing et al., 2012; Wang et al., 2014).  
 
1.4.1 Fruits and Vegetables and Colorectal Cancer Risk 
Many of the health benefits of fruits and vegetables are associated with their vitamins and 
minerals, phytochemicals and dietary fibre contents (Boeing et al., 2012; Slavin and Lloyd, 
2012). 
 Meta-analysis of data from the Dutch cohort studies on diet and cancer with over 120,800 (age 
group, 55-69) participants suggest protective effects of fruits and vegetables vary with types of 
fruits and vegetables, cancer site and sexes (Voorrips et al., 2000). No significant statistical 
association between colon cancer and total fruits or total vegetables was observed whilst inverse 
association was observed in women who took fruits and vegetables together. Of the vegetables 
investigated Brassica and cooked leafy vegetables had greater protective effect in men than in 
women. This effect was stronger in the distal than in the proximal colon (Voorrips et al., 2000). 
Also, meta-analysis by Nomura et al. (2008) showed a significant reduction in CRC cancer risk 
reduction in men with fruits and vegetables consumption which was more pronounced in the 
colon than rectum. This prospective study which included 215,000 participants and over 1.4 
million person observation years, corroborated the findings of (McCullough et al., 2003; Park 
et al., 2007). Park et al., (2007) investigated data from a 5 year follow-up study of 488,043 
retired individuals (NIH-AARP National Institute of Health-American Association of Retired 
Persons) and suggests a strong inverse association between colorectal cancer and green leafy 
vegetable consumption in men but not in women. Significantly, the study also found, risk of 
CRC was high in men with very low intake of fruits and vegetables and decreased with 
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increased intake. A similar inverse association for colon cancer was reported by McCullough 
et al., (2003). Pooled meta-analysis of data from 14 prospective studies of 756, 217 men and 
women and a follow-up period of 6 – 20 years showed fruit and vegetable intake decreased risk 
of developing cancer in terminal colon (Koushik et al., 2007).  
Other prospective studies however, suggest no association between fruits and vegetable intake 
and CRC risk in men and women. This includes studies by Michels et al. (2000), which 
examined data from the Nurses’ Health Study and Health Professionals’ Follow-up Study. 
Similarly Tsubono et al. (2005) reported no association among Japanese men and women.  On 
the other hand, analysis of data from eight years follow up Alpha-tocopherol, beta-carotene 
cancer prevention study suggested consumption of cruciferous vegetables related positively to 
the risk of colorectal cancer incidence (Pietinen et al., 1999).  
Despite the controversies of epidemiological studies many in vitro and animal experiments, 
involving total fruit and vegetable or isolated phytochemicals produced biologically plausible 
evidence to suggest protection against CRC. Feeding Black/6 mice individual vegetables or 
mixed vegetables diet suggest modulation of expression of genes associated with CRC (van 
Breda et al., 2005a), whilst a ten week dietary administration of sulforaphane, one of the main 
isothiocyantes in cruciferous vegetables such as  broccoli, was shown to reduce intestinal 
tumour number and size in ApcMin/+ mice (Shen et al., 2007). In vitro investigation revealed 
retinoic acid decreased concentration of nuclear beta-catenin, an important cancer biomarker 
which enhances transcription of genes such as Cyclin D1, C-Myc and Matrix metalloproteinase 
(MMP7) involved in cell proliferation in intestinal tumour development (Dillard and Lane, 
2007a). 
 
1.4.2 Dietary Fibre  
The role of dietary fibre in colorectal cancer risk has been inconsistent. Whereas most case-
control studies support the hypothesis that dietary fibre intake decreased risk of CRC, 
prospective studies have been inconsistent. Meta-analysis of 13 case control studies suggested 
increased intake of fibre decreased colorectal cancer risk in both men and women (Howe et al., 
1992). Ecological analysis of data from case control studies over seven countries also showed 
a strong inverse association between increase intakes of fibre and colorectal cancer risk. This 
study suggests increase intake of 10 g/day of fibre was associated with 33 % reduction in risk 
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(Jansen et al., 1999). Increased intake of dietary fibre was also shown to decrease colorectal 
cancer risk in a nested case control study of colorectal cancer patients (Dahm et al., 2010). 
Data from prospective cohort studies of Nurses’ Health Study and from Swedish population 
indicate, dietary fibre intake offered no protection against CRC (Fuchs et al., 1999; Terry et al., 
2001). Similarly, analysis of data from 10 to 16 years prospective study of US health workers 
showed no significant effect of dietary fibre on colorectal cancer risk (Michels et al., 2000). 
However, in a systematic review, Aune et al. (2011) reported inverse association between 
dietary fibre intake and CRC risk in a dose response analysis of meta-analysis of data from a 
large number of prospective cohort studies. Fibre from fruits was shown to be more protective 
against colorectal cancer than fibre from other food sources (Papas et al., 2004). Bingham et al. 
(2003), reported increased intake of dietary fibre reduced risk of colon cancer from European 
Prospective Investigation in Cancer and Nutrition Study (EPIC). A report from the same study 
in 2005 but with 656 additional new cases suggests a stronger protective effect of fibre against 
CRC (Bingham et al., 2005).  Evidence from Malemo Diet and Cancer Study (MDCS), Sweden 
suggests the protective effects of fibre against CRC are influenced by the cancer site, source of 
fibre and gender of affected persons. High intake of fruits and berries reduced colon cancer risk 
in women and high intakes of fibre-rich cereal may be protective against metastasis (Vulcan et 
al., 2015), whilst EPIC study report suggests cereal fibre reduced risk of cancer in the rectum 
rather than fruit and vegetables (Murphy et al., 2012). 
It was proposed that the protective ability of fibre against colorectal cancer may be due to 
mechanisms that are limited to the colon (Vulcan et al., 2015). These include decrease in stool 
colonic transit time, absorption of moisture, and increase in stool bulk, dilute potential 
carcinogens, and induced anaerobic fermentation of fibre by colonic microbacteria. Bacteria 
fermentation produces short-chain fatty acids which reduce pH and prevents conversion of 
primary bile acids to secondary bile acids. The primary bile acids inhibit cell proliferation and 
induce differentiation and apoptosis (Young et al., 2005). 
 
1.5 Developmental Origin of Adult Diseases 
Barker hypothesis suggests that the environmental factors to which an individual is exposed 
during intrauterine and neonatal life modulate disease risk during adulthood. These factors 
include nutritional factors (McMillen and Robinson, 2005), psychological or physiological 
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stressors (Lazinski et al., 2008) and changes in endocrine signalling between mother and fetus 
(Seckl, 2004). 
These factors cause development of survival adaptations/adaptive response which may involve 
modulation of cell proliferation and differentiation to maintain normal function of essential 
organs (Langley-Evans and McMullen, 2010; Mathew and Ayyar, 2012). These adaptations 
may produce irreversible structural and functional modifications of the body/organs with the 
capacity to modulate response to the environment in later life (Langley-Evans, 2006). The 
degree of the modifications achieved is determined by the nature and timing or developmental 
stage of exposure to the stimuli or insult (Langley-Evans, 2000). The effect of timing or stage 
of development of fetus at which it is exposed to stimuli was observed in the Dutch famine 
during the World War II. Infants who were subjected to nutrient deficiency during early 
gestation had normal weight but developed coronary heart disease, atherogenic lipid profile, 
obesity and altered blood clotting, whilst exposure during mid and late gestation produced low-
birth weight, glucose intolerance and micro albuminuria (Roseboom et al., 2001). For example 
people with low-birth weight have reduced number of glomeruli in the kidney and increased 
flow of blood through the glomeruli later in life cause hyper filtration and subsequently 
glomerulosclerosis (Luyckx and Brenner, 2005). There is also loss of glomeruli with age. These 
together results in increased blood pressure with further loss of glomeruli which is self-
perpetuating (Barker, 2004a). A similar observation of reduced number of nephron was 
observed in mice (Hoppe et al., 2007) and rats (Woods et al., 2004) exposed to low-maternal 
protein diet. 
Reports suggest that individuals with low-birth weight develop in later life diseases such as, 
coronary heart disease, hypertension, obesity, type II diabetes and metabolic syndrome 
((Barker, 2004b). Low birth weight has been associated with inadequate nutrition thus the 
development of the diseases are the results of adaptive response to nutritionally challenged 
environment (Mathew and Ayyar, 2012). According to Langley and Jackson (1994), rats 
exposed to low-protein diet in utero develop high blood pressure in adulthood. This effect of 
low-protein diet is influenced by the type of carbohydrates in the diet. As suggested by Langley-
Evans (2000), high blood pressure occurs in rats if the low-protein diet they were exposed to in 
utero contained complex carbohydrates but absent if the diet contained largely glucose. 
The ‘Thrifty hypothesis, has it that, under conditions of nutritional deprivation the fetus  
channels nutrients to the development of vital organs (brain) at the expense of non- essential 
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organs  (beta cell od islet) (Mathew and Ayyar, 2012). This is underlined by the concept of 
hormonal programming which suggests metabolic and endocrine adaptations in the fetus aimed 
at energy preservation.  
The mechanism by which the fetus maintains normal function of the brain for instance in 
nutrient deficient environment is to divert blood and nutrient supply to the brain whilst directing 
insulin and growth hormone resistance to the periphery (Mathew and Ayyar, 2012). Insulin 
resistance enables the maintenance of glucose concentration in the blood for the developing 
brain (Barker, 2004). The resulting phenotype therefore has survival advantage in a nutritionally 
poor environment postpartum. However in a postpartum nutrient rich environment, the 
phenotype is disadvantaged by enhanced metabolic efficiency  (Neel, 1962).Such individuals 
are associated with low-birth weight or thin body at birth with most exhibiting good catch-up 
growth early postnatal and are at risk of developing cardiovascular diseases, type II diabetes 
and polycystic ovarian syndrome (Forsen et al., 1997; Osmond and Barker, 2000). 
The association between nutrition, early life and disease in later life may be explained by 
epigenetic modifications of gene expression through DNA methylation or histone acetylation 
(Razin, 1998). These modifications which have been shown to occur during prenatal and early 
postnatal stages of development are associated with long-term anatomical and physiological 
implications in later life (Razin, 1998; McMullen et al., 2004). The process is mediated by 
nutrition through the availability of possible methyl donors such as amino acids (eg., 
methionine), folic acids, vitamin B6 and B12 in diet or by affecting the activities of DNA 
methyl transferase (enzymes involved in DNA methylation) (Niculescu and Zeisel, 2002; 
Waterland and Jirtle, 2003; Young et al., 2004). In animals, effects of dietary factors on DNA 
methylation vary with site or organ and nature of methylation (McKay and Mathers, 2011). For 
example in rats increased intake of dietary Selenium increased DNA methylation in the colon 
and not in the liver whilst folate deficient diet decreased methylation of p53 gene and not 
genomic DNA (McKay and Mathers, 2011). This suggests that adequate maternal nutrition 
during early development is a prerequisite for healthy adult life. 
Results from investigation by Langley‐Evans et al. (2005) indicate that the expression of a 
number of genes in the kidney and genes related to appetite in the hypothalamus is modulated 
by maternal protein restriction during gestation. Also preconception maternal folate, B2, B6, 
and B12 supplementation affected intestinal tumour number in adult APC1638N mice offspring 
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(Ciappio et al., 2011). Similarly, maternal folic acid supplementation was shown to decrease 
azoxymethane induced adenocarcinoma in rats (Sie et al., 2011). 
In addition to genetic and nutritional factors in utero and during early postnatal life influencing 
the health status in adulthood, studies have shown that, individual’s life styles such as moderate 
to heavy smoking, and excessive alcohol consumption also play a critical role. The interplay of 
these factors in the development of adulthood diseases is summarised by Conceptual health 
pendulum model for cardiovascular and cancer risks (Mathers, 2002). 
 
Figure 1. 2 The Health Pendulum (Mathers 2002). Conceptual model of health determining 
factors 
 
1.6 Colorectal cancer model  
The development of CRC is a multistep process and it develops over decades through 
accumulation of genetic alterations in tumour suppressor genes, oncogenes and mismatch repair 
genes in individuals (Fearon and Vogelstein, 1990; Kinzler and Vogelstein, 1996). The long 
period over which the disease  develops coupled with the knowledge of defined steps of changes 
in colonic epithelium provide molecular targets for therapeutic interventions (Wong et al., 
2007). A number of models have been developed to facilitate chemoprevention trials. 
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1.6.1 Cell line model 
Human colorectal cancer cells such as HCT-116 p53 wild type, HCT-116 null (HCT-116 p53-
/-), HT-29 and SW-620 extracted from tumour tissues of colorectal cancer patients provide cell 
line models for in vitro investigations of colorectal carcinogenesis in human (Nautiyal et al., 
2011). Cell lines produce large number of live cells in relatively short time and at a much 
reduced cost whilst enabling the researcher control over the experimental factors (Ahmed et al., 
2013). Using cell line in in vitro studies revealed certain characteristics (aggregation, migration 
and invasion) of tumour cells (Young et al., 2013). It was also possible to determine the effects 
and mechanisms of action of cancer preventing agents on tumour cells such as antiplatelet 
aggregation (Alanko et al., 1994) inhibition of cell proliferation (Hansen et al., 2003) and 
apoptosis of tumour cells (Purup et al., 2009). Cell line models however have limitations; 
colorectal cancer develops over long periods and the processes of tumour initiation, and growth 
are not easily followed in a given cell culture (Johnson and Fleet, 2013). Cell lines grow in a 
medium devoid of complex interactions in the microenviroment which may affect homeostasis 
of normal colon cell, eg. oxygen levels between cells (Young et al., 2013). Further more it was 
not possible to determine effects of tumour development on human immune systems and 
angiogenesis in vitro (Johnson and Fleet, 2013; Young et al., 2013). The transfer of results of 
cell line investigations to humans may be limited by ethical considerations (Johnson anf Fleet, 
2013). 
 
1.6.2 Animal Model 
The deficiencies associated with of cell lines provide the opportunity for the development and 
use of animal models to investigate possible effects of chemopreventive agents and to test 
hypothesis from cell models in the complex mammalian physiology of the colon (Johnson and 
Fleet, 2013). 
1.6.3 Xenograft 
This model permits investiagtion of cancer cell invasion and metastasis (Young et al., 2013). A 
number of methods are available for this and involves the injection of tumour cells or cell 
suspension directly into the intestine (orthotopic injection), into the portal vein or 
subcutaneously or injected intraperitoneally (Karim and Huso, 2013; Young et al., 2013).  The 
cells may also be implanted surgically to sites of interest (Young et al., 2013). To prevent 
rejection of tumour, the recipient rodent or mice are either nude (lack the ability to produce  T-
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lymphocyte) or severely combined immune deficiency (SCID) mice ( lack both B and T-
lymphocytes) (Karim and Huso, 2013; Young et al., 2013).  
The model has the advantage of using cells or tumour tissues from sites that in parallel represent 
the relevant human cancer and grow in a microenvironment with complex cellular interactions 
(Karim and Huso, 2013). Orthotopic implantation enables monitoring of metastasis by 
imaging.(Karim and Huso, 2013) A major disadvantage with xenograft is the use of 
immunocompromised mice or rodents which my reduce the extent of complex interactions 
between host and tumour (Young et al., 2013). 
 
1.6.4 Carcinigen-induced Model 
One of the models for investigating the potency of colorectal cancer chemopreventive agents is 
the 1,2-dimethylhydrazine (DMH)/Azoxymethane (AOM) model of chemically induced CRC 
(Wong et al., 2007). These chemicals are employed to induce colon tumour in rats and mice. In 
rats intraperitoneal injection of  AOM, once a week for two weeks is enough to cause  tumour 
development in a manner similar to humans (Reddy, 2000; Femia and Caderni, 2008) whilst 
mice require repeated injection of lower doses for the development of colonic tumours (Reddy 
and Maeura, 1984). With this model, tumours are developed mainly in the colon and the 
progression from abberant crypt foci (ACF) through adenomas and to carcinomas are similar 
to human (Wong et al., 2007). However, the chemicals are carcinogenic to the experimentor 
and are excreted by breathing (Wong et al., 2007). Also the tumours rarely show mutations in 
Apc or p53 genes which are commonly found in human. (Wong et al., 2007).  
 
1.6.5 Genetically modified model 
One of the animal models widely used in the colorectal cancer research is ApcMin/+ (Min, 
multiple intesinal neoplasia) mouse. The Apcmin/+ mouse carries a dominant germ line 
heterozygous mutation at codon 850 of the mouse homologue of human APC gene (Moser et 
al., 1990). This mutation causes Apcmin/+ mice to develop multiple intestinal adenomas, 
predominantly in the small intestine and die of intestinal obstruction and/or severe anaemia, 
often not surviving beyond 120 to 150 days (Su et al., 1992; Moser et al., 1990). This models 
colorectal tumourigenesis in humans, where APC mutations are common. Apcmin/+ mice 
therefore provide a very unique model for both mechanistic and chemopreventive investigation 
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of colorectal cancer and has been used frequently by many researchers (Ju et al., 2005; Shen et 
al., 2007; Fini et al., 2011). However the relevance of this model to the study of colorectal 
cancer has been subjected to criticism on the bases of differences in location of tumours 
between ApcMin/+ mice and human and also K-ras and p53 mutations are not detected in Min 
mice (Wong et al., 2007). 
 
1.7 Research Hypothesis 
This research was aimed at determining the effects of carrot consumption on intestinal cancer. 
Largely, however, studies have been centred on isolated or purified bioactive compounds 
(Mahmoud et al., 2000; Kállay et al., 2002; Swamy et al., 2006). Investigations involving the 
use of vegetable diet in animal models is limited  (Rijnkels and Alink, 1998; van Breda et al., 
2005b) and not much is known of the downstream molecular effects. Furthermore, the effects 
of vegetable diet consumption during specific windows of time, i.e. in utero and post weaning, 
on intestinal tumourigenesis is unknown. In addition the significant reduction in intestinal 
tumour number by preconception maternal supplementation of folic acid in APC1638N 
offspring mice (Ciappio et al., 2011) coupled with intestinal tumour number reduction in 
ApcMin/+ mice by post weaning dietary intake of plant secondary metabolites (Shen et al., 2007; 
Ju et al., 2005) suggest the availability of opportunity to influence intestinal tumourigenesis 
either in utero or post weaning with a diet rich in these compounds. 
 
I therefore hypothesis that  
 Carrot consumption in utero and/or post weaning reduce intestinal tumourigenesis in 
ApcMin/+ mouse. 
 
To thoroughly address the hypotheses, the following questions were considered; 
 Does carrot consumption in utero affect intestinal tumourigenesis in later life? 
 Does carrot consumption post-weaning affect intestinal tumourigenesis? 
 How is intestinal tumourigenesis affected if individuals exposed to carrot diet in utero 
are fed non carrot diet post-weaning? 
 What is the effect on intestinal tumourigenesis if individual exposed non carrot diet in 
utero is fed carrot diet post-weaning? 
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 What are the effects of the diet treatments in this study on the expression of cancer 
related biomarkers (Retinoid X receptor beta, (RXRb); Retinoid acid receptor alpha, 
(RARα); Cyclin D; ββ-Carotene 15,15-monooxygenese-1, (BCMO1); Cyclooxygenase-
2, (COX-2); and Metrilysin-7, (MMP7) 
The design necessary to address these questions is explained in detail in materials and methods 
section. 
Following the results of study one where consumption of heat processed carrot pellet increased 
intestinal tumour number significantly in the ApcMin/+ mice, contradicting many 
epidemiological and animal experimental investigations, a second hypothesis was proposed to 
investigate the findings of study one. 
 
Second Research Hypothesis: 
 
 Consumption of carrot powder in utero post weaning decreased intestinal tumourigenesis 
ApcMin/+ mouse 
 
This hypothesis was investigated on the principles of the first hypothesis but with carrot powder 
and without heat processing. 
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2 Chapter 2 Material and Methods 
 
2.1 Section A 
 
2.1.1 General Animal Housing and Husbandry 
The study was undertaken with the approval of Newcastle University Ethics Committee within 
the limits defined by The United Kingdom Home Office Animals (Scientific Procedures) Act 
1986 under the Project Licence, PPL60/4294 and Personal Licence No. 10265C1BE. 
Six heterozygous  male Min mice (C57BL/6J-Apcmin/+) were purchased from Jackson 
Laboratory (Bar Harbor, USA) and fifteen wild-type (C57BL/6J) female mice purchased from 
the Charles River Laboratories at the age of five weeks and a breeding colony was established 
in the animal facility at the Campus for Ageing and Vitality (CAV), Newcastle University. They 
were housed under standard laboratory conditions of 21 ± 2oC, 55 % ± 10 % humidity and 12 
hour light/dark cycles. They were acclimatised for two weeks on standard Rats and Rodents 
diet pelleted (RM3 E) (control diet) produced by Special Diet Services ((SDS), Essex, CM8 
3AD, UK.), after which they were randomised to either control or experimental diets for two 
weeks prior to mating (see individual study descriptions for details of diets) in order to capture 
all periods of intrauterine development. Mating trios consisted of two wild-type females and a 
min male. The dams remained on their respective diet throughout mating, gestation and 
lactation alongside the offspring. The females were removed to a separate cage and their diet 
increased to 10 g/day on the presence of a vaginal plug. Two weeks post-partum the diet for the 
dams in each cage was increased to 20 g/day in recognition of increased nutritional needs of 
the young offspring. At a mean age of 28 days ± 3 StDev), offspring were randomly weaned to 
control or experimental diets, with an equal number of each sex allocated to each diet. Each 
cage contained an average of six mice and allocated diet and water were available ad libitum. 
Offspring were weighed at weaning and on a weekly basis (in the morning of every seventh day 
before feeding) thereafter and weights were recorded. All mice were examined on daily bases 
for any sign of ill health such as weight loss, anaemia and intestinal obstruction throughout the 
study. Food intake was measured twice over seven days, at the age of six and nine weeks. Food 
contained in food hoppers was weighed at the start and end of these periods without refilling. 
Food intake per mouse was calculated as the mean of the total amount of food consumed divided 
by the number of animals per cage. The mice were caged on the bases of sex, with mixed 
genotypes in each cage, therefore the effect of genotype on food intake was not be determined. 
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2.1.2 Mouse Identification and Genotyping 
For the purposes of identifying individual mice in each cage, animals were ear notched at 
weaning. For a given cage notches were positioned at unique ear locations for each mouse. 
Mice were anaesthetised with gaseous isoflourane and transferred into their cages following the 
notch procedure.  Ear notch samples were placed in labelled well plates, sealed and sent to 
Transnetylx Inc. (Cordova, Tennessee, USA) for genotyping for the presence of the Min 
mutation. 
2.1.3 Source of Carrot 
Carrots for the study were organic variety Nairobi carrot baton (6 x 6 x 40) mm obtained from 
Hartley’s, York, UK. These were blanched, cut into batons, and freeze dried by European 
Freeze Dry Limited, Preston, UK at below 50oC. The freeze dried batons were packed in sealed 
aluminium bags and stored at -20oC until required. 
 
2.2 Section B 
2.2.1 Study One 
Animal housing and husbandry is described above (section A). A summary of the study design 
is outlined in Figure 2.1 below. Dams were randomised to either pelleted control diet RM3 (E) 
(control pellet) or carrot enriched pelleted (carrot pellet) experimental diets. At weaning, 
offspring were further randomised to either control pellet or carrot pellet experimental diets 
resulting in adult offspring exposed to one of the following 4 in utero-post weaning dietary 
regimes; carrot pellet-carrot pellet; carrot pellet-control pellet; control pellet-control pellet; 
control pellet-carrot pellet.  
 
2.2.2 Control and Experimental Pelleted diets 
Diets were manufactured by Special Diet Services (SDS) with standard professional equipment 
to specification and dried at a temperature range of 90oC to 120oC. Control pellet diet (RM 3 
E) was as the manufacturer’s usual specifications (see Appendix). The carrot pellet diet 
consisted of 20 % powdered freeze dried carrot and 80 % Rats and Rodents powder (RM3 P) 
mixed and subsequently pelleted. The choice of 20 % carrot for this study was based on the 
evidence of preliminary results from the study by Saleh et al. (2013) where it was shown to 
reduce intestinal tumour number in ApcMin/+ mice at age 12 weeks without any significant 
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difference in mean bodyweight gain between treatment groups or produced any observable 
toxicity effect. Mice have the ability to detect and reject nutritionally inadequate diet and select 
for diets that support normal growth especially those with the complements of indispensable 
amino acids (IAAs) (Gietzen et al., 2007). The twenty percent carrot may be considered 
physiologically relevant since this was the amount chosen by the mice when given free access 
to freeze dried carrot and laboratory chow (Saleh et al., 2013). Twenty percent carrot 
component of human diet translates into consumption of 740 g carrot/day which may be 
relevant in reducing the risk of developing diseases. Disease specific recommendation by WHO 
suggests that a minimum daily intake 400 g of total fruits and vegetables will reduce the risk of 
developing cancer (World Health Organization, 2005).  
 
Figure 2. 1: Summary of experimental protocol to evaluate the effects carrot pellet on 
intestinal tumourigenesis in Apcmin/+ mice 
 
2.2.3 Sample size 
Sample size was determined using General Full factorial Design (Sample and Power Size) of 
Minitab 17 Inc. Software. It was estimated that 23 mice in each dietary group will allow for 
detection of differences in dietary effects in group means in a statistical model at a statistical 
power of 80 %. This was determined based on 40 % small intestinal tumour inhibitory effect of 
0.08 % (-)-epigallocatechin-3-gallate, the main catechin in green tea in intestine of ApcMin/+ 
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mice at a standard deviation of 15.5 and treatment effect of 13.1 compared to the control (Ju et 
al., 2005).  See appendix for power curve. 
 
2.2.4 Necropsy 
Mice were killed at 15 weeks (mean age of 110 days ± 0.497 days) by cervical dislocation to 
prevent death from intestinal tumour complications. ApcMin/+ mice develop multiple intestinal 
tumours largely in the small intestine and die of intestinal obstruction and /or severe anaemia, 
often not surviving beyond 120 to 150 days (Su et al., 1992; Moser et al., 1990). It was also 
expected to enhance tumour number for observation of differences in treatment effect if there 
was any.  Salah et al., (2013) recorded an average of three and two tumours per control diet fed 
female and male ApcMin/ mice respectively killed at 12weeks. On the other hand ApcMin/+ mice 
killed at 15 weeks developed mean number of 51.5 intestinal polyps per mouse (Shen et al 
2007). Similarly, Mahmoud et al., (2000) at age 14 weeks observed an average of 48.8 ± 4.3 
and 34.3 ± 3.8 in male and female Min mice respectively. 
 
2.3 Study Two 
Animal housing and husbandry was as described above (Section A).  A summary of the study 
design is outlined in Figure 2.2 below. Dams were randomised to either control powder (RM3 
(P)) diet or carrot powder experimental diets. At weaning, offspring were further randomised 
to either control powder, carrot powder or stored carrot pellet experimental diets resulting in 
adult offspring exposed to one of the following 5 in utero-post weaning dietary regimes; Control 
powder-control powder, control powder-carrot powder, control powder –stored carrot pellet, 
carrot powder-control powder and carrot powder-carrot powder. 
 
2.3.1 Control and Experimental diets 
The control powder and stored carrot pellet diets were manufactured by Special Diet Services 
(SDS) as the manufacturer’s usual specification (See Appendix.). The carrot powder diet was 
made of 20 % powdered freeze dried carrot and 80 % RM3 (P). The carrot powder was produced 
by milling freeze dried carrot baton in a sample mill (Tecator Cyclo Tec 1093, Sweden). These 
were weighed using Myweigh i2600 electronic scale (capacity 2600 x 0.1 g) and mixed in 
Hobart (HSM30, UK) food mixer at low speed until a visually uniform mixture was obtained. 
The diet was then store at -20oC and removed from the freezer at least 12 hours prior to 
administration to ensure sufficient defrosting at room temperature in an air tight container. The 
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stored carrot pellet used in this study was the same carrot pellet used in study 1 that was stored 
at -20oC for nine months. 
 
Proximate Analysis 
Macro nutrient composition of the diets was determined (see Appendix 2 for procedures). Also 
nutrient composition (macro and micro nutrient composition) determined by SDS on control 
and carrot pellets are available in Appendix 1. 
 
 
 
 
Figure 2. 2: Summary of experimental protocol to evaluate the effects carrot powder on 
intestinal tumourigenesis in Apcmin/+ mice 
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2.3.2 Necropsy 
Mice on this study, according to the initial study design were to be killed at age15 weeks but 
for reasons beyond the control of the researcher, they were killed at different time points, 
starting from age 13 weeks to age 15 weeks. 
 
2.4 Section C 
2.4.1 Data and tissue sample collection 
This was done according to the procedure of McKay et al., (2008) 
2.4.2 Data collection           
All weight measurements during sample collection were taken with the Mettler AJ150 
Weighing Balance (Toledo Ltd, Switzerland) 
 
2.4.3 Tissue sample collection 
Animals were killed by cervical dislocation, and body weights recorded immediately after 
death. Organs (liver, heart, right and left kidney, spleen), were removed, weighed and snap 
frozen in liquid nitrogen and stored at -80oC.   
 
2.4.4 Intestinal sampling 
The intestine was removed from the pyloric sphincter of the stomach to the rectal end and 
mesenteric fat removed. This was then dissected into small intestinal, caecal and colonic 
sections.  
2.4.5 Small intestine 
The length of the small intestine was measured with minimum stretching and the weight when 
full was recorded. It was then transversely divided in to proximal and terminal parts which were 
sprayed with Phosphate Buffered Saline (PBS). Each section was opened longitudinally and 
food and faecal materials gently removed. The two sections were weighed together and 
recorded as weight of empty small intestine. 
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2.4.6 Colon 
The colon was minimally stretched and the length measured. The weight when full was also 
recorded.  It was sprayed with PBS, opened longitudinally and faecal materials gently scrapped 
off. The weight was taken and recorded as weight of empty colon. 
 
2.4.7 Tumour Mass/ Volume 
Tumour diameter was visually estimated in millimetre and tumour volume calculated as 
Volume (mm3) = 4/3 π (R/2)2, where R = estimated tumour diameter (mm) (Cai et al., 2010). 
 
2.4.8 Tumour and tissue sampling 
The segments of the intestine (proximal, terminal and colon) were carefully examined under 
the dissecting microscope and visible tumours recorded in terms of location, size and number. 
From each of the three sections of the intestine, mucosa and tumour samples were taken. For 
normal tissue samples, one centimetre of seemingly normal tissue sections were cut from the 
midpoint of each of the three intestinal segments and immersed in RNAlater. From the three 
intestinal segments mucosa samples were gently scrapped with glass microscope coverslip into 
RNAlater. In addition visible tumour samples were excised using a pair of scissors and 
immersed in RNAlater. All samples preserved in RNAlater were kept at 4oC overnight before 
storing at -20oC for gene expression studies. 
 
2.5 Section D 
 
2.5.1 Molecular studies 
2.5.2 Extraction of RNA from intestinal tissue tumour samples 
Total RNA was extracted from seemingly normal intestinal tissue and intestinal tumour samples 
preserved in RNAlater using RNeasy Plus Mini Kit from Qiagen according to the 
manufacturer’s instructions. Between 23 and 30 mg of tissue was homogenised in 600 µl of 
Buffer RLT with aid of Tissue Ruptor probes (Qiagen). The lysate was centrifuge at maximum 
speed for 3 minutes in Eppendorf Centrifuge 5430R (Eppendorf AG 2231, Hamburg, Germany) 
and the supernatant carefully transferred into gDNA Eliminator spin column in a 2 ml collection 
tube and centrifuged at 10,000g for 30secs.  
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Six hundred microliters of 70 % ethanol was added to the filtrate, mixed thoroughly and pipetted 
into RNeasy spin column in a 2 ml collection tube and centrifuged at 10,000 g for 15 seconds. 
The residue/filter was washed with 700 µl Buffer RWI and centrifuge at 10,000 g for 15 
seconds. The residue is again washed twice consecutively with 500µl RPE Buffer (containing 
absolute ethanol in the ratio of 4 to1 (v/v) (ethanol to Buffer RPE)) and centrifuged at 10,000 g 
for 15seconds and 2 minutes respectively.  There after it was centrifuged at full speed for 1 
minute to remove any traces of alcohol. The purified RNA was then eluted with 50 µl RNase-
free water into 1.5 ml collection tube and preserved at -80oC until required. The purity and yield 
of isolated RNA was determined with the Nanodrop ND-1000 Spectrophotometer. The ratio of 
absorbance at 260/280 for all the isolates ranged between 2.0-2.14 suggesting good quality 
RNA. 
 
2.5.3 Reverse Transcription 
One microgram (1µg) DNase free RNA was reverse transcribed to generate cDNA in a 20 µl 
reaction volume using QuantiTect® Reverse Transcription Kit (Qiagen) as described by the 
manufacturer using Eppendorf Master Cycler Gradient (Eppendorf AG 22331 Humburg, 
Germany). Any traces of genomic DNA (gDNA) in the isolated RNA was removed in a 14ul 
gDNA elimination reaction consisting of 2 µl of gDNA Wipeout Buffer, 1 µg of RNA and 
RNase free water and incubated at 42oC for 2 minutes. The reverse transcription was carried 
out by incubating a 20 µl reaction volume containing 14 µl gDNA elimination reaction, 1µl 
Reverse-transcriptase, 4 µl Quantiscript RT Buffer and 1ul RT Primer Mix for 15 minutes at 
42oC. cDNA transcription included a no-template control (NTC) (no RNA included in reaction 
mix) and no-enzyme control (NEC) (Reverse Transcriptase was excluded from the reaction) 
which served as contamination control. The cDNA produced was made up to 200µl with RNase 
and DNase-free water and aliquoted in 50 µl volumes for storage at -80oC.  
 
2.5.4 Real time PCR amplification 
Real-time PCR was performed on six target genes of interest, Retinoid X receptor alpha 
(RXRα), β, β-carotene-monooxygenase (BCMO1), Retinoid acid receptor-beta (RARβ), Cyclin 
D1, Cyclooxygenase-2 (COX-2), and Matrix metalloproteinase/Matrilysin (MMP7) and β-
Actin which served as the Reference gene. Transcript levels of the genes of interest were 
measured on a CFX-96 Thermal Cycler with Real-Time Detection System (Bio-Rad) in a total 
reaction volume of 20 µl using 1.0µl transcript specific primers (Eurofins, UK), 10 µl 
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QuantiTect SYBR green mix (Qiagen Cat. No. 204145), 4 µl 1:20 diluted cDNA and 4.0 µl 
water. 
The amplification conditions were denaturation at 94oC for 15seconds followed by 40 cycles 
of annealing for 30 seconds at differing temperatures for individual genes (Table 2.1), extension 
at 72oC for 30 seconds and a melting curve. 
 
Table 2. 1: Primer details and annealing temperatures 
Gene Oligo-nucleotide Primer sequence 
Annealing  
temperature 
Cyclin D1 
Forward 5'-ATGGAACACCAGCTCCTGTG-3' 
60oC 
Reverse 5'-ACCTCCAGCATCCAGGTGGC-3' 
RXRa 
Forward 5'-CTTTGACAGGGTGCTAACAGAGC-3' 
60oC 
Reverse 5'- ACGCTTCTAGTGACGCATACACC-3 
BCMO1 
Forward 5'-TCTGAGTTCGGAACCATGGC-3' 
60oC 
Reverse 5'-GTGTGAGACAAGTAGGAGAAAGCT-3' 
RARb 
Forward 5'-GCCTGCAGAAGTGCTTTGAAGT-3' 
56.5oC 
Reverse 5'-GCTTTCCGGATCTTCTCAGTGA-3' 
MMP7 
Forward 5'-GATGAGGACGCAGGAGTGAAC-3' 
56.5oC 
Reverse 5'-GAAGAGTGACTCAGACCCAGAGAGT-3' 
COX-2 
Forward 5'-GCATTCGCCCAGCACTT-3' 
52.5oC 
Reverse 5'-AGACCAGGCACCGACCAAAGA-3' 
Β-Actin 
Forward 5'-TAGACTTCGAGCAGGAGATGGC-3' 
60oC 
Reverse 5'-CCACAGGATTCCATACCCAAGA-3' 
 
An Internal control (IC) sample, to compare data between individual runs, was prepared by 
combining cDNA reverse transcribed from RNA obtained from mice on various dietary groups, 
includes males and females of both min and wild-type. An IC-NEC was also prepared. A third 
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control group was no template controls (NTC) which were contained all reaction components 
but included water instead of cDNA to test for the presence of contamination control during 
Real-Time PCR. For each sample to be tested the amplification reactions were carried out in 
duplicate, with single NEC amplification reactions alongside them to test for contamination at 
the level of cDNA synthesis.  All other control reactions (IC, IC-NEC and NTC) were in 
triplicate.  
 
2.5.5 Assay Optimisation 
IC cDNA described above was used to optimise PCRs for each primer set in Eppendorf Master 
Cycler Gradient (Eppendorf AG 22331 Hamburg). (See Appendix 3 for Standard curves) PCR 
was performed at different annealing temperatures using gene specific oligonucleotide primers 
and QuantiTect® SYBR® Green with the following PCR amplifications conditions; 
denaturation at 94oC for 15seconds followed by 40cycles of annealing for 30 seconds between 
51oC and 61.8oC, followed by extension at 72oC for 30 seconds and a final melting curve step. 
For each oligonucleotide primer, annealing temperature gradient between 51oC and 61.8oC was 
employed. The reactions were carried out in duplicate. The amplicons were subjected to gel 
electrophoresis using standard 2 % agarose in IX TBE and stained with 1.5µl Ethidium 
Bromide. The stained images were viewed with UV light in Syngene, Multi Genius Bio Imaging 
system (Division of Synoptic LTD). Observation of a single band of required product length 
suggests primer specificity and the corresponding annealing temperature is selected and used 
in the next step (Table 2.1).   
Serial dilutions were produced from the IC cDNA sample and real-time PCR performed using 
QuantiTect® SYBR® Green, gene specific oligonucleotide primer, 4ul of each dilution and 
DNase-RNase-free water in a reaction volume of 20 µl using CFX-96  Thermal Cycler with 
Real-Time Detection System  (Bio-Rad Laboratories Ltd) in line with the manufacturer’s 
protocol. Each reaction was carried out in duplicate and standard curves generated by plotting 
the threshold cycles (CT) values against the log of the dilution factor in the range of 1:5 to 
1:500. Table 5 A below presents PCR amplification information of target genes are presented  
Amplification efficiency (E) and percentage efficiency (% E) of the assay were therefore 
calculated using the formula: 
E =10-1/slope             
E= EFFICIENCY 
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% E = (E-1) X 100 % 
Expression of target gene is calculated with the formula 
  2^CT 
   
Where CT = (%ER)^CtR 
                        (%ET)^CtT  
           %ER=efficiency of reference gene;  CtR= mean ct of reference gene 
           %ET= efficiency of target gene;    CtT= mean ct of target gene 
 
Table 2. 2: PCR Amplification information of target gene and reference gene 
Target  
Gene 
Amplicon 
Size (bp) 
Slope of 
standard  
curve   
% 
Efficiency 
R2 
BCMO1 77 -2.88 122.47 0.999 
RARbeta 151 -3.15 107.85 0.986 
RXRalpha 173 -3.37 98.02 0.992 
Cyclin D1 200 -3.12 109.27 0.992 
COX-2 192 -3.41 96.58 0.99 
BetaActin1 151 -3.33 99.84 0.998 
MMP7 78 -342 96.18 0.99 
1 Reference gene 
 
2.6 Statistical Analysis 
ANOVA (General Linear Model and Fit General Linear Model) of Minitab 17 
was employed for the analysis to determine the effects of maternal and post 
weaning diets, sex, genotype and their interactions on growth, tumour number and 
volume, body weight, and internal organ dimensions of mice in a factorial design.  
Statistical details are outlined on the results pages.  
Values presented by tables and graphs were LSM (Least square means) 
considered to be most appropriate estimates of means of effects of diet treatment 
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after the adjustments of any inequalities in sex and genotype distribution to dietary 
regime.  
Before analyses all data were tested for normal distribution by examining the 
skewness and kurtosis using descriptive statistics and probability plots. Where 
data was not normally distributed it was transformed to reduce skewness and 
Kurtosis using Box Cox transformation Tool of Minitab 17 Statistical Software. 
This provides the best transformation for a given data set and is defined by value 
of lambda as follows;(Osbourne, 2002) 
0 = log transformation    
0.5   =  square root transformation 
 1  = no transformation required 
2 = square transformation 
-1 = reciprocal transformation 
 
2.7 Differences between current research and the research of Saleh et al., (2013) 
Saleh et. al., (2013) investigated the effects carrot consumption on intestinal tumour 
tumorigenesis in ApcMin/+ mice. In their study carrot pellets were fed to breeding trio prior to 
mating, through gestation and lactation. Weaned pups were continued on their respective dams’ 
diet until killed at age 12 weeks. 
In the current study, carrot feeding started at gestational age zero by randomising breeding trio 
to experimental diet (carrot pellet) or control pellet prior to mating, through gestation and 
lactation. However, unlike Saleh et al., (2013), weaned offspring were randomised to either 
control pellet or experimental diet to create four in utero-post weaning dietary groups strictly 
adhered to until killed at 15 weeks. This study therefore examined the effects of maternal and 
post weaning carrot diet on intestinal tumourigenesis.in adult offspring, a complete departure 
from the study of Saleh et al., (2013) and to my knowledge is the first of its kind.  
The similarity between the current study and that of Saleh et al., (2013) is the use of carrot 
pellet diet consisting of 20 % carrot powder and 80 % RM3 (P). However, the pellet used by 
Saleh et al., (2013) was handmade and therefore lacked consistency in terms of size and texture 
and hardness. Also drying was at room temperature as such required much time to dry creating 
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opportunity for growth of mould. These were conditions that informed the mode of 
experimental diet production for the current study. Pellet for the current study were 
manufactured in the industry with professional equipment to specification and dried at a 
predefined temperature range of 90 – 120oC. 
The second part of the current study investigated effects of carrot powder consumption in utero 
and post weaning and also effects of stored carrot pellet post weaning on intestinal 
tumourigenesis.  
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3 Chapter 3 Results for Study One 
 
3.1 Proximate Composition 
Proximate data was analysed using ANOVA, General Linear Model (GLM) with carrot powder, 
control powder and stored carrot pellet as factors. Data was not transformed. Results are 
presented as LSM ± SEM. Tukey's test was employed to locate significant difference between 
means where necessary. Data on micro nutrient composition of carrot pellet and control diet are 
presented in appendix 1. 
There were significant differences in macronutrient composition of the experimental diets 
however the total energy content based on the total macro nutrient composition of the diets was 
not statistically different suggesting the diets were isocaloric (Table 3.1). See Appendix 2 for 
analytical procedures.  
 
Table 3. 1: Nutrient composition of experimental diet 
Sample   Carrot  powder Control powder Stored carrot pellet  
P-Value 
Parameter (%) Mean  ± StDev Mean  ± StDev Mean  ± StDev 
Oil (%)      2.84 ± 0.259b   3.05  ± 0.122b   4.69 ± 0.344a < 0.001 
Fibre (%)      6.26  ± 0.166a   3.98  ± 0.058b 6.72  ± 0.31a < 0.001 
Ash (%)      6.5 ± 0.025b   6.9  ± 0.004a   6.93 ± 0.026a < 0.001 
Moisture (%)   10.16  ± 0.07 b 10.58 ± 0.052a  9.05 ± 0.081c < 0.001 
Protein (%)   15.58 ± 0.893b 19.48 ± 0.361a  18.7 ± 0.651a < 0.001 
NFE (%)   58.61 ± 1.111a     56.03 ± 0.288 b 50.87 ± 4.68c  < 0.001 
Energy (mj/kg)  13.69 ± 0.111a    13.99  ± 0.025a  13.59 ± 0.967a   0.069 
Means that do not share a letter in a row are significantly different. 
 
3.2 Effects of diet on pregnancy outcome 
Effects of maternal diets, control pellet and carrot pellet on pregnancy outcome was determined 
by comparing the litter size, sex distribution, and genotypes of offspring of dams across the 
diets using ANOVA (GLM). All weaned offspring were included in the analysis. Data was 
presented as LSM ± SEM.  
Eight dams were randomised to control pellet and seven to carrot pellet diets. A total of 96 
offspring were weaned, 46 were born to dams on carrot pellet and 50 to dams on control pellet. 
Maternal diet had no significant effect on pregnancy outcome except on the number of wild 
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type females that was significantly (P = 0.02) higher in litter of wild type dams fed carrot pellet 
(Table 3.2).  
Table 3. 2: Maternal diet and pregnancy outcome 
 Maternal diet 
P value 
Carrot pellet 
(n = 7) 
Control pellet 
(n = 8) 
Mean± SEM Mean ± SEM 
Litter size 6.57  ± 0.409 6.25 ± 0.382 0.576 
Total male  2.71  ± 0.322 3.5   ± 0.301 0.098 
Total female  3.86  ± 0.424 2.75 ± 0.397 0.079 
Total Min 3.57 ±0.625 3.38 ±0.585 0.822 
Total Wild type 3.00 ±0.501 2.88 ±0.469 0.858 
Min males 1.57  ± 0.435 1.75 ± 0.407 0.769 
Min females 2.0    ± 0.39 1.63 ± 0.365 0.495 
Wild type male 1.14  ± 0.397 1.75 ± 0.372 0.285 
Wild type 
female 
1.86  ± 0.203 1.13 ± 0.189 0.02 
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3.3 Dietary Groups of animals on study  
A total of 96 mice (47males and 49 females) were randomised at weaning to control or carrot pellet diets to form four in utero post weaning dietary 
groups. One female ApcMin/+ mouse of carrot pellet-control pellet dietary group died during the course of the study. Chi-square analysis suggested that 
there was no difference between the number males and females (P = 0.15) (Table 3.3). 
Table 3. 3: Dietary Groups of Experimental Animals Stratified by Sex and Genotype  
Control pellet-control pellet Control pellet-carrot pellet Carrot pellet-control pellet Carrot pellet-carrot pellet 
Wild type Min Wild type Min Wild type Min Wild type Min 
Male Female Male Female Male Female Male Female Male Female Male Female Male Female Male Female 
9 5 7 6 5 4 7 7 5 6 4 6 3 7 7 8 
 
 
3.4 Growth Data Analysis 
Effects of maternal diet, post weaning diet, sex and genotype on growth were analysed in a factorial design using ANOVA (GLM). Weaning weight was 
subtracted from weekly weights for statistical analysis. To determine the effects of sex and genotype on growth data for both sexes and genotypes were 
put together and genotype added as covariate looking at effects of sex whilst sex was added as covariate looking at effects of genotype. As sex and 
genotype significantly affected growth they were added as covariate to investigate effects of maternal diet and post weaning diet on growth. The effects 
of maternal and post weaning diets on growth were analysed for Min and Wild type separately and also with combined data for the genotypes. Effects 
of maternal diet on weaning weight was investigated with maternal diet, sex and genotype as factors alongside their interactions with litter size as 
covariate. Results are presented as Least Square Means (LSM) ± SEM. All data were uniformly distributed and therefore not transformed. 
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3.4.1 Weaning weight 
Maternal diet had no significant effect on mean weaning weight of offspring (Table.3.4). Male offspring were heavier than females by 6.5 % (P < 0.001) 
whiles wild type mice were heavier than ApcMin/+ mice by 4.4 % (P = 0.023) at weaning. Neither of the interactions between the main factors had any 
significant effect on weaning weight (Table 3.4). 
Table 3. 4: Effects of Maternal diet, Sex and Genotype on weaning weights of experimental mice 
 
Maternal diet Sex Genotype Probability effects of main factor interactions 
Control pellet 
(n = 50) 
Carrot pellet 
(n = 46) 
P value 
Female 
(n = 49) 
Male 
(n = 47) 
P value 
ApcMin/+ 
(n = 52) 
Wild 
type       
(n = 44) P value 
Maternal 
diet*Sex 
Maternal 
diet* 
Genotype 
Sex * 
Genotype 
Maternal 
diet*Sex* 
Genotype 
Mean ± SEM Mean ± SEM 
Mean ± 
SEM 
Mean ± 
SEM 
Mean ± 
SEM 
Mean ± 
SEM 
Weaning 
weight 
13.7  ± 0.333 
12.80  ± 
0.349 
0.084 
12.39 ± 
0.335 
14.11 ± 
0.345 
< 0.001 
12.67 ± 
0.321 
13.83 ± 
0.357 
0.023 0.639 0.874 0.231 0.646 
Weaning weight data was Box Cox transformed for P value 
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3.4.2 Effects of Sex and Genotype on Growth of Mice 
As expected males were heavier (P < 0.001) than females at death at age 15 weeks (Fig.3.1). 
Sex, maternal diet and post weaning diet interactions had no significant effect on mean weight 
gain post weaning at death. Wild type mice were also heavier (P < 0.003) than Min mice at 
death at age 15 weeks (Fig. 3.2). Genotype, maternal diet and post weaning diet interactions 
had no significant effect on mean weight gain post weaning. 
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Figure 3. 1:  Growth curves of mean weight gain post weaning for male and female mice from 
all dietary groups. Genotype was added as covariate in looking at effects sex on growth (Female 
n = 48; male n = 47). Weaning weight was subtracted from weekly weights for statistical 
analysis. Data were uniformly distributed and therefore not transformed.  
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Figure 3. 2: Growth curves of mean weight gain post weaning for Min and Wild type mice 
from all dietary groups. Sex was added as covariate in looking at effect of genotype on growth 
(ApcMin/+ n = 51; Wild type n = 44). Weaning weight was subtracted from weekly weights for 
statistical analysis. Data were uniformly distributed and therefore not transformed. 
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3.4.3 Effects of Maternal and Post weaning diet on Growth of Mice 
As sex and genotype significantly influenced growth they were added as covariate to investigate 
effects of maternal diet and post weaning diet on growth measured as mean weight gain post 
weaning. 
Curves present effects of maternal and post weaning diet interactions on growth. At death at 
age 15 weeks, maternal and post weaning diet interactions had no statistically significant (P = 
0.957) effect on mean weight gain post weaning by Min mice (Fig. 3.3). Neither maternal (P = 
0.562) nor post weaning (P = 0.386) diet had any significant effect on mean weight gain post 
weaning (data not shown). 
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Figure 3. 3: Growth curves of mean weight gain post weaning for Min mice exposed to 
different dietary regimes. Sex was added as covariate looking at the effects of the diets on 
growth, (Control pellet-control pellet n = 13; Control pellet-carrot pellet n = 14; Carrot pellet-
control pellet n = 9; Carrot pellet-carrot pellet n = 15). Weaning weight was subtracted from 
weekly weights for statistical analysis. Data were uniformly distributed and therefore not 
transformed. 
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Curves present effects of maternal and post weaning diet interactions on growth. Interactions 
of maternal and post weaning diets had no statistically significant effect on mean weight gain 
post weaning by wild type mice at death at age 15 weeks (P = 0.099) (Fig. 3.4). Wild type mice 
fed carrot pellet post weaning had 6.4 % (P = 0.04) higher mean weight gain compared to 
control pellet fed at death at age 15 weeks. Maternal diet had no statistically significant effect 
(P = 0.712). Data not shown. 
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Figure 3. 4: Growth curves of mean weight gain post weaning for wild type mice exposed to 
different dietary regimes. Sex was added as covariate looking at the effects of diet on growth. 
(Control pellet-control pellet n = 14; control pellet-carrot pellet n = 9; carrot pellet-control pellet 
n = 11; carrot pellet-carrot pellet n = 10) Weaning weight was subtracted from weekly weights 
for statistical analysis. Data were uniformly distributed and therefore not transformed. 
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Curves present effects of maternal and post weaning diet interactions on growth. At death at 
age 15weeks interactions of maternal and post weaning diet had no significant effect (P = 0.321) 
on mean weight gain post weaning by mice (both Min and Wild type) exposed to different 
dietary regimes ((Fig.3.5). Mice fed carrot pellet post weaning had 4.7 % (P = 0.041) higher 
mean weight gain than those fed control pellet at death at age 15 weeks. Maternal diet had no 
statistically significant effect (P = 0.677) (data not shown). 
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Figure 3. 5: Growth curves of mean weight gain post weaning for mice (Min and Wild type) 
exposed to different dietary regimes. Sex was added as covariate looking at the effects of diet 
on growth, (Control pellet-control pellet n = 27; Control pellet-carrot pellet n = 23; Carrot 
pellet-control pellet n = 20; Carrot pellet-carrot pellet n = 25). Weaning weight was subtracted 
from weekly weights for statistical analysis. Data were uniformly distributed and therefore not 
transformed. 
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3.5 Effects of Maternal and Post weaning diets, Sex and Genotype on Body weight and 
Internal Organ dimensions of mice at death 
Effects of maternal diet, post weaning diet and sex and their interactions on body weight and 
internal organ dimension of mice at death at age 15 weeks were analysed in a factorial design 
using ANOVA (LSM). SI length, body, colon, right and left kidneys and spleen weights and 
were Box Cox transformed for P values. Means were calculated as LSM ± SEM. Results are 
presented in tables 3.5, 3.6, and 3.7. 
 
3.5.1 Effects of Sex and Genotype on Body weight and Organ dimensions  
As expected, male mice were significantly heavier, (27.62 g ± 0.287 SEM) (P < 0.001) than 
their female counterparts (21 g ± 0.28 SEM) at time of death at 15 weeks (Table 3.5). Apart 
from weights of terminal SI (P = 0.075) and colon (P = 0.087) all organs weighed were 
significantly heavier in males than females. The length of SI (P < 0.001) and colon (P = 0.008) 
were also longer in males than in females.  
Also at time of death as expected, Wild type mice had higher mean body weight (25.67 ± 0.294) 
(P < 0.001) than Min mice (23.06 ± 0.275 SEM) (Table 3.5). Significantly heavier in the Wild 
types were liver (P = 0.026), right and left kidneys (P < 0.001) and the heart (P < 0.001). The 
weights of terminal SI, colon and spleen were higher (P < 0.001) in Min mice than in Wild 
types. Weights of the liver and right kidney were significantly affected by sex and genotype 
interaction (Table 3.5). 
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Table 3. 5: Effects of sex and genotype on body and organ dimensions of mice exposed to different dietary regime at death at 
    age 15 weeks  
 Sex Genotype 
Probability 
effects of 
Sex * Genotype 
 Female 
(n = 48) 
Male 
(n = 47) P value 
ApcMin/+ 
(n = 51) 
Wild type 
(n = 44) P value 
 Mean ± SEM Mean ± SEM Mean ± SEM Mean ± SEM 
Body weight (g) 20.99 ± 0.28 27.62 ± 0.287  < 0.001 23.06 ± 0.275 25.67 ± 0.294 < 0.001 0.175 
Full colon weight (g)   0.41 ± 0.012   0.47 ± 0.12  < 0.001   0.45 ± 0.011   0.43 ± 0.012    0.212 0.144 
Proximal SI weight (g)   0.67 ± 0.01   0.75 ± 0.01  < 0.001   0.72 ± 0.01   0.7   ± 0.01    0.136 0.581 
Terminal SI weight (g)   0.58 ± 0.01   0.6 ± 0.01     0.075   0.63 ± 0.01   0.55 ± 0.01 < 0.001 0.671 
SI length  (cm) 29.18 ± 0.304 31.23 ± 0.312  < 0.001 30.17 ± 0.292 30.31 ± 0.312    0.936 0.183 
Colon weight (g)   0.23 ± 0.006    0.25 ± 0.006     0.087   0.26 ± 0.006   0.22 ± 0.006 < 0.001 0.233 
Colon length (cm)   6.14 ± 0.071 6.41 ± 0.073     0.008   6.35 ± 0.068   6.24 ± 0.073    0.253 0.965 
Caecum weight (g)   0.56 ± 0.014 0.71 ± 0.014  < 0.001   0.63 ± 0.014   0.62 ± 0.014    0.453 0.194 
Liver weight (g)   1.08 ± 0.029 1.51 ± 0.03  < 0.001   1.25 ± 0.029   1.34 ± 0.031    0.026 0.039 
Right kidney weight (g)   0.14 ± 0.003 0.18 ± 0.003  < 0.001   0.14 ± 0.003   0.17 ± 0.003 < 0.001 0.017 
Left kidney weight(g)   0.14 ± 0.002 0.17 ± 0.002 < 0.001   0.14 ± 0.002   0.16 ± 0.002 < 0.001 0.067 
Spleen weight (g)   0.19 ± 0.014 0.21 ± 0.014    0.029   0.29 ± 0.013   0.09 ± 0.014 < 0.001 0.484 
Heart weight (g)   0.19 ± 0.006 0.23 ± 0.006 < 0.001   0.2   ± 0.006   0.23 ± 0.006 < 0.001 0.153 
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3.5.2 Effects of Maternal and Post weaning diet on Body and Organ Dimensions of Mice 
at Death  
At time of death mean body weight of adult offspring born to dams fed control pellet (24.8 g ± 
0.272 SEM) (P = 0.011) was higher than offspring born to carrot pellet fed dams (23.8 g ± 0.288 
SEM) (Table 3.6).  Carrot pellet consumption by dams decreased mean weight of the heart (P 
= 0.005) (Table 3.6). 
Feeding carrot pellet diet to mice post weaning increased mean weights of proximal SI, terminal 
SI and caecum (P < 0.001) but decreased that of the heart (P = 0.01) at time of death. Maternal 
and post weaning diet interactions affected the weight of heart (P = 0.047) (Table 3.6).  
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    Table 3. 6 Effects of Maternal and Post weaning diets on body and internal organ dimensions of mice at death at 15 weeks  
        Maternal diet Post weaning diet 
Probability effects 
of Maternal diet * 
Post weaning diet 
 Control pellet 
(n = 50) 
Carrot pellet  
(n=45) 
P value 
Control pellet 
(n = 47) 
Carrot pellet 
(n = 48) P value 
 Mean ± SEM Mean ± SEM  Mean ± SEM Mean ± SEM 
Body weight (g) 24.80 ± 0.272 23.76 ± 0.288 0.011 24.66 ± 0.284 23.91 ± 0.278    0.089 0.314 
Full colon weight (g)   0.45 ± 0.011   0.44 ± 0.012 0.663   0.44 ± 0.012   0.45 ± 0.012    0.583 0.32 
Proximal SI weight (g)   0.70 ± 0.01   0.71 ± 0.010 0.724   0.67 ± 0.01   0.74 ± 0.01 < 0.001 0.732 
Terminal SI weight (g)   0.59 ± 0.01   0.59 ± 0.010 0.823   0.57 ± 0.01   0.62 ± 0.01 < 0.001 0.763 
SI length  (cm) 30.46 ± 0.296 29.9   ± 0.313 0.181 29.99 ± 0.308 30.36 ± 0.302    0.433 0.158 
Colon weight (g)   0.23 ± 0.006   0.25 ± 0.006 0.155   0.24 ± 0.006   0.24 ± 0.006    0.622 0.087 
Colon length (cm)   6.31 ± 0.07   6.25 ± 0.074 0.582   6.26 ± 0.073   6.30 ± 0.071    0.68 0.298 
Caecum weight (g)   0.62 ± 0.013   0.63 ± 0.014 0.609   0.56 ± 0.014   0.70 ± 0.014 < 0.001 0.737 
Liver weight (g)   1.31 ± 0.029   1.27 ± 0.031 0.337   1.28 ± 0.03   1.3 ±  0.03    0.696 0.464 
Right kidney (g)   0.16 ± 0.003   0.16 ± 0.003 0.497   0.16 ± 0.003   0.16 ± 0.003    0.317 0.427 
Left kidney (g)   0.15 ± 0.002   0.15 ± 0.002 0.247   0.15 ± 0.002   0.15 ± 0.002    0.796 0.408 
Spleen   0.19 ± 0.013   0.20 ± 0.014 0.063   0.2   ± 0.014   0.2  ± 0.013    0.621 0.341 
Heart   0.22 ± 0.006   0.20 ± 0.006 0.005   0.22 ± 0.006   0.2  ±  0.006    0.01 0.047 
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Table 3. 7: Probability effects of interactions of Maternal and Post weaning diets, Sex and 
Genotype on Body and organ Dimensions Study  
 
Maternal diet * Sex * 
Genotype 
Post weaning diet* 
Sex * Genotype 
Maternal diet *  
Post weaning diet 
Sex * Genotype  
Body weight (g)  0.842 0.813 0.283 
Full colon weight (g)  0.743 0.237 0.951 
Proximal SI weight (g)  0.691 0.358 0.546 
Terminal SI weight (g)  0.067            0.72 0.469 
SI length  (cm)  0.718 0.573 0.533 
Colon weight (g)  0.853 0.162 0.771 
Colon length (cm)  0.251 0.744 0.367 
Caecum weight (g)  0.906            0.44 0.301 
Liver weight (g)  0.852 0.804 0.267 
Right kidney (g)                0.33 0.456 0.743 
Left kidney (g) 0.533 0.168 0.288 
Spleen weight (g) 0.457 0.526 0.428 
Heart weight (g) 0.283 0.397 0.701 
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3.6 Tumour Data Analysis  
Tumour number in the three sections of the intestine of the Min mice was compared in One-
Way ANOVA. Effects of maternal diet, post weaning diet, sex and their interactions on tumour 
number and volume were analysed as a factorial design using ANOVA, GLM. Data from 
proximal SI, terminal SI, colon and total gut were Box Cox transformed for P values. The main 
factor effects are presented in figures 3.7 - 3.12. Effects of main factor interactions are presented 
in table 3.8.  
 
3.6.1 Tumour Distribution in Intestine of Min mice 
There were significant (P < 0.001) differences in distribution of tumour in gut of Min mice at 
time of death. Most of the tumour occurred in the terminal SI (31.4 ± 1.49 SEM). Tumour 
number in proximal and colon were 11.3 ± 1.49 SEM and 1.8 ± 1.49 SEM in the colon (Fig.3.6). 
Mean tumour number per mouse for the dietary regimes ranged from 43.2 ± 5.5 SEM (carrot 
pellet-control pellet) to 53.3 ± 4.9 SEM (carrot pellet-carrot pellet). Mean tumour number per 
mouse for carrot pellet-carrot pellet was higher than that control pellet-control pellet by 12.5 (P 
= 0.002)  
 
.  
Figure 3. 6: Tumour distribution in the intestine of min mice (n = 51) Error bars represent SEM,   
Means with different letters are significantly different P < 0.001 
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3.6.2 Effects of Sex on Tumour Number and Volume 
Sex had no statistically significant effect on intestinal tumour number (Fig. 3.7) and 
volume (Fig. 3.8) in min mice.   
 
Figure 3. 7: Effects of sex on (A) proximal small intestine (B) terminal small intestine (C) 
colon and (D) total gut intestinal tumour number in Apcmin/+ mice. (Male n = 25, female n =26) 
Error bars represent standard error of means (SEM) 
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Figure 3. 8: Effects of sex on tumour volume in (A) proximal SI (B) terminal SI(C) colon and 
(D) total gut intestinal tumour volume in Apcmin/+ mice. (Female n = 26; males n = 25) Error 
bars represent SEM. 
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3.6.3 Effects of Maternal diet on Tumour Number and Volume 
Maternal diet had no significant influence on tumour number (Fig.3.9) and volume (Fig. 3.10) 
in adult Min mice offspring at death at age 15 weeks. 
  
Figure 3. 9: Effects of maternal diet  on tumour number in (A) proximal SI (B) terminal SI (C) 
colon and (D) total gut intestinal tumour number in Apcmin/+ mice  ( Control pellet n = 27, carrot 
pellet n = 24).Error bars represent standard error of means (SEM). 
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Figure 3. 10: Effects of maternal diets on (A) proximal SI (B) terminal SI (C) colon and (D) 
total gut  intestinal tumour volume in Apcmin/+ mice. (SEM) Control pellet n = 27, carrot pellet 
n = 24) Error bars represent (SEM). 
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3.6.4 Effects of Post weaning diet on Tumour Number and Volume 
Carrot pellet consumption by offspring post weaning significantly increased mean tumour 
number (P = 0.044) in terminal small intestine (Fig. 3.11 B) and mean total gut tumour number 
(P = 0.038) (Fig. 3.11 D). Post weaning diet had no significant effect on tumour volume in the 
intestine of Min mice at death (Fig.3.12). 
 
Figure 3. 11: Effects of post weaning diet  on (A) proximal SI  (B) terminal SI (C) colon and 
(D) total gut intestinal tumour number in Apcmin/+ mice (Control pellet n = 22, carrot pellet n = 
29) Error bars represent SEM. 
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Figure 3. 12: Effects of post weaning diet on tumour volume in (A) proximal SI (B) terminal 
SI (C)colon and (D) total gut tumour volume in Apcmin/+ mice (Control pellet n = 22, carrot 
pellet n = 29) Error bars represent SEM. 
 
3.6.5 Effects of Interaction of Maternal and Post weaning diet and Sex on Tumour 
Number and Volume 
No statistically significant interaction was observed between sex, maternal and post weaning 
diets for tumour number and volume at death in the intestine of Min mice (Table 3.7).  
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Table 3. 8: Effects of interactions of sex, maternal and post weaning diets on intestinal tumour number and volume (mm3) in Min mice at time of death at 
age 15 weeks (CP = control pellet, CPP = carrot pellet, Fem = female). 
 
Maternal diet * Post weaning diet Maternal diet * Sex Post weaning diet *Sex 
CP-CP 
(n = 13) 
CP- CPP 
(n = 14) 
CPP-CP 
(n = 9) 
CPP-
CPP     
(n = 15) 
P value CP-Fem 
(n = 13) 
CP-Male 
(n = 14) 
CPP-Fem 
(n = 13) 
CPP-male 
(n = 11) 
P value CP-Fem 
(n = 11) 
CP-Male 
(n = 11) 
CPP-Fem 
(n = 15) 
CPP-Male 
(n = 14) 
P value 
Mean Mean Mean 
Proximal SI 
Tumour Number 
8.23 11.29 10.08 14.44 0.674 10.44 9.07 15.14 9.38 0.228 10.28 8.02 15.29 10.43 0.487 
Terminal SI 
Tumour Number 
21.64 35.36 31.10 36.72 0.364 30.93 26.07 32.04 35.79 0.377 25.10 27.64 37.87 34.21 0.667 
Colonic Tumour 
Number 
1.33 1.86 2.13 2.12 0.591 1.55 1.64 2.19 2.05 0.753 1.83 1.63 1.90 2.07 0.56 
Total Gut Tumour 
Number 
31.2 48.5 43.3 53.28 0.574 42.9 36.79 49.36 47.21 0.906 37.22 37.29 55.06 46.71 0.612 
Proximal SI 
Tumour volume 
(mm3) 
110.9 140.2 96.9 175.4 0.157 127.4 123.8 107.3 165 0.620 84.4 123.5 150.3 165.3 0.736 
Terminal SI 
Tumour volume 
(mm3) 
115.2 109.9 98.5 139.1 0.717 96.8 128.3 98.9 138.7 0.588 82.4 131.3 113.3 135.7 0.831 
Colonic Tumour 
volume (mm3) 
158.4 78.5 118 123.6 0.714 134 102.9 129 112.6 0.843 186.1 90.3 76.9 125.2 0.258 
Total gut tumour 
volume (mm3) 
384.5 328.6 313.4 438.2 0.335 358.2 354.9 335.2 416.4 0.769 352.8 345.1 340.6 426.2 0.697 
Maternal diet*post weaning diet* sex had no statistically significant effects on any of the tumour parameters evaluated, data not shown. 
71 
 
4 Chapter 4 Results for Study Two 
 
4.1 Effects of Maternal diet on Pregnancy Outcome 
Twenty one and sixteen dams were randomised to carrot and control powder respectively. Litter 
size, sex distribution and genotype of offspring were compared between dams across diet using 
ANOVA.  All offspring that reached weaning age were included in the analysis. One hundred 
and fourteen offspring born to dams on carrot powder and 100 to control powder fed dams were 
weaned.  Two wild type male offspring born to carrot powder fed dams and randomised to 
carrot powder diet post weaning, died a week after weaning. This was probably due to either 
struggle for food or ear punch sampling for genotype analysis. 
Maternal diet had no significant effect on pregnancy outcome except total mean number of Min 
offspring born to dams fed control powder which was significantly (P = 0.015) higher compared 
to the number born to carrot powder fed dams. The mean number of males and females born to 
dams in each dietary group did not differ; control pellet fed dams (P = 0.827, males, n = 3.2 ± 
0.38 SEM, females, n = 3.1 ± 0.42 SEM), carrot pellet fed dams (P = 0.256. males n = 3 ±0.41 
SEM, females n = 2.4 ± 0.27 SEM) (Table 4.1) 
Table 4. 1: Maternal diet and pregnancy outcome of dams  
 Maternal diet  
Carrot powder 
(n =21) 
Control powder 
(n = 16) 
P value 
Mean  ± SEM Mean  ± SEM  
Litter size 5.4 ± 0.44 6.3 ± 0.51 0.231 
Total male 3.0 ± 0.38 3.2 ± 0.44 0.748 
Total female 2.4 ± 0.32 3.1 ± 0.36 0.198 
Total Min 1.9 ± 0.31 3.1 ± 0.36 0.015 
Total wild type 3.5 ± 0.31 3.1 ± 0.36 0.411 
Min males 1.0  ± 0.24 1.7 ± 0.28 0.071 
Min females 0.9 ± 0.24 1.4 ± 0.27 0.151 
Wild type male 2.0 ± 0.30 1.5 ± 0.34 0.280 
Wild type female 1.5 ± 0.22 1.6 ± 0.26 0.769 
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4.2 Animal Distribution on Study 
Two hundred and fourteen (214) weaned pups were randomised onto the five dietary groups at weaning. Two wild type males from carrot powder fed 
dams and randomised to carrot powder post weaning died a week after weaning, reducing the number of wild type males in carrot powder-carrot powder 
to 15 from 17 (Table 4.3). The death was suspected to be due to genotyping. There was no significant difference in the distribution of animal on the 
study, (P = 0.53) (Table 4.2). 
Table 4. 2: Dietary Groups of Experimental Animals stratified by Sex and Genotype (F= female; M = male). 
Control powder – control  
powder 
Control powder – carrot  
powder 
Carrot powder – control  
powder 
Carrot powder – carrot  
powder 
Control powder – stored     
carrot pellet 
Wild type ApcMin/+ Wild type ApcMin/+ Wild type ApcMin/+ Wild type ApcMin/+ Wild type ApcMin/+ 
M  F M F M F M F M  F M F M F M F M F M F 
6 10 12 4 6 11 9 13 25 22 8 9 17 10 13 11 12 5 6 5 
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4.3 Growth Data Analysis 
Growth was followed to seven weeks of post weaning diet exposure after which animals were killed at different time points. As all mice had at least 
seven weeks of post weaning dietary exposure growth analysis was limited to seven weeks to remove effects of variations in number of days on diet. 
Effects of maternal diet, post weaning diet, sex and genotype were analysed in a factorial design using ANOVA (GLM). To determine the effects of sex 
and genotype on growth data for both sexes and genotypes were put together and genotype added as covariate looking at effects of sex whilst sex was 
added as covariate looking at effects of genotype. As sex and genotype significantly affected growth they were added as covariate to investigate effects 
of maternal diet and post weaning diet on growth. Weaning weight was subtracted from weekly weights for statistical analysis. Results are presented as 
Least Square Means (LSM). Error bars represent ± SEM. Factors for weaning weight analysis were maternal diet, sex and genotype with litter size as 
covariate.  
4.3.1 Weaning weight 
Mean weaning weight of offspring born to carrot powder fed dams was significantly lower by 7.73 % (P < 0.001) compared to that of offspring born to 
control powder fed dams. Females had 5.3 % (P < 0.001) lower mean weaning weight compared to the males. Probability effects of maternal diet 
interaction sex and sex interaction genotype were P = 0.052 and P = 0.056 respectively (Table 4.3). Weaning weight data was not uniformly distributed 
and was therefore transformed for P values. 
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Table 4. 3: Effects of Maternal diet, Sex and Genotype on weaning weights of mice  
 
Maternal diet Sex Genotype Probability effects of main factor interactions 
 Control 
powder         
(n = 100) 
Carrot 
powder      
(n = 114) 
P value 
Female 
(n = 100) 
Male 
(n =114) 
P value 
ApcMin/+ 
(n = 90) 
Wild 
type 
(n = 124) P value 
Maternal 
diet*Sex 
Maternal 
diet* 
Genotype 
Sex * 
Genotype 
Maternal 
diet*Sex* 
Genotype  Mean ±  
SEM 
Mean ± 
SEM 
 
Mean ± 
SEM 
Mean ± 
SEM 
 
Mean ± 
SEM 
Mean ± 
SEM 
Weaning 
weight 
16.86 ± 
0.214 
14.44 ± 
0.21 
< 0.001 
14.82 ± 
0.213 
16.48 ± 
0.203 
< 0.001 
15.58 ± 
0.223 
15.73 ± 
0.192 
0.618 0.052 0.941 0.056 0.913 
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4.3.2 Effects of Sex and Genotype on Growth of Mice 
Growth of mice was significantly influenced by sex and genotype. At seven weeks of post 
weaning diet exposure, males had as expected, higher (P  < 0.001) mean weight gain post 
weaning compared to the females ( Fig. 4.1) Wild type mice also had higher mean weight gain 
post weaning (P = 0.002) (Fig. 4.2) than Min mice. Interactions of sex maternal diet (sex * 
maternal diet) and sex post weaning diet (sex * post weaning diet) had no significant effects on 
growth. 
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Figure 4. 1: Growth curves of mean weight gain post weaning for males and females from all 
dietary regimes. Weaning weight was subtracted from weekly weights for statistical analysis. 
Genotype was added as covariate looking at effects of sex on growth. (Females n = 100; males 
n = 112). Data were uniformly distributed and therefore not transformed. Error bars represent 
± SEM. 
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Figure 4. 2: Growth curves of mean weight gain post weaning for Min and wild type mice from 
all dietary regimes. Weaning weight was subtracted from weekly weights for statistical analysis 
Sex was added as covariate looking at effects of genotype on growth. (ApcMin/+ mice n = 90; 
Wild type mice n = 122). Data were uniformly distributed and therefore not transformed Error 
bars represent ± SEM. 
 
4.3.3 Effects of Maternal and Post weaning diet on Growth of Mice 
As sex and genotype significantly influenced growth they were added as covariates looking at 
effects maternal and post weaning diets. Mice fed carrot pellet post weaning were born to dams 
fed control powder they were excluded to investigate effect of maternal diet on growth. 
Maternal diet significantly influenced mean weight gain post weaning by offspring. Mice born 
to carrot powder fed dams were 9 % (P = 0.011) heavier compared to those from control powder 
fed dams (Fig. 4.3).  
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Figure 4. 3: Growth curves of mean weight gain post weaning for mice exposed to maternal 
carrot powder diet and fed control powder post weaning. Weaning weight was subtracted from 
weekly weights for statistical analysis Means were calculated as Least Square Means (Control 
powder n = 32; carrot powder n = 63) Error bars represent ± SEM. Data were uniformly 
distributed and therefore not transformed. 
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Feeding mice carrot powder post weaning had no significant effect on mean weight gain post 
weaning compared to control powder (P = 0.187) at death. (Fig. 4.4) 
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Figure 4. 4: Growth curves of mean weight gain post weaning for mice fed carrot powder post 
weaning but born to dams fed control powder. AS sex and genotype had significant effects on 
growth they were added as covariate.in evaluating effects of post weaning diet Weaning weight 
was subtracted from weekly weights for statistical analysis. Means were calculated as LSM 
(Control powder n = 32, carrot powder n = 40). Error bars represent ± SEM. Data was Box Cox 
transformed for P value. 
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Stored carrot pellet consumption post weaning by mice had no statistically significant effect on 
mean weight gain post weaning at death (Fig. 4.5).
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Figure 4. 5: Growth curves of mean weight gain post weaning of mice fed carrot pellet post 
weaning. These mice were born to dams fed control powder. As sex and genotype had 
significant effects on growth they were added as covariate.in evaluating effects of post weaning 
diet. Weaning weight was subtracted from weekly weights for statistical analysis. Means were 
calculated as LSM (Control powder n = 32, stored carrot powder n = 28) Error bars represent ± 
SEM. Data was not transformed. 
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As all mice fed stored carrot pellet diet post weaning were born to control pellet fed dams, they 
were excluded in order to investigate effects of maternal and post weaning diet interactions. 
There were no statistically significant (P = 0.187) difference in mean weight gain post weaning 
by mice from different post weaning dietary regimes (Fig. 4.6). 
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Figure 4. 6: Growth curves of mean weight gain post weaning for mice exposed to different 
dietary regimes excluding mice fed stored carrot pellet post weaning. As sex and genotype had 
significant effects on growth they were added as covariate.in evaluating effects of treatment 
diets on weight gain post weaning. Weaning weight was subtracted from the weekly weights 
for statistical analysis. Means were calculated as LSM. (Carrot powder-carrot powder n = 49; 
carrot powder-control powder n = 63; control powder-carrot powder n = 40; control powder-
control powder n = 32) Error bars represent SEM. Data was not transformed. 
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4.4 Effects of Maternal and Post weaning diets, Sex and Genotype on Body weight and 
Internal Organ dimensions of mice at death 
The effects were determined in a factorial design using ANOVA GLM with diet (maternal diet-
post weaning diet), sex and genotype as main factors. Maternal diet and post weaning diet were 
treated as diet dietary regime because dams were not fed stored carrot pellet and all mice fed 
stored carrot pellet were born to dams fed control powder As mice were killed at different time 
points, days on diet was added as covariate looking at effects of the factors and their interactions. 
Means were calculated as LSM ± SEM. Body, full SI, colon, caecum, liver, right kidney, left 
kidney and spleen weights and colon length were Box Cox transformed for P values as data 
were not uniformly distributed. Results are presented in Tables 4.4, 4.5 and 4.6. 
 
4.4.1 Effects of Sex and Genotype on Body weight and Organ Dimensions of Mice at 
death 
As expected males were (26.9 g ± 0.168 SEM) (P < 0.001) heavier compared to the females 
(21.5 g ± 0.184 SEM) at the time of death. With the exception of the spleen (P = 0.911) all 
organs measured were significantly heavier in the males than the female counterparts. SI and 
colon were longer in males (P < 0.001) than in females at death (Table 4.4).  
Wild type mice (25.1 g ± 0.166 SEM) at death were heavier than Min mice (23.3 g ± 0.189 
SEM) (P < 0.001). Also heavier in the wild types were, the right (P < 0.005) and left (P < 0.001) 
kidneys and the liver (P < 0.001). Weights of the full colon, colon, terminal SI (P < 0.001), and 
spleen (P < 0.001) were higher in Min mice compared to wild type mice. SI and colon were 
longer in Wild types (P < 0.001) than in the Min mice (Table 4.4).                 
Full SI weight was significantly affected by genotype-sex interaction  
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Table 4. 4: Effects of sex and genotype on body and organ dimensions of mice at death 
 Genotype Sex 
Genotype*Sex  ApcMin/+ 
(n = 90) 
Wild type 
(n = 122) P value 
Female 
(n = 100) 
Male 
(n= 112) P value 
 Mean  ±  SEM Mean  ±  SEM Mean  ±  SEM Mean  ±  SEM 
Body weight (g) 23.29  ±  0.189 25.09  ±  0.166 < 0.001 21.46  ±  0.184 26.92  ±  0.168 < 0.001   0.08 
Full SI weight (g)   1.54  ±  0.014  1.51  ±  0.012    0.476   1.50  ±  0.013   1.55  ±  0.012    0.007   0.024 
Full colon weight (g)   0.47  ±  0.011  0.43  ±  0.009    0.004   0.43  ±  0.010   0.47  ±  0.009    0.003   0.495 
Proximal SI weight (g)   0.66  ±  0.009  0.65  ±  0.008    0.666   0.63  ±  0.009   0.68  ±  0.008 < 0.001   0.669 
Terminal SI weight (g)   0.58  ±  0.009  0.51  ±  0.008 < 0.001   0.53  ±  0.009   0.56  ±  0.008    0.008   0.700 
SI length  (cm) 28.96  ±  0.306 31.97  ±  0.269 < 0.001 29.60  ±  0.298 31.32  ±  0.272 < 0.001   0.624 
Colon weight (g)   0.26  ±  0.006  0.22 ±  0.005 < 0.001   0.23  ±  0.006   0.25  ±  0.005    0.002   0.084 
Colon length (cm)   6.17  ±  0.081   6.8   ±  0.071 < 0.001   6.29  ±  0.079   6.68  ±  0.072 < 0.001   0.920 
Caecum weight (g)   0.61  ±  0.012  0.62 ±  0.010    0.594   0.54  ±  0.011   0.69  ±  0.010 < 0.001   0.876 
Liver weight (g)   1.27  ±  0.020 1.35  ±  0.017 < 0.001   1.13  ±  0.019   1.49  ±  0.018 < 0.001   0.331 
Right kidney (g)   0.17  ±  0.003 0.18  ±  0.003    0.005   0.15  ±  0.003   0.2    ±  0.003 < 0.001   0.999 
Left kidney (g)  0.16  ±  0.002 0.18  ±  0.002 < 0.001   0.15  ±  0.002   0.19  ±  0.002 < 0.001   0.082 
Spleen weight (g)  0.19  ±  0.007 0.1    ±  0.006 < 0.001   0.14  ±  0.007   0.14  ±  0.006    0.612   0.394 
Heart weight (g)  0.2    ±  0.005 0.21  ±  0.004    0.086   0.18  ±  0.005   0.23  ±  0.004 < 0.001   0.114 
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4.4.2 Effects of Maternal and Post weaning dietary group on Body Weight and Organ  
Dimensions of Mice at Death 
The dietary groups to which the mice were exposed had significant effect on mean body weight 
(P = 0.003) at the time of death (Table.4.5.). Mean body weights ranged from 23.7 g ± 0.233 
SEM to 24.9 g ± 0.314 SEM for carrot powder-carrot powder and control powder-control 
powder respectively. The first diet of each dietary regime refers to maternal diet and the second 
to post weaning diet. Except the weights of the liver, right kidney and spleen, parameters of all 
internal organs evaluated were significantly affected by the dietary regimes with P values 
ranging between 0.001 and 0.037 (Table 4.5). The weights of the proximal and terminal SI 
varied from 0.6 g ± 0.011 SEM and 0.5 g ± 0.012 SEM to 0.9 g ± 0.013 SEM and 0.6 g ± 0.013 
SEM (P = 0.006 and P = 0.037) respectively for carrot powder-control powder to control 
powder-carrot powder. The SI (P = 0.004) and colon (P < 0.001) lengths were also affected by 
the dietary regimes. The SI was longer in mice fed carrot powder-control powder compared to 
the other dietary groups while colon length was higher in those fed control powder-carrot 
powder (6.8 cm ± 0.115 SEM) and control powder carrot pellet (6.8 cm ± 0.141 SEM). 
Exposing mice to control powder-carrot pellet and control powder carrot powder dietary 
regimes significantly increased their caecum weights compared to other dietary regimes. 
Feeding mice carrot powder-control powder produced no change in weight of heart compared 
to those fed control dietary regime whiles weight of the heart was the same in those fed carrot 
powder-carrot powder and control powder-carrot powder. (Table 4.5). With exceptions of SI 
and right kidney, it could be suggested that the weights of organs measured and the length of 
the colon at time of death were determined by the post weaning diet of a given dietary regime. 
No statistically significant effect of interactions between dietary regimes and sex was observed 
for any of the measured organs and body except for the liver (P = 0.005). Diet and genotype 
interaction significantly affected the mean weights of full SI, proximal and terminal SI, full 
colon, colon and the left kidney. Diet, sex and genotype interaction also affected the mean 
weights of body, full colon, colon, proximal SI weights and mean colon length (Table 4.6.)  
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Table 4. 5:  Effects of maternal and post weaning dietary groups and their interactions with sex and genotype on body and 
 organ dimensions of mice at death  
 
Dietary Groups 
  Carrot powder    - 
carrot powder 
(n = 49) 
Carrot powder - 
control powder 
(N = 63) 
Control powder – 
carrot powder 
(n = 40) 
Control powder - 
control powder 
(n = 32) 
Control powder - 
carrot pellet 
(n = 28) 
 
P value 
 Mean  ±  SEM  Mean  ±  SEM Mean  ±  SEM  Mean  ±  SEM Mean  ±  SEM  
Body weight (g) 23.65  ±  0.233b 24.61  ±  0.235a 23.97  ±  0.268ab 24.89  ±  0.314a 23.82  ±  0.329ab    0.003 
Full SI weight (g)   1.58  ±  0.017a   1.44  ±  0.017b   1.59  ±  0.019a   1.45  ±  0.023b   1.58  ±  0.024a < 0.001 
Full colon weight (g)   0.44  ±  0.013b   0.42  ±  0.013b   0.47  ±  0.015b   0.41  ±  0.018b   0.53  ±  0.018a < 0.001 
Proximal SI weight (g)   0.67  ±  0.011a   0.63  ±  0.011b   0.68  ±  0.013a   0.64  ±  0.015ab   0.66  ±  0.016ab    0.006 
Terminal SI weight (g)   0.56  ±  0.012ab   0.52  ±  0.012b   0.57  ±  0.013a   0.54  ±  0.016ab   0.55  ±  0.016ab    0.037 
SI length  (cm) 30.50  ±  0.377ab 31.15  ±  0.381a 30.86  ±  0.433a 28.79  ±  0.509b 31.00  ±  0.532a    0.004 
Colon weight (g)   0.25  ±  0.007b   0.22  ±  0.007a   0.24  ±  0.008b   0.23  ±  0.01ab   0.25  ±  0.010b < 0.001 
Colon length (cm)   6.43  ±  0.100ab   6.17  ±  0.101b   6.82  ±  0.115a   6.23  ±  0.135b   6.78  ±  0.141a < 0.001 
Caecum weight (g)   0.64  ±  0.014b   0.56  ±  0.014a   0.67  ±  0.016b   0.54  ±  0.019a   0.68  ±  0.02b < 0.001 
Liver weight (g)   1.31  ±  0.024   1.33  ±  0.025    1.3   ±  0.028   1.32  ±  0.033   1.29  ±  0.035    0.865 
Right kidney (g)   0.16  ±  0.004   0.18  ±  0.004   0.18  ±  0.005   0.18  ±  0.006   0.17  ±  0.006   0.085 
Left kidney (g)   0.17  ±  0.003b   0.18  ±  0.003a   0.16  ±  0.003b   0.18  ±  0.003a   0.16  ±  0.004b < 0.001 
Spleen weight (g)   0.14  ±  0.008   0.15  ±  0.008   0.12  ±  0.01   0.16  ±  0.011   0.13  ±  0.012   0.153 
Heart weight (g)   0.2   ±   0.006b   0.22  ±  0.006ab   0.2    ±  0.007ab   0.22  ±  0.008a   0.19  ±  0.009b   0.007b 
  
The first of each dietary group refers to maternal diet and the second to post weaning diet 
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Table 4. 6:  Probability effects of interactions of Diet (Maternal-Post weaning), Sex 
and Genotype on Body and organ Dimensions Study  
 
Diet* Genotype Diet* Sex 
Diet * Sex *  
Genotype 
 
Body weight (g)  0.087 0.295    0.042 
Full SI weight (g)             < 0.001 0.474    0.862 
Full colon weight (g)  0.004 0.510    0.013 
Proximal SI weight (g)  0.025 0.425    0.12 
Terminal SI weight (g)  0.033 0.463    0.461 
SI length  (cm)  0.333 0.822    0.538 
Colon weight (g)  0.014 0.633 < 0.001 
Colon length (cm)  0.789 0.980    0.049 
Caecum weight (g)  0.257 0.292    0.446 
Liver weight (g)  0.808 0.005    0.705 
Right kidney weight (g)                0.117 0.210    0.509 
Left kidney weight (g) 0.051 0.062    0.37 
Spleen weight (g) 0.080 0.543    0.218 
Heart weight (g) 0.240 0.084    0.137 
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4.5 Tumour Data Analysis 
Tumour number in the three sections of the intestine of the Min mice was compared in One-
Way ANOVA Tumour data (number and volume) was analysed as a factorial design using 
ANOVA, GLM with maternal diet, post weaning diet and sex as main factors alongside their 
interactions. As mice were killed at different time points, days on diet was added as covariate 
to control for the effects of age differences on tumour number and volume. Data from proximal 
SI, terminal SI, colon and total gut were Box Cox transformed for P values. Data analysis was 
done in two forms. The first analysis included data from stored carrot pellet diet fed to offspring 
post weaning. Results of main factor effects for this analysis are presented in figure 4.8 – 4.13. 
Effects of significant interactions (post weaning diet and sex) for terminal SI and total gut 
tumour number are shown in figures 4.14 and 4.15 respectively. No significant interaction was 
observed for maternal diet interactions with sex, data not presented. Maternal diet post weaning 
diet interactions could not be estimated because mothers were not fed stored carrot pellet.  
The second part of tumour data analysis evaluated effects of carrot powder. As all mice fed 
stored carrot pellet post weaning were born to dams fed control powder, they were removed 
from the analysis to investigate effects of maternal and post weaning diets interactions. Results 
of significant main effects and interactions are presented in 4.16 to 4.20 and Table 4.6 
respectively. 
 
4.5.1 Tumour Distribution in Intestine of Min mice 
Most tumours were found in the terminal SI (22.7 ± 0.848 SEM) (P < 0.001) compared to 
proximal SI (4.4 ± 0.849 SEM) and colon (2.3 ± 0.848 SEM) at time of death (Fig. 4.7).  
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Figure 4. 7: Tumour distributions in intestine of min mice. (n = 90) Days on diet was added as 
a covariate. Error bars represent SEM. Means with different letters are significantly different, 
P < 0.001. 
 
4.5.2 Effects of Sex and Diet on Tumour Number and Volume in Min mice  
Tumour data (number and volume) was analysed as a factorial design using ANOVA, GLM 
with maternal diet, post weaning diet and sex as main factors alongside their interactions. As 
mice were killed at different time points days on diet was added as covariate to control for the 
effects of age difference on tumour number and volume. Data from proximal SI, terminal SI, 
colon and total gut were Box Cox transformed for P values. Data analysis was done in two 
forms. The first analysis included data from carrot pellet diet fed to offspring post weaning. 
Results of main factor effects for this analysis are presented in figure 4.8 – 4.13. Effects of 
significant interactions (post weaning diet and sex) for terminal SI and total gut tumour number 
are shown in figures 4.14 and 4.15 respectively. No significant interaction was observed for 
maternal diet interactions with sex, data not presented. Maternal diet post weaning diet 
interactions could not be estimated because mothers were not fed stored carrot pellet. 
The second part of tumour data analysis evaluated effects of carrot powder. As all mice fed 
carrot pellet post weaning were born to dams fed control powder, they were removed from the 
analysis to investigate effects of all interactions. Significant main effects and interactions are 
presented in 4.16 to 4.20 and Table 4.6 respectively. 
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4.5.3 Effects of Sex on Tumour Number and Volume 
There was no significant difference in tumour number and volume between male and female 
mice (Figs 4.8 and 4.9) except in the colon where female had significantly reduced tumour 
number compared to males (P = 0.033) (Fig. 4.8 C).  
 
 
Figure 4. 8: Effects of sex on tumour number in (A) proximal SI (B) terminal SI (C) colon and 
(D) total gut of min mice (Male n = 48, female n = 42) Days on diet was added as covariate. 
Error bars represent SEM.   
 
0
1
2
3
4
5
Female Male
Sex
M
ea
n
 p
ro
xi
m
al
 S
I t
u
m
o
u
r 
n
u
m
b
er
A
0
5
10
15
20
25
30
Female Male
Sex
M
ea
n
 t
er
m
in
al
 S
I t
u
m
o
u
r 
n
u
m
b
er
B
0
0.5
1
1.5
2
2.5
3
Female Male
Sex
M
ea
n
 c
o
lo
n
ic
 t
u
m
o
u
r 
n
u
m
b
er P = 0.033
0
5
10
15
20
25
30
35
Female Male
Sex
M
ea
n
 t
o
ta
l g
u
t 
 t
u
m
o
u
r 
n
u
m
b
er
C D 
89 
 
 
 
Figure 4. 9: Effects of sex on tumour volume in (A) proximal SI (B) terminal SI (C) colon and 
(D) total gut of min mice (Male n = 48, female n = 42) Error bars represent SEM. Days on diet 
was added as covariate. 
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4.5.4 Effects Maternal diet on Tumour Number and Volume 
Maternal diet type had no significant effect on intestinal tumour number and volume in adult 
offspring at death (Fig. 4.10 and 4.11).  
 
 
Figure 4. 10: Effects of maternal diet on tumour number in (A) proximal SI (B) terminal SI (C) 
colon (D) total gut of min mice (Control powder n = 50, carrot powder n = 40) Error bars 
represent standard error of means (SEM). Days on diet was added as covariate. 
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Figure 4. 11: Effects of maternal diet on tumour volume in (A) proximal SI (B) terminal SI (C) 
colon and (D) total gut of min mice (Control powder n = 50, carrot powder n = 40) Error bars 
represent standard error of means (SEM) Days on diet was added as covariate. 
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4.5.5 Effects of Post weaning diet on Tumour Number and Volume 
Feeding carrot powder and stored carrot pellet from weaning had no significant effect on 
tumour number (Fig. 4.12) or volume (Fig. 4.13) 
 
 
Figure 4. 12: Effects of post weaning diets on tumour number in (A) proximal SI (B) terminal 
SI (C) colon (D) total gut of min mice (Control powder n = 32, carrot powder n = 47, stored 
carrot pellet n = 11). Error bars represent standard error of means (SEM) Days on diet was 
added as covariate. 
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Figure 4. 13: Effects of post weaning diets on tumour volume in (A) proximal SI (B) terminal 
SI (C) colon (D) total gut of min mice (Control powder n = 32, carrot powder n = 47, stored 
carrot pellet n = 11) Error bars represent standard error of means (SEM) Days on diet was added 
as covariate. 
 
There was a statistically significant interaction between post weaning diet and sex for tumour 
number in terminal small intestine (P = 0.044). Carrot powder diet consumption post weaning 
by female mice, reduced tumour number in terminal small intestine significantly (P = 0.027) 
compared to control powder (Fig. 4.14). No significant (P = 0.375) effect was observed in male 
mice (data not shown).   
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Figure 4. 14: Effects of post weaning diet on terminal intestinal tumour number in female Min 
mice (Female: carrot powder n = 25, control powder n = 12, stored carrot pellet n = 5) Error 
bars represent SEM. Bars that do share letter are significant P = 0.027 
 
Also there was an interaction (P = 0.054) between post weaning diet and sex with total gut 
tumour number. Though the interaction was near significance a further probe reveals that in 
female mice, consumption of carrot powder diet post weaning decreased significantly (P = 
0.039) mean total gut tumour number (Fig. 4.15). No significant effects of post weaning diets 
were observed in the males (Data not shown). The effects of post weaning diet on total gut 
tumour in the female mice appeared to be drawn from the dietary effect in the terminal SI. 
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Figure 4. 15:  Effects of post weaning diet on total gut tumour number in female mice at death 
(Female: Carrot powder n = 25, control powder n = 12, stored carrot pellet n = 5) Error bars 
represent SEM. Bars that do not share letter are significantly different. P = 0.039 
 
4.5.6 Effects of Carrot powder on Tumour Number 
As all mice fed the stored carrot pellet diet post weaning were born to control powder fed dams, 
these mice were removed to investigate carrot powder and interaction between maternal and 
post weaning diets. 
 
Consumption of carrot powder post weaning decreased terminal small intestinal tumour number 
(P = 0.046) (Fig. 4.16) in Min mice and total gut tumour number (P = 0.044) (Fig. 4.17).  
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Figure 4. 16:.Effects of post weaning diet on terminal Si tumour number (Carrot n = 47, control 
powder n = 32) Error bars represent SEM 
 
 
Figure 4. 17: Effects of post weaning diet on total gut tumour number using sex  
as covariate (Carrot powder n = 47, control powder n = 32) Error bars represent SEM 
 
4.5.7 Effects of Interactions of Maternal and Post weaning diet and Sex on Tumour 
Number and Volume 
There was a significant interaction between maternal and post weaning diets (P = 0.017) for 
colonic tumour number (Table 4.6). Offspring born to control powder fed dams and then 
randomised to carrot powder post weaning had fewer tumours in the colon than offspring from 
control powder dietary regime (Fig 4.18).  A significant interaction between post weaning diet 
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and sex (P = 0.007) for terminal SI tumour number was observed. Female offspring fed carrot 
powder post weaning had reduced tumour number in terminal SI compared to control powder 
fed females (Table 4.6, Fig 4.19). 
A significant interaction between post weaning diet and sex (P = 0.01) was also observed for 
the total gut tumour number. Again, females fed carrot powder post weaning had significantly 
lower total gut tumour number compared to control powder fed females. (Table 4.6 Fig 4.20).  
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Table 4. 7: Effects of interactions of sex, maternal and post weaning diets on intestinal tumour number and volume in min mice. (Diet: CP = control 
powder, CPP = carrot powder; Sex: Fem = female) (Control powder-control powder n = 16, carrot powder-carrot powder n = 24, carrot powder-control 
powder n = 16, control powder carrot powder n = 23) Days on diet was added as covariate 
 
Maternal diet * Post weaning diet Maternal diet * Sex Post weaning diet * Sex 
CP-CP 
(n = 16) 
CP-CPP 
(n=23) 
CPP-
CP 
(n=16) 
CPP-
CPP 
(n=24) 
P value CP-Fem 
(n=13) 
CP-
Male 
(n=14) 
CPP-
Fem 
(n=13) 
CPP-
male 
(n=11) 
P value CP-
Fem 
(n=11) 
CP-
Male 
(n=11) 
CPP-
Fem 
(n=15) 
CPP-
Male 
(n=14) 
P value 
Mean  Mean  Mean  
Proximal SI tumour 
number 
4.13 4.12 4.69 3.81 0.644 4.77 3.48 4.87 3.64 0.979 5.41 3.41 4.22 3.71 0.315 
Terminal SI tumour 
number 
28.20 19.40 22.81 23.91 0.175 24.61 22.99 21.74 24.98 0.335 28.91 22.11 17.44 25.86 0.007 
Colonic tumour 
number 
2.69 1.23 1.38 1.87 0.017 1.83 2.08 1.14 2.11 0.331 1.87 2.19 1.10 2.00 0.524 
Total gut tumour 
number 
35.10 24.79 28.82 29.56 0.172 31.26 28.63 27.76 30.62 0.351 36.29 27.63 22.73 31.62 0.010 
Proximal SI tumour 
volume (mm3) 
35.30 34.37 25.94 27.11 0.784 36.34 33.33 28.54 24.52 0.97 31.46 29.79 33.42 28.06 0.843 
Terminal SI tumour 
volume (mm3) 
59.70 82.10 54.40 63.00 0.876 70.00 71.80 61.80 55.60 0.951 67.80 46.30 64.00 81.00 0.139 
Colonic tumour  
volume (mm3) 
93.40 34.30 116.70 122.00 0.079 69.20 58.50 60.20 178.50 0.187 85.60 124.50 43.80 112.50 0.961 
Total gut tumour 
 volume (mm3) 
188.50 150.70 197.10 212.10 0.438 175.60 163.60 150.60 258.60 0.151 184.90 200.60 141.30 221.60 0.417 
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Figure 4. 18: Interactive effects of maternal and post weaning diets on colonic tumour number 
in Min mice (Control powder-control powder n = 16, control powder-carrot powder n = 23, 
carrot powder-control powder n = 16, carrot powder-carrot powder n = 24). Error bars represent 
SEM. Means that do not share a letter are significantly different, P = 0.017. First two words 
refer to maternal diet and the next two refer to post weaning diet. 
 
 
 
Figure 4. 19: Effects of post weaning diet on tumour number in terminal SI of male and female 
Min mice. Data was not transformed Effects of post weaning diets were separately analysed. 
(Control powder –Female n = 12, control powder-male n = 20, carrot powder-female n = 25, 
carrot powder-Male n = 22) Error bars represent SEM. Means that do not share a letter are 
significantly different at P = 0.002. 
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Figure 4. 20: Effects of post weaning diet on mean total gut tumour number in male and female 
mice. (Carrot powder-Female n = 25, carrot powder-male n = 22, control powder-female n =12, 
control powder-male n = 20) Error bars represent SEM. Means that do not share a letter are 
significantly different at P = 0.003. 
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5 Chapter 5 Results: Gene expression studies 
 
5.1 Genes expression in Min and Wild type tissue  
5.2 Data analysis 
Effects of maternal and post weaning diets and sex and their interactions on gene expressions 
was analysed in a factorial design using ANOVA GLM separately for Min and Wild type mice. 
Data was presented as LSM ± SEM. Stability of reference gene was analysed for dietary 
regimes, genotype and tissue type in a One-way ANOVA using Tukey’s comparison Test and 
results presented as Mean ± StDev.  
 
5.2.1 Stability of Reference Gene 
There was no significant variation in reference gene expression between the dietary groups, 
Min and Wild type mice and tumour and intestinal tissues (Table .5.1) 
 
Neither maternal nor post weaning diets had any significant effect on expression of mRNA of 
target gene in tumour (Table 5.2) and normal (Table 5.3) terminal SI (TSI) tissue of ApcMin/+ 
mice.   
Sex significantly affected expression of Cyclin D1 in tumour tissues. The expression was higher 
in females (P = 0.035) than in males (Table 5.2).  The expression of MMP7 in normal TSI 
tissues of the Min mice was higher in males (P = 0.043) than in females (Table 5.3). No 
statistically significant effects of maternal diet, post weaning diet and sex interactions on the 
expression of any of the target genes was observed. 
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Table 5. 1: Effects of dietary regime, genotype and tissue type on expression of reference gene in analytical groups  
 
Dietary regimen Genotype Tissue type 
Carrot powder 
Carrot powder   
(n = 36) 
Carrot powder-
control powder 
 (n = 28) 
Control powder 
carrot powder 
 (n = 36)  
Control powder 
control powder 
 (n = 36) 
P value 
ApcMin/+ 
( n = 88) 
Wild type 
( n = 48 ) 
P value 
Tumour 
( n = 44 ) 
Normal 
Intestine         
(n = 92 ) 
P value 
Mean  ± StDev Mean  ± StDev Mean ± StDev Mean  ± StDev  Mean ± StDev Mean ± StDev  Mean ± StDev Mean ± StDev  
CT 16.24 ± 0.670 
 
16.05 ± 0.679 
 
 
16.48 ± 0.770 
 
 
16.11 ± 0.725 
 
0.091 16.27   ± 0.688 16.15 ± 0.782 0.387 16.12  ± 0.727 16.28 ± 0.717 0.218 
 Analysis was by One-Way ANOVA. And comparison was by Tukey’s Test. CT = Threshold cycle 
 
5.2.2 Target Gene expression 
Table 5. 2: Effects of sex, maternal and post weaning diets on expression of mRNA of target gene in terminal small intestinal tumour of Min mice at death 
 
mRNA 
of target 
gene 
 
Maternal diet Post weaning diet Sex Probability effects 
Carrot 
powder 
(n = 10) 
Control 
powder 
(n = 12) P value 
Carrot 
powder 
(n = 11) 
Control 
powder 
(n = 11) P value 
Female               
(n = 10) 
Male 
(n = 12) P value 
Maternal * 
Post 
weaning 
Maternal 
* Sex 
Post 
weaning 
diet*Sex Mean  ± SEM Mean  ± SEM Mean  ± SEM Mean  ± SEM Mean  ± SEM Mean  ± SEM 
RXRalpha 3.02±0.049 3.03 ± 0.042 0.929 3.05  ± 0.044 3 ± 0.048 0.451 2.99 ± 0.049 3.06 ±  0.042 0.285 0.887 0.665 0.931 
Cyclin D1 1.09 ± 0.004 1.09 ± 0.003 0.428 1.09  ± 0.003 1.09 ± 0.004 0.42 1.1   ± 0.004 1.08 ± 0.003 0.035 0.446 0.785 0.471 
BCMO1 1 ± 0.000 1 ± 0.000 0.428 1      ± .000 1     ±0.000 0.786 1       ± 0.000 1 ± 0.000 0.135 0.067 0.754 0.752 
RARbeta 1.09 ± 0.004 1.08 ± 0.004 0.759 1.08 ± 0.004 1.09 ± 0.004 0.763 1.08  ± 0.004 1.08 ± 0.004 0.2 0.446 0.921 0.43 
MMP7 4.45 ± 0.048 4.52 ± 0.042 0.297 4.49 ± 0.043 4.48 ± 0.048 0.792 4.42  ± 0.048 4.55 ± 0.042 0.07 0.295 0.895 0.118 
COX-2 6.22 ± 0.4 6.48 ± 0.346 0.591 6.48 ± 0.357 6.22 ± 0.394 0.965 6.24  ± 0.4 6.46 ± 0.346 0.518 0.992 0.649 0.419 
Maternal diet * Post weaning diet * Sex was not statistically significant 
103 
 
Table 5. 3: Effects of sex, maternal and post weaning diets on expression of target genes in normal terminal small intestinal tissue of Min mice at death 
mRNA 
of  
target 
gene 
 
Maternal diet Post weaning diet Sex Probability effects 
Carrot  
powder 
(n = 10) 
Control 
Powder 
(n = 12) P value 
Carrot  powder 
(n = 11) 
Control 
powder 
(n = 11) P value 
Female               
(n = 10) 
Male 
n = 12) P value 
Maternal 
* Post 
weaning 
diet  
Maternal 
*Sex 
Post 
weaning 
diet*Sex Mean  ± SEM Mean  ± SEM Mean  ± SEM Mean  ± SEM Mean  ± SEM Mean  ± SEM 
RXRalpha 3.06 ± 0.05 3.1   ± 0.046 0.599 3.09 ± 0.048 3.07 ± 0.0525 0.796 3.06 ± 0.053 3.1 ± 0.046 0.548 0.48 0.875 0.755 
Cyclin D1 1.08 ± 0.004 1.08 ± 0.003 0.574 1.08 ± 0.003 1.08 ± 0.0035 0.224 1.08 ± 0.004 1.08 ± 0.003 0.404 0.419 0.992 0.99 
BCMO1 1.00 ± 0.000 1.00 ± 0.000 0.444 1      ± 0.000 1 ± 0.00019 0.673 1 ± 0.000 1 ± 0.000 0.413 0.921 0.412 0.841 
RARbeta 1.08 ± 0.006 1.07 ± 0.005 0.523 1.08 ± 0.005 1.08 ± 0.006 0.703 1.08 ± 0.006 1.07 ± 0.005 0.517 0.943 0.984 0.831 
MMP7 4.66 ± 0.064 4.69 ± 0.055 0.7 4.66 ± 0.0567 4.68 ± 0.063 0.835 4.58 ± 0.063 4.76 ± 0.055 0.043 0.91 0.295 0.989 
COX-2 6.7   ± 0.429 7.13 ± 0.371 0.453 7.09 ± 0.383 6.73 ± 0.423 0.533 6.65 ± 0.429 7.18 ± 0.371 0.358 0.877 0.579 0.699 
Maternal diet * Post weaning diet * Sex was not statistically significant (data not shown). 
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Feeding dams carrot powder significantly decreased expression of MMP7 mRNA in TSI of 15 weeks old wild type offspring (Table 5.4)                                       
MMP7 mRNA was also expressed more in TSI of males (P = 0.007) than females. Significant interaction between maternal diet and sex (P= 0.028) 
was observed for MMP7 mRNA expression in TSI of wild type mice (Table 5.4, Fig. 5.1). Post weaning diet and sex interactions were observed 
for   expressions of mRNA of Cyclin D1 (P = 0.002) (Table 5.4, Fig.5.2), MMP7 (P = 0.028) (Table 5.4, Fig. 5.3) and BCMO1 (P= 0.025) (Table 
5.4, Fig 5.4). 
Table 5. 4: Effects of sex, maternal and post weaning diets on expression of mRNA of target genes in terminal small intestinal tissue of Wild type 
mice at time. Data for MMP7 was Box Cox transformed for P value. 
mRNA 
of  
target gene 
Maternal diet Post weaning diet Sex Probability effects 
Carrot  
powder 
 (n= 12 
Control 
powder    
(n= 12 ) 
P value 
Carrot  
powder  
(n= 12) 
Control 
powder  
(n = 12) 
P value 
Female               
(n = 12 ) 
Male        
(n = 12 ) P value 
Maternal 
* Post 
weaning 
Maternal 
Diet * 
Sex  
Post 
weaning 
diet*Sex 
Mean  ± SEM Mean  ± SEM  Mean  ± SEM Mean  ± SEM  Mean  ± SEM Mean  ± SEM 
RXRalpha 3.05 ± 0.034 3.05 ± 0.034 0.863 3.06 ± 0.034 3.04 ± 0.034 0.609 3.02  ± 0.034 3.08  ±  0.034 0.187 0.443 0.894 0.173 
Cyclin D1 1.08 ± 0.003 1.08 ± 0.003 0.865 1.08 ± 0.003 1.08 ± 0.003 0.402 1.08 ± 0.003 1.08 ± 0.003 0.241 0.072 0.862 0.002 
BCMO1 1.00± 0.000 1.00 ± 0.000 0.274 1.00 ± 0.000 1.00 ± 0.000 0.377 1.00  ± 0.000 1.00  ± 0.000 0.208 0.061 0.915 0.025 
RARbeta 1.08 ± 0.004 1.08 ± 0.004 0.608 1.08 ± 0.004 1.08 ± 0.004 0.716 1.08  ± 0.004 1.08 ± 0.004 0.598 0.615 0.96 0.138 
MMP7 4.43 ± 0.047 4.65 ± 0.045 0.003 4.6 ± 0.047 4.48 ± 0.045 0.086 4.44 ± 0.047 4.64 ± 0.045 0.007 0.692 0.028 0.027 
COX-2 6.69 ± 0.294 6.77 ± 0.294 0.835 6.77 ± 0.294 6.69 ± 0.294 0.829 6.53 ± 0.294 6.93 ± 0.294 0.325 0.237 0.82 0.096 
Maternal diet * Post weaning diet * Sex was not statistically significant (data not shown). 
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5.2.3 Interactions of Maternal and Post weaning diet in Terminal SI Tissue of Wild type 
Mice 
Wild type males born to carrot powder fed dams had low level expression of MMP7 mRNA (P 
= 0.01) compared to female offspring born to carrot powder fed dams (Fig.5. 1). 
 
Figure 5. 1: Effects of maternal diet on expression of MMP7 mRNA in terminal SI of (A) 
female (B) male wild type mice (Carrot powder n = 6, control powder n = 6) Error bars represent 
SEM 
 
Post weaning carrot powder consumption reduced Cyclin D1 mRNA expression in wild type 
males (P = 0.023) but enhanced it in females (P = 0.076) (Fig. 5. 2). 
 
Figure 5. 2: Effects of post weaning diet on expression of Cyclin D1 mRNA in terminal SI (A) 
male (B) female wild type mice (Carrot powder n = 6; control powder n = 6) Error bars represent 
SEM 
Post weaning consumption of carrot powder significantly increased level of expressed of MMP7 
mRNA in wild type males (P = 0.039) compared to control powder. (Fig. 5.3). 
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Figure 5. 3: Effects of post weaning diet on expression of MMP7 mRNA in terminal SI of (A) 
female (B) male wild type mice (Carrot powder n = 6; control powder n = 6) Error bars represent 
SEM. 
 
Though a significant interaction between post weaning diet and sex was noticed for BCMO1 
mRNA expression, it only approaches significance in males (P = 0.069) when the effect in the 
sexes was investigated (Fig. 5.4). 
 
Figure 5. 4: Effects of post weaning diet on expression of BCMO1 mRNA in terminal SI of (A) 
male (B) female wild type mice (Carrot powder n = 6; control powder n = 6). Error bars 
represent standard error of means (SEM) 
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Target gene mRNA levels of expression in normal and tumour tissues in the terminal SI of the 
Min mice were compared in a Two-Sample T-Test 
Results suggest, expression of Cyclin D1 mRNA was higher in tumours (P = 0.004) than in 
normal TSI tissue whilst MMP7 mRNA was higher in normal (P = 0.003) than in tumour tissues 
(Table 5.5).    
Expressions of target gene mRNA in normal tissue of Min and Wild type mice (genotype effect) 
were compared a One-Way ANOVA. 
MMP7 mRNA expression was higher in Min (P = 0.055) compared to Wild type mice (Table 
5.6). 
Table 5. 5: Differences in expression of mRNA of target genes in tumour and  
normal terminal SI tissue samples of Min mice at death 
mRNA 
of  
target genes 
Terminal small intestinal tissue type 
P value Tumour  
 (n = 22) 
Normal  
(n = 22) 
Mean ± SEM Mean ± SEM 
RXRalpha 3.03  ±  0.027 3.07  ±  0.029 0.237 
Cyclin D1 1.09  ±  0.002 1.08  ±  0.002 0.004 
BCMO1 1.00  ±  0.000 1.00  ±  0.000 0.771 
RARbeta 1.08  ±  0.003 1.08  ±  0.003 0.104 
MMP7 4.51  ±  0.031 4.68  ±  0.041 0.003 
COX-2 6.41  ±  0.22 7       ±  0.24 0.077 
 
Table 5. 6: Effects of genotype on expression of target genes in normal  
terminal small intestinal tissues of Min and Wild type mice at death  
mRNA 
of 
target genes 
 
Min 
(n = 22) 
Wild type   
 (n=  24) P value 
Mean ± StDev Mean ± StDev 
RXRalpha 3.07 ± 0.137 3.05 ±  0.113 0.531 
Cyclin D1 1.08 ±  0.01 1.08 ±  0.011 0.346 
BCMO1 1.00 ±  0.001 1.00 ±  0.000 0.741 
RARbeta 1.08 ±  0.015 1.08 ±  0.014  0.549 
MMP7 4.69 ±  0.192 4.54 ±  0.246 0.055 
COX-2 7.02 ±  0.114 6.73 ±  0.983 0.39 
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6 Chapter 6 General Discussion 
 
6.1 Weight measurements 
As expected gender and genotype had significant effect on growth throughout study one and 
study two.  Distinguishing males from females and wild type from ApcMin/+ mice regarding 
weight gain post weaning, indicates that the weight measurements for both studies were well 
executed and therefore would be sufficiently robust to detect any of the effects of diet on growth 
discussed under each of the two studies. 
 
6.2 Effects of maternal and post weaning diet on Body weight and Organ Dimensions of 
mice at Death 
Nutrition is important non-genetic factor that affects the growth and body composition (Corva 
and Medrano, 2000) and nutritional status of mothers prior to conception and during conception 
may influence physical characteristics of the offspring in later life (Mortensen et al., 2010).  
Maternal carrot consumption in study one reduced mean body weight in adult offspring by 2 % 
at time of death. The results contradict findings of other studies which suggest maternal nutrient 
deficiency (depleted folate) had no significant effect of mean body weight of adult offspring 
(McKay et al., 2008). Most individuals who suffer nutritional insult in utero and have low birth 
weights or thin bodies show rapid catch-up growth early post-natal (Osmond and Barker, 2000). 
The reduction in body weight with maternal diet could be due to nutritional insult in utero 
probably as a result of poor digestion and absorption of carrot diet not only by mothers but also 
by offspring post weaning. Birth weight was not investigated on this study but if individual with 
low birth weight existed and were continued on carrot diet post weaning then the possibility of 
reduced body weight could occur as suggested by dietary regimes in study 2. Offspring fed 
carrot diet post weaning irrespective of maternal diet had 2 % lower mean body weight 
compared to those fed control diet to suggest the significance of post weaning diet in adult life. 
In addition data from this study showed that at weaning offspring born to carrot powder fed 
dams were 7.7 % lower in mean body weight compared to control. This was in contrast to the 
results obtained by Saleh et al., 2013 where 20 % carrot consumption in utero and post weaning 
produced no difference in body weight. Similarly no significant effect on body weight was 
observed when rats were fed a diet containing 10 % freeze dried carrot (Kobæk-Larsen et al., 
2005). Also feeding mice a diet containing 40 % freeze dried conventionally grown carrots 
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produced no significant difference in body weight compared to the control (Jensen et al., 2012). 
In line with the current results were findings of a study that investigated effects of Western diet 
and annurca apple juice on intestinal tumourigenesis in ApcMin/+ mice (Fini et al., 2011). Rao et 
al. (2000), observed differences in body weight at time of death when ApcMin/+ mice were fed a 
diet containing 1, 4-phenylene bis (methylene) (p-XSC) compared to control. These differences 
could be attributed to intestinal tumour and associated complications including anaemia and 
cachexia (Swamy et al., 2006; Fini et al., 2011). ApcMin/+ mice were shown to develop multiple 
intestinal tumours largely in the small intestine and die of intestinal obstruction and /or severe 
anaemia, often not surviving beyond 120 to 150 days (Moser et al., 1990; Su et al., 1992; Heyer 
et al., 1999).  
Findings of study2 suggest dietary regimes to which mice were exposed (in utero-post weaning) 
had significant effects on mean body weight and dimensions of internal organs measured 
The observed differences in dimensions of internal organs may be the results of nutritional 
insults during early developmental stages. Studies have shown that in adequate nutrient supply 
may lead to survival adaptations in a fetus with the capacity to modulate response to the 
environment in later life (Gluckman et al., 2005). Those adaptive modifications are not limited 
to intrauterine stages of development but even through neonatal stages (Gluckman et al., 2005).  
Such adaptations may involve restriction of nutrients to organs the fetus might consider non-
essential leading to irreversible structural and functional modifications of affected organs 
(Langley-Evans and McMullen, 2010). Certain organs may therefore develop more than others 
in what may be described as selective trade off or disproportionate growth (Bateson et al., 
2004). Studies suggest that the small intestine is the main site for digestion and absorption of 
nutrients and its structural organisation could significantly influence the performance and 
nutrient utilisation of an offspring (Duarte et al., 2013). The increase in SI length could be 
adaptation to increase the internal surface area to enhance nutrient absorption capacity. 
Enhanced intestinal dimensions were reported in many studies, Duarte et al. (2013), reported 
increased weight and length of small intestine alongside enhanced structure of villi in bovine 
fetus of diet restricted mothers. McKay et al., (2008) reported longer colon in offspring of folic 
acid restricted Black/6 dams.  
Also the significant increase in weight of the intestine may be explained by the high tumour 
number, especially the terminal and proximal SI where more than 70 % of tumour occurred in 
both studies. As observed in study one carrot pellet consumption post weaning enhanced tumour 
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number in the proximal and terminal SI by 39 %. Weights of these sections of the intestine also 
increased (P <0.001) by 11 and 10 % respectively compared to the control 
This is in conformity with observed tumour distribution in many chemoprevention studies using 
ApcMin/+ mouse model (Ju et al., 2005; Mohammed et al., 2011). 
 
Summary 
 Carrot diet significantly decreased body weight 
 Carrot diet consumption post weaning significantly increased the weights of proximal 
and terminal SI and the caecum 
 Carrot diet enhanced length of proximal and terminal SI and colon  
 
6.3 Tumour distribution 
In both studies irrespective of the dietary regime, most tumours occurred in the terminal SI 
compared with the proximal SI and the colon. A similar trend of tumour distribution was 
reported in several studies (Hu et al., 2006; Cai et al., 2010; Fini et al., 2011), making it 
convenient to compare the finding with other studies. 
 
6.3.1 Effects of Maternal and Post Weaning Diets on Tumour Number and Volume 
6.3.2 Effect of post-weaning diet on tumour number 
Post weaning consumption of carrot pellet increased total gut tumour number by 41.5 % (P = 
0.038) and terminal SI tumour number by 39.4 % (P = 0.044) in fifteen week old adult ApcMin/+ 
offspring in study one, while post weaning consumption of carrot powder and stored carrot 
pellet reduced total gut tumour number by 14.96 (P = 0.037) and 14.11 % and terminal SI 
tumour number by 15.5 % (P = 0.044) and 5.8 % respectively, compared to the control powder. 
These results appear to contradict each other, however findings of similar studies show that 
similar discrepancies have been reported previously. Feeding ApcMin/+ mice a diet containing 
20 % carrot powder post weaning significantly decreased intestinal tumour number (Saleh et 
al,. 2013). Kobæk-Larsen et al. (2005) found that an experimental diet with 10 % carrot powder 
showed a reduction in number of chemically induced colon polyps in of BDIX male rats.. 
Dietary supplementation of sulforaphane, an isothiocyanate commonly consumed in 
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cruciferous vegetables was also shown to decrease number of polyps in intestine of ApcMin/+ 
mice (Hu et al., 2006). Further experimental evidence suggest a reduction in number of 
intestinal polyps in ApcMin/+ mice with separate dietary administration of sulforaphane and 
dibenzoylmethane and in combination by 48 %, 50% and 57 % respectively (Shen et al., 2007). 
The description of the diet preparation in these papers did not specify whether or not the diets 
were dried at high temperatures. In addition a number of other experimental animal studies 
involving fruits and vegetables and purified or semi purified phytochemical in ApcMn/+ mice 
suggest protective effect (Myzak et al., 2006; Rajamanickam and Agarwal, 2008; Murphy et 
al., 2011). However, in agreement with study one, van Kranen et al. (1998) reported an increase 
in SI tumour number by 20 % in male and 12 % in female ApcMin/+ mice fed  pelleted vegetable 
fruit mixture.  Also in agreement was the findings of  Alink et al. (1993) that addition of 
vegetables and fruits into baked or heated human diets enhanced 1,2-dimethylhydrazine 
induced colon tumours in rats. However this result is contrary to many epidemiological 
observations which suggest reduction in colorectal cancer risk with increased intake of fruits 
and vegetables (Aune et al., 2011). The above-mentioned studies where carrot feeding 
increased cancer severity in animal models has one factor in common: the experimental diets 
were pelleted, while studies using powdered or fresh diets generally reduced tumour numbers 
or other measures of cancer. A possible reason for the observed high tumour number with 
consumption of carrot pellet diet post weaning in study one could therefore be the presence of 
furan, a volatile carcinogen. Furan is a low boiling cyclic ether identified by FDA as a possible 
human carcinogen detected in many heat treated canned foods (Food and Drug, 2004; Duan 
and Barringer, 2012). It is produced when carrots at moisture content of 10 % and below are 
exposed to temperatures of 93°C or higher (Duan and Barringer, 2012). As moisture content 
falls below 40 %, furan concentration begins change and increases with increasing temperature 
and decreasing moisture. The production increases exponentially at 4-7 % moisture and 
between 100 and 133°C. The carrot pellet used in this study was dried between 80-120°C to 
attain moisture content of about 10 %, which may have resulted in the presence of furan in the 
diet. In the present study, the relevance of furan was not noticed initially, until it was too late 
to test for it. However if furan was present in the pellets in study one, it may be responsible for 
the observed increase in tumours in carrot pellet fed mice. When the same pellets were tested 
in study two, after one year of storage, the detrimental effect on tumour number had disappeared. 
This observation reemphasised the possible effect of furan which is likely to have evaporated 
during storage and therefore may plausibly explain the difference in the effects of carrot pellet 
and stored carrot pellet feeding on tumorigenesis observed between study one and study two. 
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Furan may be measured in carrots by selected ion flow tube mass spectrometry (SIFT-MS) 
method described by (Duan and Barringer, 2012) 
Combining all this information, the study’s results support the epidemiological observations 
that consumption of raw or boiled carrots reduce the growth of already formed tumours, while 
no benefit was observed during the tumour initiation period (in utero and pre-weaning). For 
humans the implication is that carrot consumption may reduce the risk or severity of cancer, 
and is likely to benefit patients with already diagnosed cancer as well as healthy adults.  
 
6.3.3 Effect of maternal diet on tumour number and volume 
In these studies, maternal diet had no significant effect on intestinal tumour number and volume 
in ApcMin/+ mice. No significant effect was observed when effect of dietary curcumin on 
intestinal tumourigenesis in ApcMin/+ mice was investigated in utero and through lactation 
(Perkins et al., 2003a). McKay et al. (2008b), also suggested that maternal folate depletion 
(0.4mg/ folic acid/kg diet) did not affect intestinal tumourigenesis significantly compared to 
normal folate (2mg/kg).  However, results from (Ciappio et al., 2011) showed that 
preconception maternal supplementation of folic acid (8m g/kg), B2 (24 mg/kg), B6 (28 mg/kg) 
and B12 (200 ug/kg) significantly reduced intestinal tumours in APC1638N offspring mice 
compared to offspring from control and deficient mothers. Additionally, maternal folic acid 
supplementation reduced by 64% azoxymethane induced adenocarcinoma in rats (Sie et al., 
2011). A possible explanation for this observation could be that the effects of maternal diet may 
not be sufficiently powerful to overcome the genetic predisposition of ApcMin/+ mice to develop 
intestinal neoplasia and thus diet may not be preventative against tumour initiation.  
Alternatively, the concentration of the carrot components of maternal diet used in these studies 
may not have been sufficient to influence tumour development in the foetus or suckling pups 
and higher consumptions may be required to observe any beneficial effect in the offspring. 
Indeed, blood level concentrations of curcumin were very low when fed to mothers (Ireson et 
al., 2001) and not much was available either from maternal blood or breast milk for 
chemopreventive efficacy in ApcMin/+ offspring (Perkins et al., 2003b). 
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6.3.4 Interactions of Gender with Other Factors 
Study two suggested males had more tumours in terminal SI (6.3 %), colon (21.2 %, P = 0.03) 
and total gut than females. Whilst females had 13.1% more tumours in the proximal SI than 
males, males had 3.5 % more tumours in the total SI than females. In study one, females had 
16.1 % and 6.7 % more tumours in the proximal SI and total gut tumour number respectively 
than males. In the two studies the females had more tumours in the proximal SI than males. 
Hormonal differences between the sexes may account for the observed disparity in tumour 
number between the sexes. A study by Amos-Landgraf et al. (2014), showed that females 
developed 5.6 % more tumours in the small intestine than males whilst males developed 20.9 % 
more tumours in the colon than females, a finding that was in agreement with this study. Amos-
Landgraf et al. (2014), investigated the effects of testosterone on tumourigenesis and suggested 
male hormone testosterone was more important in promoting tumour development than the 
inhibition from female hormone. Other studies attributed the observed differences between the 
sexes to the female hormone, oestrogen which has significant influence on permeability of the 
intestinal epithelium in women (Vulcan et al., 2015). Low levels of oestrogen in 
matured/menopausal females enhance permeability of the colon to much substance which may 
result in cancer (Vulcan et al., 2015).  This was consistent with suggestions of Weyant et al. 
(2001) that 17β-oestradiol, a potent ovarian and placental oestrogen protects female mice 
against intestinal tumourigenesis. Another study suggested that females had 27.2 % more 
tumours in SI than males with no significant difference in colonic tumour number between the 
sexes (McKay et al., 2008a). Also no difference in total tumour number was observed when 
ApcMin/+ males and females were treated with different concentrations of green tea polyphenols. 
Hao et al. (2007), reported a larger variation in the reduction of tumour volumes after treatment 
in females than males, with reported reductions varying between 24.4-71 % in females, and 14 
-39.9 % in males. The current, study two, observed that the effects of sex on tumour volume 
was also seen on increased tumour number, for example, 0.9 %, 23.7 %  and 14.4 % higher 
tumour volume in terminal SI, colon and total gut compared to females  and 6.3, 21.2 %, and 
0.4 % higher tumour numbers than females respectively.  
A post weaning diet * sex interaction  (P = 0.044) was observed for tumour number in the 
terminal SI whereby females fed carrot powder post weaning had reduced tumour number in 
terminal SI compared to their male counterparts. They also had 36 % (P= 0.027) less tumours 
in the terminal section compared to the control powder fed females. A similar interaction (P = 
0.006) was again observed when analysis was done after removal of stored carrot pellets. These 
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data suggests carrot powder may be better anticarcinogen in females than in males if 
administered post weaning. This brings into focus the suggestion by Vulcan et al. (2015) that 
development of tumours in females is influenced by the permeability of the intestinal epithelium 
which is controlled by female hormone, oestrogen. These mice were relatively young (15 weeks 
old) and the level of oestrogen may be high enough to regulate effectively the permeability of 
the intestinal epithelium to compounds that could enhance tumour development and growth. It 
may also be possible that components of carrot powder interacted with female hormone or some 
other compound to reduce permeability thus reducing the entry of potential carcinogen. Another 
interaction, post weaning diet and sex (P = 0.054) was observed for total gut tumour number in 
which females fed carrot powder post weaning had lesser tumours than males and lesser (P = 
0.039) than females fed control powder. This observation was probably driven by tumour 
number in the terminal SI  
There was maternal * post weaning diet interaction (P = 0.023) for colonic tumour number 
whereby offspring exposed to maternal control powder but fed carrot powder post weaning had 
fewer colonic tumour number (54.3 %) compared to offspring exposed to control powder 
dietary regime. 
This interaction suggests carrot powder may have the potential of reducing intestinal cancer 
risk if administered to females post weaning. 
 
Summary 
 Post weaning consumption of carrot pellet significantly increased the total gut tumour 
number and terminal SI tumour. 
 Post weaning consumption of carrot powder decreased total gut and terminal SI tumour 
number. 
 Post weaning consumption of stored carrot pellet reduced total gut and terminal SI 
tumour number. 
 Carrot consumption either raw or boiled reduced the growth of already formed tumours 
but has no effect on tumour initiation. 
 Maternal diet had no significant effect on tumour number and volume. 
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6.4 Effects of Maternal and post weaning Diet on the Expression Target gene 
The present study investigated the effects of maternal and post weaning diet on the expression 
of genes in the tumour and normal terminal SI of ApcMin/+ and wild type mice. Gene investigated 
were Retinoid X receptor alpha (RXRα), β, β-carotene-monooxygenase (BCMO1/BCO1), 
Retinoid acid receptor-beta (RARβ), Cyclin D1, Cyclooxygenase-2 (COX-2), and Matrix 
metalloproteinase/Matrilysin (MMP7) 
Neither maternal nor post weaning diet had any significant effect on the expression of target 
genes in the tumour and normal intestinal tissues of the Min mice. In Min mice MMP7 mRNA 
expression was lower in tumour tissue of females by 1.4% (P = 0.07) compared to males and is 
also generally lower in tumour tissue by 1.8 % (p = 0.055) than in normal tissue. In the wild 
type mice maternal consumption of carrot powder decreased expression of MMP7 by 2.4 % (P 
= 0.003) whilst post weaning carrot powder enhanced expression (P = 0.086). A similar trend 
was observed in the tumour and normal tissue of Min mice, though statistically insignificant. 
These results suggest that carrot had a modulating effect on MMP7 mRNA expression.  
There was a significant interaction effect (P = 0.028) between maternal diet and sex on one 
hand and post weaning diet and sex on the other hand on expression of MMP7 mRNA in Wild 
type mice. Whilst maternal carrot diet reduced expression of MMP7 mRNA in the male 
offspring (P = 0.01), post weaning carrot powder upregulated the expression in same suggesting 
antagonistic effects of the dietary regime in males in relation to MMP7mRNA. Both diets had 
no significant effect in female offspring. Relating these results to the observed effects in the 
Min suggest maternal diet has the potential of reducing intestinal tumour risk in male offspring. 
MMP7 is a downstream target of β-catenin and is involved in digestion of extracellular matrix 
and therefore promotes tumour cell invasion and metastasis (Curran and Murray, 2000). It is 
known to be involved in tumour initiation and growth (Brabletz et al., 1999) and over expressed 
in most colorectal cancers (Zeng et al., 2002; Pham et al., 2013)  Downregulating its expression 
will enhance  intestinal cancer risk reduction. It was therefore possible that the reduced tumour 
number associated with carrot powder consumption was as a result of reduced expression of 
MMP7 mRNA. 
The absence of significant modulating effect of carrot powder in Min mice on expression of 
some of the biomarkers in the current study could be due to low concentration of active 
components of carrot required for effect either as a result of poor digestion and absorption by 
mothers and /or offspring due to tumours in the intestine or the carrot component of diet was 
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low. Carotenoids are poorly absorbed in the intestine of mice and rats and to achieve a 
significant modulating effects in short term studies higher doses are required (Sharoni et al., 
2004).  van Breda et al. (2005b), investigated the effects of vegetable diet on the expression of 
cancer biomarkers in mice and observed significant effects only with diet containing 40 % 
vegetable.  Anticancer activities of carotenoids are mediated by retinoic acid acting to activate 
RARs and RXRs, two critical receptors whose expressions are regulated at the transcription level 
by retinoic acid (Ribot et al., 2004; Pham et al., 2013). The expression of these receptors (RXR 
and RAR) both in vivo and in vitro were shown to require a concentration of retinoic acid above 
normal physiological concentration in tissues of rodents (Ribot et al., 2004, Bonet et al, 1997). 
Considering the suggestion that retinoic acid modulates the activities of BCO1/BCMO1 and 
MMP7 (Leclerc et al., 2013), Cyclin D1 (Fu et al., 2004), RXRα and RARβ (Bonet et al., 1997; 
Ribot et al., 2004), it was possible that the apparent lack of significant differences in the 
expression of the study biomarkers was due to the concentration of retinoic acid which was too 
low to overcome the genetic predisposition of the mice to development tumours and/or too low 
for any chemopreventive action post  weaning. It could also be said that the reduction in tumour 
number observed was due mechanisms that did not involve some of the investigated biomarkers.  
Min females had increased expression of Cyclin D1 by 0.5 % (P = 0.035) in the tumour tissue 
compared to the males in the current study. Cyclin D1 is associated with regulation of cell 
proliferation by restricting cell cycle progression at the G1 phase. This regulation occur by 
modulating the expression of  retinoblastoma protein (pRb) (Fu et al., 2004) which in normal 
function binds to transcription factor, EF2 to prevent transcription of genes whose transcription 
products are required for cell cycle progression (Sherr, 2000). Activated Cyclin D1 causes the 
release EF2 in tumour cells which then initiates DNA replication (Donnellan and Chetty, 1998). 
At very high levels of expression cyclin D1 inhibits DNA replication, thus reducing cell 
proliferation (Fukami-Kobayashi and Mitsui, 1999). This may account for the reduced tumour 
number especially in the terminal SI of female mice fed carrot powder post weaning. Tumour 
number in the terminal section of females fed carrot powder post weaning was 22.2 % (P = 
0.027) lower than control powder fed and 8.1 % lower than in stored carrot pellet fed mice. 
Results of the current study showed that in the Wild type mice carrot powder consumption post 
weaning enhanced expression of Cyclin D1 mRNA in females by 0.5% (P= 0.076) but down 
regulated the expression in males by 0.8 % (P = 0.023) compared to the controls.  
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Summary 
MMP7 mRNA expression was lower in tumour of females than in males 
Maternal and post weaning carrot had antagonistic effects on expression of MMP7 mRNA in 
male mice. Maternal carrot decreased expression whilst post weaning carrot diet increased 
expression. 
The downregulation of MMP7 associated with maternal carrot consumption in male offspring 
suggest a putative sex-specific protection against intestinal tumourigenesis.  
Post weaning carrot powder consumption reduced tumour number in females by enhancing 
expression of Cyclin D1. 
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7 Chapter 7 Conclusion and future work 
 
7.1 Conclusion 
This study has demonstrated that consumption of freeze-dried blanched carrot powder post 
weaning reduced intestinal tumour number in ApcMin/+ mice, whilst consumption of the same 
carrot material shortly after it was incorporated into pellets and dried at high temperatures 
enhanced tumourigenesis. 
Maternal consumption of carrot powder diet prior to gestation and during gestation and lactation 
had no effect on intestinal tumourigenesis in ApcMin/+ offspring, and a trend for increased 
tumorigenesis after maternal consumption of high-temperature treated pellets was not 
significant. 
Consumption of carrot powder by females post weaning reduced the risk of tumourigenesis 
more than in males. 
The implication of these findings for human is that consumption of carrots cooked without 
removal of water (boiled, steamed, fried, roasted etc.) may reduce the risk or severity of cancer, 
and is likely to benefit patients with already diagnosed cancer as well as healthy adults. 
However it raises potential concerns about the safety of vegetable products produced by high-
temperature drying. 
 
7.2 Future work 
In this study furan was suspected to be responsible for the increased tumour number observed 
with feeding ApcMin/+ mice carrot pellets dried at a high temperature. This was noticed long 
after the effect when furan might have evaporated from the diet. It will therefore be necessary 
to repeat the experiment with similarly processed carrot diet and test for the presence of 
compounds formed during the drying process to confirm or otherwise the presence of furan or 
other possible carcinogens. 
Also, carrot diet seems to have no significant effect on the expression of target genes possibly 
because of the low dose of carrot in the diet. In the next experiment it might be important to 
increase the dose to either 30 % or 40 %. 
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Furthermore, if possible a study should be designed to investigate post weaning diet (carrot) 
and sex interaction which in the present study suggest a beneficial effect in females.  
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Appendices 
 
Appendix 1 Diet formulation and specification 
 
121 
 
 
 
 
122 
 
 
123 
 
 
 
124 
 
 
Appendix 2 Proximate composition 
 
Dry Matter |Method (DM, AOAC Official method934.01) 
Apparatus 
Aluminium foils and porcelain crucible 
Analytical weighing scale (Mettler AJ150, Toledo Ltd, Switzerland) 
A desiccator 
Sample mill (Tecator Cyclotec 1093, Sweden.) 
Oven drier 
 
Procedure 
Pelleted feed samples were finely ground to pass through 1mm mesh sieve in a mill (Tecator 
Cyclotec 1093, Sweden). About 0.5 g of each sample was weighed into a pre washed and oven 
dried and weighed porcelain crucible. Porcelain and sample was then dried in a hot air oven at 
105oC for 24 hours. Porcelain with dried samples were removed from oven, cooled in a 
desiccator and weighed. Dry matter content of sample was calculated as follows: 
Equation: 
C : Wt of crucible(g) 
CS0 : Wt of crucible with fresh sample (g) 
S0 : Wt of fresh sample (g), S0 = CS0 - C 
CS1 : Wt of crucible with dry sample (g) 
S1 : Wt of dried sample (g), S1 = CS1 – C 
     S1 
DM (gDM/kg fresh sample) = ------------------- x 100 
     S0 
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Ash Determination 
Apparatus 
Furnace (Carbolite, AAF11/18, England) 
Analytical weighing scale (Mettler AJ150, Toledo Ltd, Switzerland) 
Desiccator 
 
Procedure: 
Sample from DM analysis were ignited in a furnace and the temperature allowed rise slowly to 
550oC for 5 hours. Sample was removed cooled in a desiccator and weighed. Ash content of 
samples were expressed in percentages. 
Equation: 
C : Wt of crucible(g) 
CS0 : Wt of crucible with dried sample (g) 
S0 : Wt of dried sample (g), S  = CS-C 
CS1 : Wt of crucible with ash (g) 
S1 : Wt of ash (g), A = CA – C 
    A 
Ash (%) = ------------------- x 100 
   S 
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Ether Extract (EE, AOAC official Method 920.39) 
Apparatus: 
A set of soxhlet extractor (thimble, flask, soxhlet extractor, condenser, heating mantle) 
Analytical weighing scale 
Condenser 
Reagents 
 Petroleum ether 40 – 60oC (solvent) 
 
Procedure: 
Adequate petroleum ether was measured into pre-oven dried round bottom flask.  About 1.5 g 
of dried finely milled sample was weighed into a thimble and plugged with cotton wool at the 
top. Thimble with sample was then placed in an extractor and fitted to the flask.  Extractor and 
flask were set on a heating mantle and connected to a condenser. The flask was heated until the 
solvent boiled gently to start extraction. This was continued for 6 hours. The flask was removed 
and residual solvent containing oil was oven dried at 60oC overnight. The flask with oil was 
cooled in a desiccator and weighed. 
Equation: 
T : Wt of thimble (g) 
F : Wt of flask (g) 
TS : Weight of thimble with dry sample (g) 
S : Wight of dried sample (g), S = TS – T 
FE : Weight of flask with ether extract 
E : Wt of ether extract (g), E = FE –F 
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   E 
EE (g/kg DM) = ………………………… x 100 
   S 
  
Crude Protein (CP),  
Apparatus 
Elementar Vario Macro Cube (Germany). This machine determines Nitrogen, carbon and 
sulphur in three-in-one process for a similar sample. 
Analytical scale 
Thin foil cup 
 
Procedure: 
About 0.1 g of dried ground sample was weighed into a pre-tarred tin foil cup. This was 
carefully folded and squashed into pellet to expel air using a tool provided by Elementar. 
Carbon and nitrogen determination was done in a CN mode using combustion, post combustion 
and reduction tube in the furnace of the analyser. The sample was dropped into at combustion 
tube at 930oC via a carousel and ball valve. Oxygen was used to burn the sample and this was 
carried off in helium the combustion and reduction tubes, which were also heated, to detectors 
within the analyser. For sulphur analysis, the combustion and reduction tubes were at 1150oc 
and 850oC respectively. Before each run a set of standards were run to ensure that the analyser 
was working correctly. Standards were also run half way through as ample run as well. To 
check that the analyzer has performed correctly, a daily factor figure is worked out after each 
run and this should fall between 0.9 and 1.1. Runs that did not meet these criteria were 
discarded. Each element was analysed separately and a percentage figure was then obtained. 
Cp content was calculated by multiplying N content with 6.25. 
Equation:  
Fc : Wt of foil cup (g) 
FcS : Wt of foil cup with sample (g) 
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S : Wt of sample 
Np : Content in percent (%) 
N : N in gram (g), N = Np/100 X100 
CP (g/kg DM) = 6.25 X N 
 
Acid detergent fibre (ADF) (van Soest, 1990),  
Apparatus: 
100 ml tubes fit to the rack on digestion chamber 
A setoff digestion chamber (Gerhardt Kjeldaterm, Germany) 
Sintered glass crucibles (porosity no. 1).  These were pre washed, ashed at 550oC for 3 hours, 
cooled in desiccator, weighed and placed back into the desiccator until required 
 A set of Buchner flask and vacuum pump 
Glass rod stirrer 
Reagents: 
Acid detergent solution (AD); Add 20 g cetyl trimethylammonium bromide (CTAB, Technical 
grade) to 1 L 0.5 M H2SO4 (added 27.7 ml H2SO4 (95 – 98%) to 972.3 ml H2O) 
Acetone 
Procedure: 
About 0.5 g of dried ground samples were weighed into digestion tubes and 50 ml AD added. 
The tubes were placed into a set of digestion chamber and the temperature set at 120oC.  The 
temperature was reduced if foaming became rapid to avoid spill over. This was allowed to boil 
for 1 hour. The tubes were then removed, swirled and the content of each filtered in a pre- 
weighed sintered glass crucible using light vacuum suction. The fibre residue in the crucible 
was washed by filling two thirds of crucible with hot water (90 – 100oC). This was stirred, 
allowed to soak for a few minutes and drained using vacuum suction. The sides of the crucible 
were washed twice with hot water. The residue was again washed with acetone. The stirring 
129 
 
rod was also washed into the crucible and acetone drained off using suction pump. The crucible 
and fibre residue were oven dried at 100oC overnight, cooled in the desiccator and weighed.  
Calculation of fibre content: 
Equation: 
F : Wt of tube (g) 
FS : Wt of tube with dried sample (g) 
S : Wt of dried sample (g) 
C : Wt of sintered glass crucible (g) 
CR : Wt of sintered glass crucible with dried fibre residue (g) 
R : Wt of dried fibre residue (g); R = CR – C 
  R - A 
ADF (%) = ……………………….. X 100 
   S 
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Appendix 3  Standard curves for Real Time PCR optimisation 
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Appendix 4  Sample size determination plot 
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